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Abstract
The precise architecture o f  the vascular system is critical to its many specialised 
functions. In sharp contrast tumour vascular architecture is highly disorganised and 
dysfunctional. The reason for this is the grossly abnormal angiogenic signalling 
prevalent in the tumour microenvironment. Aberrant tumour vasculature is a key 
determinant o f spatial and temporal heterogeneities o f blood flows. Additionally, 
irregularities in the tumour vascular wall, a lack o f functional lymphatics and a severely 
retarded trans-mural hydrostatic pressure gradient also diminish convective transport 
out o f  the vessels. Diffusion therefore remains the dominant transport mode in tumours 
and presents a considerable barrier to macromolecular therapy (e.g. Antibody-directed 
enzyme prodrug therapy (ADEPT)).
A number o f recent studies o f vascular morphology in both clinical and xenograft 
tumours have demonstrated the existence o f type-specific architectures. Precisely how 
these type-specific architectures translate to blood flow through the vascular system had 
not been determined. To address this we have developed a method for studying the 3D 
architecture o f the tumour and simulating flows through it. This technique uses 
corrosion casts to capture the 3D tum our vascular system. 3D morphometry was 
determined by stereoimaging and X-ray micro-computed tomography. A computational 
fluid dynamics model was then used to study the hydrodynamics o f the vascular 
networks.
My results show that vessel structure and architecture varies in clinical colon cancers, 
but these differences were substantially smaller than those o f two human colorectal 
xenografts (LS147T and SW1222) commonly used in pre-clinical studies. The results 
also provide evidence that LS147T is, in general, a closer model to most clinical 
colorectal tumours than SW1222.
To our knowledge this is the first attempt to utilise X-ray micro-computed tomography 
to study vascular corrosion casts o f tumours, and using this data, produce 3D flow 
profiles.
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1.1 Introduction, problem definition and objectives
Animal model systems o f tumours have been used extensively in the study o f tumour 
biology [Kubota, 1994] and drug development research [Pedley et al., 2001;Sharma et 
al., 2005]. However there are significant limitations to the experimental studies which 
can be carried out on human tumours in-situ, so animal model systems are been used to 
bridge this gap. These animal models broadly fall into two categories: xenografts and 
induced tumours. There are however shortcomings with both systems. In xenografts, 
human tissue is being grown in animal tissue (either orthotopically or ectopically) 
whereas with induced tumours an animal tumour resides within animal tissue. Neither 
system adequately replicates the behaviour o f clinical tumours and so it is often the case 
that therapies will display entirely different responses in the model system [Rofstad, 
1994;Goldbrunner et al., 2004;Retsky et al., 1994;Tan et al., 2005].
M odem  computing advances have now raised the possibility o f modelling many aspects 
the human-tumour in-silico [Alarcon et al., 2004]. The concept proposed here is similar 
in kind to projects such as the Cardiome heart model [Bassingthwaighte et al., 
1998;Smith et al., 2000], BEACON liver projects [UCL BEACON project, 2007] and 
M icrocirculation Physiome [Popel et al., 1999;Popel et al., 1998].
A tum our is a vastly complicated biological system. Time and length scale ranges 
involved in biological systems have until recently been inhibitive to integrative in-silico 
biology. It is however possible to approach this by considering important constituents of 
the system, as small collectives, which satisfy the objectives o f the model. With this in 
mind, the project focus was centred on modelling the tumour vascular architecture and 
blood flow through this structure. The vascular system plays a crucial part in the 
delivery o f intravenous therapy, nutrients and tissue oxygen. In a tumour, tissue 
oxygenation affects metabolic rates, cell division and radiotherapy (including some 
chemotherapy) efficacy [Vaupel et al., 1989]. The central role played by the vascular 
system in tumour physiology makes it a high priority for any tum our model. 
Consequently a morphologically accurate model o f the tum our vascular system would 
provide an excellent framework to incorporate other components such as cells, 
extracellular matrix and therapeutic agents at a later date with the possibility for its use 
in simulations o f the tumour: growth, microenvironment and therapeutic delivery.
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The principal objectives o f this thesis are:
I. To provide a characterisation o f the vasculature in human colorectal cancer
(adenoma/carcinoma) and experimental colorectal tumours grown as xenografts in 
nude mice.
II. Provide a novel system for defining three-dimensional geometries for use in blood 
flow models.
III. To provide new paradigms and methodologies to tackle microvascular blood flow 
models.
IV. Provide a characterisation o f blood flow in the different vascular systems o f the 
model tumours.
V. Demonstrate possibility for modelling flow in whole tum our vascular systems 
represented by a whole xenograft tumour.
[Chapters 1&2] provide a review o f the biological background o f cancer, tumour 
angiogenesis (vessel formation) and the biological models currently in use. A review o f 
computational models o f (i) vascular network formation and (ii) blood flow was carried 
out in [Chapter 3]. Aims 1 & 2 are addressed in [Chapter 4]. Aims 3, 4 & 5 are 
addressed in [Chapter 5]. Considerations o f future work and extensions to the project 
are discussed in [Chapter 6].
1.2.1 Cancer
In the industrialised world cancer is currently only surpassed by cardiovascular disease 
as the leading cause o f disease related fatalities. It is estimated by the W orld Health 
Organisation (WHO) that approximately six million people die each year from various 
forms o f cancer. Further to this, as cancer is predominantly an age linked disease, this 
figure is expected to increase as the average population life expectancy rises.
The process o f oncogenic transformation can broadly be depicted as the loss o f control 
over cell division in conjunction with cellular immortalisation. Although these 
processes are highly regulated with many layers o f control, these are often breached
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sequentially over the transformation process in some cases taking several years from the 
first transformation event. Generally cells are most vulnerable to mutation during the 
process o f division where changes are readily incorporated into the newly synthesised 
DNA. For this reason, tissues which continuously undergo cell division are more 
commonly associated with cancer than others (immune cells, gut lining, skin cells). 
These Mutations are generally the result o f oncogenic agents which can be classed into 
physical, chemical and biological groups, each with their own particular mode o f 
producing changes at the DNA level. Physical agents (e.g. X-rays or UV-light) and 
chemical agents (e.g Ethyl-nitroso-urea) produce chemical changes to DNA bases. 
Whereas biological agents such as viruses (e.g. Human Papillomaviruses) and bacterial 
(e.g. Agrobacterium Tumefaciens) act by inserting genes into the cell/genome, these 
insertions may directly disrupt endogenous genes or induce new oncogenic behaviour 
through newly introduced genes. Mutations can arise spontaneously at the level o f 
individual nucleotides or during the normal ‘cross-over’ mechanism through which 
chromosomes exchange genetic material. The resulting effects o f oncogenic 
transformations are modifications o f oncogene and/or tumour suppressor gene 
expression through which the tumour phenotype is realised.
While the causes o f cancer originate at the microscopic (intracellular) scale, the 
mesoscopic (cellular) and macroscopic (tissue) scales are also vitally important in the 
development o f the tumour. The cellular scale orchestrates processes such as migration 
o f metastatic cells, angiogenesis and hypoxia. Tissue level events include blood flow 
and the tumour invasion front.
Angiogenesis is requirement for a tumour to develop beyond the 1-2 mm diameter 
[Folkman et al., 1989]. Through this process the tum our actually sequesters the body’s 
own blood supply to nourish its demand for metabolites. The endogenous system for 
stimulating angiogenesis is hijacked by the tumour to its own ends. This process is not 
properly regulated when induced by cancer, resulting in highly aberrant vascular 
architecture.
Due to the pleiotropic nature o f cancer, treatments for it are considerably wide ranging. 
Traditional chemotherapeutics have tended to favour small molecular weight agents, but 
in the post-genomic era this is now changing. The majority o f new therapeutics in
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development are principally macromolecular i.e. protein, nano-particle (liposomes and 
viruses) and cellular. One o f  the common obstacles to the efficacy o f these 
macromolecular therapies is their poor delivery profiles. These delivery profiles are 
characterised by heterogeneous distribution and reduced transvascular and interstitial 
transport within the tumour.
1.2.2 Colo-rectal cancers
Colorectal cancers are the second and third most common cause of cancer related death 
in the United States and UK respectively. As can be seen in [Figure 1.1] an encouraging 
reduction in mortality rates o f 26% in men and 42% in women has been achieved over 
the last 35 years [Office For National Statistics, 2006]. As with many cancers, 
colorectal cancer is primarily age linked, with presentation most frequent in patients 
older than 50 years, incidence peaking within the range o f  60-70 years of age.
F igure 1.1. Colorectal cancer mortality rates
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F ig u re  1.1. R ates o f  co lon  cancer m ortality  over the last SOyears, by  sex. D ata  have been  age 
standard ised  using the E uropean standard  popu la tion  [O ffice F or N ational S tatistics, 2006].
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Adenomas are found in 5-10% o f asymptomatic patients older than 40 years old. The 
presence o f adenoma polyp(s) within the bowl indicates the transformation o f  the 
colonic mucosa into a premalignant state.
The progression o f adenoma to carcinoma has been well substantiated [Muto et al., 
1975]. Evidence to support this includes: 1) a similar mapping o f  adenomas and 
carcinomas in the colon, 2) comparative prevalence o f adenomas and carcinomas in the 
populations having varied colonic cancer risk levels, 3) increased risk o f carcinoma in 
patients with adenomas and the subsequent decrease o f carcinoma risk in patients where 
adenomas have been removed and 4) the similarity o f DNA constitution o f  adenomas 
and carcinomas. Although approximately 5% o f adenomas will progress to form a 
carcinoma, the presence o f adenomatous growths is not a prerequisite for carcinoma 
formation. On occasion a carcinoma may arise from premalignant areas o f  dysplasia 
within the flat mucosa.
The propensity o f the adenoma to progress into adenocarcinoma has been noted to 
depend primarily on size and histological classification [Buetow et al., 1995;Muto et al., 
1975]. Adenomas with diameters o f less than 1 cm have approximately a 1% prevalence 
o f carcinoma, for 1-2 cm this increases to 10% and for an adenoma greater than 2 cm 
the prevalence o f  carcinoma is 30-50%.
Adenoma are histologically classified as: tubular, villous or a mixture o f both 
(tubulovillous) [Potter, 1992;Eisenberg et al., 1982]. Tubular adenomas (typically 1 cm 
in diameter) demonstrate glandular formations incorporating clusters o f colonic 
epithelium within the layer o f connective tissue below the mucosa {lamina propria). 
These are sometimes pedunculated with the main mass o f the tumour extended on a 
narrow stalk. Villous adenomas (defined by >80% villous architecture) are often 
associated with larger, aggressive adenocarcinomas. These tumours exhibit thin branch­
like projections from their surface with colonic epithelium surrounding these 
projections, giving them a furry or cauliflower-like surface.
Characteristics o f the adenocarcinoma often depend on location within the colon. 
Adenocarcionmas on the right side (ascending colon) are usually polypoid tumours, and 
may be associated with chronic bleading and intussusception. On the left side
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(descending colon), annular constricting lesion are more commonly observed; these 
tumours spread through the circumferential lymphatics o f the muscularis propria (a 
concentric layers o f muscle below the mucosa) resulting in reduction o f the bowel 
lumen.
A number o f genetic anomalies are known to be associated with around 6% o f 
colorectal carcinoma. These include familial adenomatous polyposis coli syndrome, 
hereditary nonpolyposis colon cancer syndrome and certain hamartomatous polyposis 
syndromes. Patients with familial polyposis o f the colon (FPC), traced to an 
abnormality in chromosome 5q, develop numerous adenoma polyps at a mean age o f  40 
years (20 years before presentation o f  non-FPC related colorectal cancers in the general 
population). Due to increased time available for progression and the large number o f 
polyps, patients with FPC have a greatly increased risk o f developing 
adenocarcinoma[Nishisho et al., 1991;Buetow et al., 1995].
The colon carcinomas are staged according to their growth characteristics. Older staging 
schemes such as the original Dukes and Astler-Coller classification methods have to 
some extent been replaced by the Tumour-Node-M etastasis (TNM ) classification [Sobin 
and W ittekind, 2002]. The TNM scheme provides classification based on the extent o f 
tum our invasion, lymph node invasion and metastasis. From the gut lumen-wall going 
outward, the layers o f the bowel are mucosa (comprised o f epithelium, basement 
membrane, lamina propria, muscularis mucosae), submucosa, muscularis propria, 
subserosa [Figure 1.2].
In contrast to other gastrointestinal cancers there is no significant difference between 
colon carcinoma in-situ (confined to the epithelium) and intramucosal colon carcinoma 
(inclusive o f tumours extending into the lamina propria) due to the colonic lamina 
propriaN lack of lymphatics. Adenocarcinomas are consequently only considered 
invasive once they have entered the submucosa, where they have access to the local 
lymphatic system. At this point the risk o f  metastasis rises with increasing penetration 
o f the disease. Métastasés from colon carcinoma are most regularly seen in the liver 
with 75% o f cases localised to this organ. The high incidence o f liver metastatic disease 
from colon carcinoma is primarily due to drainage o f the portal vein from the colon. 
Rectal carcinoma may additionally drain into the systemic venous system and therefore
16
may manifest disease in other areas of the body bypassing the liver; it is otherwise 
uncommon to observe more distant metastasis without associated disease in the liver.
F igure 1.2 A cross-section o f the colon
Epittielial cetfs
Basement memùrane 
Lamau propna (connective tissue) 
Uvscvtar^ mucosae
—  Suomucosa
— Uuscie layers
Subserosa (conneaive tissue) 
Serosa
-Mucosa
F igure 1.2. A  cross-section  o f  the co lon  show ing the d ifferen t layers o f  tissue  [Patien tcen ters, 2007].
In addition to the metastatic importance o f the vascular system in colorectal cancers, 
there is evidence o f  distinctive vascular structure in adenomas and adenocarcionmas of 
the colon [Konerding et al., 2001]. Pavalopolos et al. studied several parameters in 
relation to the vascular morphology, this study highlights an inverse correlation between 
microvascular density and Dukes stage classification o f  the colorectal tumours studied. 
Vessel shape parameters, and branching frequencies in this study were also found to be 
significantly different in both adenomas and carcinomas [Pavlopoulos et al., 1998].
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1.3 The micro-vascular system
The properties o f blood flow through the vascular system are highly dependent on the 
geometry o f the network [Popel and Johnson, 2005]. A microvascular network consists 
o f a number o f vessels supplied by one or more feeding arterioles and drained by one or 
more collecting venules. These networks are usually three dimensional in structure 
(exceptions such as the mesentery and retina are approximately two-dimensional). The 
characteristic structure o f the microvascular network is specialised to the function o f  the 
tissue o f origin; examples o f  vasculature from skeletal muscle, liver and gut are shown 
in [Figure 1.3]. In the liver where the vasculature is involved in filtration, sinusoids 
form hexagonal networks that drain into a central vein [Figure 1.3 (A)]. In the 
microvasculature networks o f  skeletal muscle, capillaries form numerous parallel 
channels enabling efficient transport o f metabolites to and from the fibrils o f  muscle 
cells [Figure 1.3 (B)]. In the colon where absorption o f water is carried out, the sub­
mucosa capillary network form a large surface area with a hexagonal/rhomboidal 
geometry [Figure 1.3 (C&D)].
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Figure 1.3. Vascular architecture in different organs
Figure 1.3. E xam ples o f  d ifferent vascu lar m orphology  as dem onstrated  by corrosion casting  in (A) 
L iver islet vessels, (B ) S keletal M uscle, (C) Low  resolu tion  C olon  and  (D) h igh reso lu tion  co lon . (A -C ) 
bar = 200pm  and (D ) bar =  50pm . Im ages w ere donated  by P ro fesso r M oritz K onerding.
Blood pumped from the heart extends through the aorta down a series o f roughly 
cylindrical vessel elements. The portion o f vasculature proximal to the capillary bed is 
termed the arterial side (decreasing vessel diameter, and length) and the vasculature 
distal to the capillary bed is termed the venular side (increasing vessel diameter and 
length). The thickness o f vessel wall throughout the vascular system varies with vessel 
calibre. This vessel wall from the inside-out consists o f a hydrated glycoprotein layer, 
endothelial cells, basement membrane, smooth muscle and concentric layers o f 
connective tissue. The function o f the wall in the arterial side is to store hydrostatic 
pressure and regulate blood flow; here it is thick and elastic. By comparison in the 
capillary system, the wall is thin and fenestrated to facilitate bi-directional transport.
19
The arteriolar vessels are characterised by elongated endothelial cells (which are aligned 
axially with the shear forces in the vessels). In many organs the arterioles are structured 
with an arcade arrangement in vessels >25[am diameter and a sequential, tree-like 
branching morphology in smaller arterioles. Flow in the arterioles is dependent on the 
status o f the cardiac cycle. In the larger arterial vessels, flow is markedly pulsatile. This 
oscillating velocity is increasingly stabilised as blood extends distally through the 
arterial system. The decreasing diameter o f vessels through the arterial side o f  the 
network results in increasing intra-vascular pressure. This is highest in the arterioles 
where the ratio o f the vessel diameter to wall thickness is largest (arteriolar walls are 
both elastic and contractile). Much o f the control o f  blood flow through the vascular 
system is performed by altering the arteriolar vessel diameter (through smooth muscle 
layer contraction/relaxation). The effect o f this can be quite dramatic, according to 
Poiseuille’s law [Section 3.3.2] a 2 fold uniform drop in the vessel radius leads to a 16 
times drop in net flow.
The capillary vessels are composed o f endothelial cells which are in turn covered by a 
patchwork o f pericyte cells and finally the whole structure is embedded within the basal 
lamina (a dense form o f specialised extracellular matrix). Though capillaries lack a 
smooth muscle layer, they may retain some contractile function through the pericyte 
cells [Yamagishi and Imaizumi, 2005]. The capillary network constitutes to the bulk of 
the vascular system. These vessels are all fairly narrow with a diameter generally less 
than 10pm [Bloor, 1968]. In the peripheral circulation the capillary surface area 
constitutes around 70m^ in an average human. This large surface area is integral to 
effective transmural transport (both convective & diffusive). Interstitial fluid transfer 
occurs through specialised channels such as aquaporins and inter-endothelial clefts 
(fenestrations) or pores. Pore size may be affected by angiogenic factors such as 
Vascular Endothelial Growth Factor which induces motility in endothelial cells 
[McDonald and Baluk, 2002].
On the luminal side o f  the capillary is a 1pm glycocalyx consisting o f glycoproteins, 
glycosaminoglycans and proteo-glycans [Pries et al., 2000] [Desjardins and Duling, 
1990]. This hydrated polysaccharide layer performs an important role in lubrication o f 
red blood cell passage and modulating the hydrodynamic resistance. A six fold flow
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resistance is attributed to the presence o f  the glycocalyx in the capillaries, due to the 
effective reduction in vessel calibre [Secomb et al., 2002].
The post-capillary venules, around 6-8pm in diameter, collect blood directly from the 
capillaries and transport it to the veins. These vessels, like capillaries, also lack a 
smooth muscle layer where diameter is <50pm. The venous and arteriolar networks are 
similar in branching architecture except the venous vessels are more numerous, with 
individual vessel elements shorter and wider. The endothelial cells lining the venules 
like the arterioles have a characteristic shape and can be identified by their rounder 
form.
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2.1 Tumour angiogenesis
Unlike normal vasculature, tumour vessels are both structurally and functionally 
abnormal, resulting in spatial and temporal heterogeneity o f blood flow through the 
tumour vascular network. The resulting microenvironment is characterised by 
interstitial hypertension, hypoxia and acidosis[Jain, 1999;Munn, 2003]. While 
adaptations in cancer cell metabolic behaviour (e.g. W arburg Effect) enables their 
survival in this environment, the delivery and efficacy o f nutrient and therapeutic 
delivery are greatly reduced and greatly heterogeneous in distribution.
In order for an in-vivo tum our to grow beyond 1mm in diameter, the so-called avascular 
stage, it must recruit the host vascular system to supply nutriment and oxygen to its 
cells by stimulating angiogenesis. Angiogenesis is a complex, multi-step process 
involving endothelial cell activation, proliferation, migration, degradation o f the 
extracellular matrix, and normally only occurs during wound healing, embryogenesis, 
and regeneration o f the uterus lining. While the molecular components o f angiogenesis 
are mostly known, the precise manner with which they orchestrate the growth and 
development o f angiogenesis is still poorly understood.
There are a great number o f angiogenesis mediators [Table 2.1] which arise from a 
range o f sources: cancer cells, extracellular matrix, stromal cells, blood, and endothelial 
cells. The most studied o f  these factors is the Vascular Endothelial Growth Factor 
(VEGF) family [Cheung et al., 1998;Grunstein et al., 1999;Holash et al., 1999]. This 
group o f chemokines is mainly under the regulation o f the Hypoxia Response Element 
(HRE) and its transcription factor Hypoxia Inducible Factor-1 (HIF) [Bando et al., 
2003]. Hypoxia or low /7O 2 is not the only trigger o f angiogenic factors; others include 
low pH, and hypoglycaemia.
23
T ab le  2.1 A n g iogen esis factors
Activators Function
V E G F fam ily  m em bers S tim u la te  ang iogenesis, vessel perm eab ility
V E G F R 1 ,N R P -1 In teg ra te  ang iogen ic  and  su rv ival signals
A n g i and  Tie2 S tab ilize  vesse ls. R educe perm eab ility
P D G F -B B  and  recep to rs R ecru it sm oo th  m uscle  cells
T G F-P , endog lin , TGF-(3 recep tors S tim ula te  ex trace llu la r m atrix  p rod u c tio n
FG F, H G F, M C P -l S tim u la te  ang iogenesis and  arteriogenesis
In tegrins R ecep to rs for m acrom olecu les
V E cadherin ; PE C  A M  (C D 31) E n d o the lia l ju n c tio n  m olecu les
E phrins R egu la te  a rte ria l/venous specifica tion
P lasm inogen  ac tiva to rs. M M Ps R em odel m atrix , re lease  and ac tiva te  g row th  factors
PAI-1 S tab ilise  n ascen t vessels
N 0 S ;C 0 X -2 S tim ula te  ang iogenesis and vasod ila tion
AC 133 R egu la te  ang iob last d ifferen tia tion
C hem okines P le io trop ic  ro le in ang iogenesis
Id l / ld 3 D eterm ine  endo thelia l p lastic ity
T ab le  2.1 . A dapted  from  [C arm eliet and Jain , 2000]
In the current schematic VEGF from hypoxic tumour cells diffuses into the surrounding 
tissue and initiates growth o f vascular sprouts from existing vessels. These sprouts 
migrate towards and penetrate the tumour forming its vascular system. This new 
vascular system does not develop in the same manner as in the surrounding tissue, 
[Konerding et al., 1999;Konerding et al., 1995]. Grunstein et al. demonstrate a 
schematic for the action o f the VEGF isoforms in recruitment and expansion o f  tumour 
vasculature [Figure 2.1]. It is likely that the isoforms function in concert to initially 
recruit peripheral vessels then expand tumour vascularisation. The ability to induce 
vascular expansion appears related to the heparin binding capacity o f the VEGF isoform 
which determines how strongly it is associated with the extracellular matrix (ECM). 
Recruitment o f host vessels requires diffusible isoform with fewer heparin binding 
domains; the converse is true for the vascularisation process. Yu et a i  demonstrate this 
behaviour in a study on the ability o f VEGF isoforms to recover angiogenic potential o f 
a VEGF-negative melanoma cell line. V EG F,21, VEGF 155 and V EG F ,89 have none, one.
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or two, heparin binding domains respectively, due to their differential splicing. The 
number o f heparin binding domains strongly affects diffusibility o f the cytokine within 
the interstitium.VEGFi89 has such a high affinity for the ECM that it remains bound to 
the periphery o f its producing cell. The resulting vascular phenotypes o f the rescued 
melanomas exhibit dramatically different vascular architectures [Yu et al., 2002].
Other factors also appear to affect the structure o f the vascular system. Konerding et al. 
studied the effects o f a different angiogenesis factor, FGF-2 on the vascular architecture 
o f H EC -l-B  cells. FGF-2 expressing cells were found to produced more tortuous 
vasculature with wider vessel diameters compared to controls [Konerding et al., 1998]. 
Giavazzi et a l  also investigated the effects o f FGF-2 and found a synergistic effect 
between VEGF and FGF-2 on tumour vascularisation [Giavazzi et al., 2003]. In another 
study, deficiency in matrix metalloprotease (MMP-9) was shown by Chantrain et al. to 
result in a dramatic reduction o f microvascular density and size in neuroblastoma 
tumours [Chantrain et al., 2004].
The angiogenic sprouts tip cells are currently a highly active research area. These 
filopodia in turn guide the motion o f the whole sprout and hence structure o f the nascent 
vessel. Factors which affect the guiding o f these sprouts tip cells may shed some light 
on where the deregulation is occurring in tumour angiogenesis and how these processes 
result in tumour specific vascular architectures. Recently, the filopodia o f sprout tip 
cells have been shown to be affected by factors such as neutropillin-1 and VEGF 
[Gerhardt et al., 2004]. Disruption or removal o f VEGF gradients are also shown to 
prevent the correct navigation o f the filopodia [Gerhardt et al., 2003].
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Figure 2.1. Action o f VEGF isoforms in tumour angiogenesis
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F igure 2 .1 . A proposed m odel o f  tum our V EG F signalling  gradient. W T is the norm al tum our type 
exp ressing  all V EG F isoform s, V E G F -  is a V E G F knockout tum our line expressing  no  V EG F and hence 
is la rgely  avascular. V EG F120 produces a d iffuse  signal (light b lue) w hich recruits peripheral vessels but 
does little to vascularise the tum or itself. V EG F 164 can  bo th  recruit vessels w ith  a partially  d iffusib le  
signal and  vascularise the tum or w ith a partia lly  cell-associa ted  signal. V E G F 188 fails to  adequately  
recru it the host vasculature, but vascu lar endo thelium  w hich is captured form s a hypervascu lar capillary  
netw ork  due to the high local concen tra tion  o f  V EG F. A dapted  from  [G runstein  et al., 2000]
Tumour vasculature is characterised as being ‘chaotic’, this description more 
specifically arises from the vessels tortuous paths, loss o f hierarchy, biind-endings and 
heterogeneous vessel calibres and densities. Additionally most tumours are 
characterised by leaky vasculature, with enlarged pores, reduced basement membrane, 
smooth muscle and pericyte coverage [Munn, 2003]. In a number o f recent studies that 
differentially mark tumour cells and vascular endothelium, the vascular architecture is 
often observed to be composed o f a mosaic o f both cell types. These studies suggest 
incorporation o f tumour cells into the endothelium is a likely precursor step to 
métastasés [Ruoslahti, 2002;Carmeliet and Jain, 2000]. In some cases there is also 
evidence for vascular mimicry [Figure 2.2] [McDonald et al., 2000;Maniotis et al..
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1999], a phenomenon where tumour cells form vessel-like channels, lined with 
extracellular matrix rather than endothelial cells.
The lymphatic system in tumours, where it exists, is structurally abnormal, having large 
vessels surrounding the tumour and poor penetration into the tissue [Figure 2.2]. The 
lack o f a properly functioning lymphatic system in most tumours causes a build-up o f 
interstitial fluid and results in the loss or severe retardation o f  the transmural pressure 
gradient. The result o f this is severely impaired hydraulic or convective transport, and 
also has a knock on effect o f impaired diffusive transport (within the intersititum), as 
the convective transportation o f plasma solutes drives the concentration gradients which 
diffusion based transport is reliant on. The implication o f this for transport o f both low 
molecular weight (reliant on both diffusion and convection) and high molecular weight 
(reliant primarily on convection) therapeutics is vast.
Other major causes o f heterogeneous and oscillatory blood flow are vessel closure due 
to oncotic pressure on the vascular wall, caused by lack o f contact inhibition, high 
interstitial fluid pressure (IFF) [Mollica et al., 2003], and microthrombi [Munn, 2003].
It is the abnormal structural architecture o f the tumour vasculature that is primarily 
responsible for reduced delivery o f metabolites in the tumour; coupled with the 
increased burden o f highly metabolically active cells, these factors result in a spatial 
patterning o f normoxia, hypoxia and necrosis in the tumour mass [Figure 4.3].
The prominent role o f abnormal vasculature as a general component o f solid tumours 
has established it as a prime target for therapy [Longo et al., 2002], with anti-vascular 
agents (e.g. Combretastatin-A4-P) and anti-angiogenic agents (e.g. Bevacizumab 
(Avastin®)) recently receiving licenses for treatment o f  colon cancers.
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Figure 2.2. Vascular anomalies in tumours
F igure 2.2. T ypical vascu lar o rgan isa tion  in a  tum our (p ink); b lood  vessels arteries (red), veins (b lue) 
and lym phatic vessels (yellow ). W here lym phatic vessels ex is t they  are largely  restricted  to the 
periphery  o f  the tum our. T he inset show s how  ‘vascu lar m im icry ’ occurs, here  channels (w hite) lined 
w ith tum our cells m ay act as p seudo -vascu lar pathw ays for the b lood. A dapted from  [R uoslahti, 2002].
2.2.1 Techniques for studying tumour vascular architecture
The biology of tumour vascular architecture has principally elicited studies in-vivo^ ex- 
vivo and in-vitro. It is difficult to study primary (clinical) micro-vascular architecture 
within human samples which represent the gold standard. Consequently studies on 
primary tumour vascular architecture still remain the exception and are largely limited 
to the ex-viva case [Konerding et al., 2001]. To address problems associated with 
studying primary tumours, alternative models include: induced tumours and 
subcutaneous/orthotopic xenografts which provide a more readily available system for 
biological studies.
Animal models have for a long time provided a system with which to investigate 
tumour biology in-vivo, however, there are some inherent problems pertaining to the 
controllability o f these models. With induced tumours (e.g. dimethylhydrazine 
dihydrochloride induced rat colon carcinoma)[Skinner et al., 1990] the tumour tissue is 
syngeneic to the animal host and may not necessarily correspond to the in-situ case in 
humans. In the case o f xenografts [Steinberg et al., 1989] the problem lies with the
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incompatibility o f  human tumours growing in animal tissue. In spite o f their drawbacks 
xenograft models remain the most convenient system for studying approximate tumour 
behaviour. Further improvements are achieved by using orthotopic xenograft models, 
which in many cases are less artifactual [Kubota, 1994;Yao et al., 2003] although 
location o f the organ o f interest may render practical limits on the use o f these models. 
In this respect subcutaneously implanted xenografts are convenient as they can be 
immobilised viewing with dorsal skin-fold, ear or cranial window chambers [Leunig et 
al., 1992;Jain, 2001a].
To study the cellular components o f the vasculature, in-vitro methods, such as the 
Boyden Chamber, utilise an endothelial cell source and a growth medium to construct 
rudimentary vascular networks [Woo et al., 2007]. Similarly Ex-vivo methods such as 
the Aortic/Vena cava Ring Assay use whole vascular tissue explants [Ruggeri et al., 
2002;Nicosia et al., 2005;Ruggeri et al., 2002]. The advantage o f these systems is their 
relative simplicity, enabling the constituents o f the system to be controllable adjusted 
(e.g. assessment o f drugs). Although the vasculature produced in in-vitro/ex-vivo 
systems is morphologically incomplete, simple principles o f angiogenesis have been 
demonstrated by Serini et al. [Serini et al., 2003] where a mono-layer o f endothelial 
cells in matrigel is shown to assemble into vessel-like tubes (the mathematical 
modelling o f angiogenesis patterns formed here are discussed in [Chapter 3]).
2.2.2 Delimiting the vascular system and corrosion casting
Some structural aspects o f the vascular system such as vessel diameter can be estimated 
from two dimensional sections stained with a vascular marker such as Factor VIII (Von 
W illebrand factor) [Pavlopoulos et al., 1998]. However, the full structural and 
topological aspects o f the vascular network can only be appreciated in three dimensions 
[Malkusch et al., 1995].
Early angiographic techniques utilised opaque filling substances such as india-ink or 
wax to delimit the vascular network. Once filled the intervening tissue is either corroded 
away or cleared with a clearing agent such as methylsalicylate prior to microscopic 
imaging. More recently acrylic based filling agents such as M ERCOX[Fait et al..
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l998;M alkusch et al., 1995] and silicone rubber based agents such as Microfill [Bentley 
et al., 2002] have been used to define the vascular system in a range o f different tissues. 
The microvascular structure is especially well preserved with MERCOX casts due to 
the low viscosity o f this casting m edium ’s unpolymerised state, which allows recovery 
of excellent detail o f the microvascular structure such as endothelial nuclei protrusion 
into the vessel lumen.
2.2.3 Morphometry of corrosion casts
The main advantage o f  corrosion casts is that the whole terminal vascular system can be 
replicated, capturing structural, topological and topographical details o f the endothelial 
luminal surface. The method fully preserves the vascular space in three-dimensions so 
once the tissue is chemically removed, the vascular architecture can be studied.
As the vascular architecture is a geometrically complex structure, it is therefore not 
straightforward to define numerically. An attempt to capture the topological character o f 
tumour vascular casts through fractal geometry was made by Baish et al. using 
skeletonised images o f two-dimensional projections o f the cast structure. Fractal 
dimension (a measure o f the tortousity) and Shortest path  (a measure o f the shortest 
connected path across the image) were then calculated from these skeletonised images 
[Baish and Jain, 2000]. Both these measures reveal that tumours varied substantially 
from the more regular normal vasculature. A criticism o f this system is it failed to take 
advantage o f the three-dimensional qualities o f  the vascular cast, instead relying on a 
projection o f  the cast into two-dimensions, and it could be argued that this not only 
results in a loss o f  information but could introduce substantial error as the topology o f 
the structure is not preserved [Figure 3.5].
Scanning electron micrographs (SEM) provide a very high resolution image o f tumour 
corrosion casts [Figure 2.3 (A)]. Using a parallax pair o f SEM images [Figure 2.3 (B)] 
with a know tilt angle, three-dimensional measures o f linear distances and angles can be 
made [Fait et al., 1998;Konerding et al., 2001;M alkusch et al., 1995;Steinberg et al., 
1989;Skinner et al., 1990]. Measurements are calculated as a function o f equivalent 
pairs o f  x-y coordinates on eaeh image. Linear distances were measured using two pairs
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of points and angles with 3 pairs o f points. Using this method Konerding et a l  
measured Inter-vessel distance, Inter-branch distance, Mean vessel diameter. Percental 
variation from  mean vessel diameter. Branching angle o f tumour corrosion casts 
[Konerding et al., 2001;Konerding et al., 1995;Konerding et al., 1999]. The 
distributions o f the measured parameters highlight the statistical differences between 
vasculature o f the tumours in these studies.
The importance o f using three-dimensional measurements is highlighted in a study by 
M innich et al. which compared two-dimensional and three-dimensional measurements 
o f the microvasculature in Xenopus laevis tadpole gill filters. An error in vessel lengths 
o f up to 58.84% was found depending on the orientation o f measured vessels [Minnich 
and Lametschwandtner, 2000]. Malkush et al. in another study claim errors o f around 
2.5% should be expected in the two-dimensional measures [Malkusch et al., 1995]. This 
is clearly an important issue as most reports (and some clinical assays) rely on two- 
dimensional tissue sections. Additionally two-dimensional morphometry studies o f 
vessel density, length, diameter and cross-section, may also vary with orientation, 
staining and counting techniques.
Though stereo-imaging methods preserve the three-dimension quality, they are unable 
to define the topology o f the vascular network. The shortfall o f  these systems is that 
they attempt to yield some information about the vascular architecture from what are 
essentially two-dimensional images o f  the cast, for more sophisticated analysis to be 
carried out, the analysis must be conducted on a volumetric structure.
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Figure 2.3. Scanning electron micrographs o f tumour corrosion casts
F igure 2.3. Electron m icrographs o f  tum our vessels from  a L S147T  xenograft from  w ork  carried  out 
in C hap te r 4. (A ) A m ono-im age and (B ) a com posite  stereo-im age w ith  a parallax  o f  6°.
2.2.4 Tomographic methods
All methods o f visualising the three-dimensional volume involve some form of 
tomography, that is to say the strueture is split into successive images along one axis, 
commonly referred to as a ‘z-stack’. The most basic method o f  generating a z-stack 
involves physically sectioning the tissue by serial microtomy [Brey et al., 2002]. This 
method is not generally practical as in many cases, aside from the considerable effort 
involved, there are technical problems with image registration o f the smallest vessels 
and loss or distortion o f individual sections.
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Collection o f the serial sections may be automated to some extent by the use o f laser 
confocal [Zipfel et al., 2003;Soltanian-Zadeh et al., 2001;M addah et al., 2005] or m ulti­
photon [Barber et al., 2003b] microscopy. With both these systems the image is derived 
from a thin plane o f focus with a minimal amount o f blurring from contiguous sections 
just outside the plane o f focus. In this way serial “optical sections” may be acquired by 
adjusting the depth o f the focal plane without physically sectioning the sample. Data 
acquisition with these systems are highly dependent on optical transmission o f the tissue 
in question, and z-stacks o f  greater than -50pm  (con-focal) and -200pm  (multi-photon) 
represent the current limits o f these technology. Some success using laser-confocal 
microscopy to quantifying microvascular density (compared with a light microscopy 
technique) was reported by Guo et al. [Guo et al., 2001], however for parameters other 
than micro-vascular density this technique would appear limited to small volumes o f 
tissue.
For visualising high resolution biological tissue both laser confocal and two/multi­
photon microscopy are effective in conjunction with appropriate fluorescent markers 
[Alexandrakis et al., 2004;Barber et al., 2003a]. Aside from penetration of light in to the 
sample, these techniques often suffer from image convolution problems where 
fluorescence intensity is affected by contributions from the area surrounding the region 
o f interest. Image convolution can however be ameliorated to some extent by using anti- 
bleaching agents, and deconvolution algorithms which adjust the intensity spread based 
on a model point spread function [Fink et al., 1998].
To visualise whole tumours greater than a few millimetres in diameter, newer methods 
which do not rely on the visual spectrum o f light can be used. These methods exploit 
radio waves or X-rays which probe deeper into the tissue than ordinary visible laser 
light, and include: M icro-computed Tomography (micro-CT or pCT), Volume 
Computed Tomography (VCT) and Magnetic Resonance M icroscopy (MRM or pMRI).
Micro-computed tomography provides a means to study three dimensional structures 
non-destructively at sub-micron resolution. Micro-CT cone-beam reconstruction 
algorithm developed by Feldkamp et a i  and was initially used to investigate the 
microstructure o f bone [Feldkamp et al., 1984]. M icro-CT scanners consist o f an X-ray 
source (usually a polychromatic cone beam although synchrotron beam may also be
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used), a rotating specimen stage, an X-ray-to-visible light scintillator and a charge- 
coupled device (CCD) based digital video camera. The sample is scanned by rotating it 
at a small angular increment in the X-ray beam, at each rotation step a transmission 
image (or shadowgram) is captured by the CCD device and repeated through a period of 
either 180° or 360°. X-ray attenuation is dependent on the X-ray energy spectrum. 
Prefiltration o f the X-ray beam to yield a more monochromatic beam reduces problems 
related to beam hardening. For very high resolution images, more uniform synchrotron 
X-rays may be used. Once a series o f transmission images are acquired they are 
reconstructed to a three-dimensional image using a modified Feldkamp filtered back- 
projection algorithm. The resulting image stack can then be rendered for volume or 
surface using a 3D ray tracing algorithm, an example o f an angiograph we produced 
with this method is shown in [Figure 2.4 (A)]. The magnification factor is dependent on 
the desired volume and resolution o f the scan, for example a cube o f 1 cm^ scanned at 
2pm^ yield approximately 30GB of image data.
The quality o f the micro-CT image is strongly influenced by the relative X-ray 
attenuation o f the volume o f interest and the surrounding media; to this end 
microangiographical studies using this technique generally require an intravascular 
contrast agent to delimit vessel boundaries [Bentley et al., 2002;Maehara, 2003]. The 
volumetric ‘im ages’ obtained using micro-computed tomography represent three- 
dimensional arrays o f voxels, each with greyscale values indicating local X-ray opacity.
Magnetic Resonance Microscopy (MRM) is a high resolution adaptation [M axwell et 
al., 2002] o f Magnetic Resonance Imaging (MR!) [Gillies et al., 2002;Leach, 2001] a 
system commonly used to study clinical tumours in-vivo. The resolution o f magnetic 
resonance microscopy depends directly on the magnetic field strength and improvement 
in super-conducting technology has lead to greatly increased resolving power with 
resolution o f up to 1pm reported by Glover et a/. [Glover P and Mansfield P, 2002]. 
Radio waves used in MRM readily penetrate and are non-destructive to biological 
tissue, a considerable advantage where living tissue is being studied. MRM can also be 
tuned to the signature o f specific molecular species, enabling various metabolic 
processes to be assayed in real-time. Three dimensional angiographs can be generated 
with MRM using contrast agents such as BSA-diethylenetriaminepentaacetic anhydride-
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gadolinium (GdAlbumin) [Erickson et al., 2003] an example o f which is show in 
[Figure 2.4 (B)].
Volume Computed Tomography (VCT) is a new technology which utilises X-rays in a 
similar manner to micro-CT. A prototype VCT machine was used by Kiessling et al. to 
study the whole vascular system o f mice bearing a subcutaneous xenografts [Kiessling 
et al., 2004] [Figure 2.4 (C&D)]. By using two flat-panel detectors with pixel sizes o f 
<40pm^, reconstruction voxel resolution o f 0.4pm^ are reported with a scan acquisition 
time o f only 16 seconds. VCT thus combines many o f the advantages o f micro-CT and 
clinical Computed Tomography (CT) scanners.
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Figure 2.4. Methods for acquiring three-dimensional tumour microangiographies
Figure 2.4. E xam ples o f  m icroangiography  using d ifferen t tom ographic m ethods (A ) X -ray  
m icrocom puted  tom ography o f  hum an co lon  carc inom a corrosion  cast from  [C hap ter 4], (B ) enhanced  
contrast m agnetic resonance m icroscopy  o f  R 3230A c m am m ary  carcinom a xenograft [E rickson  e t al., 
2003], (C ) volum e com puted  tom ography  o f  a w hole m ouse bearing hum an sk in  carc inom a xenograft 
(inset), yellow  arrow s indicate equ ivalen t vessels on w hole scan and inset, and  (D ) a high reso lu tion  
rendering  o f  the perfused vessels in (C), num bering  indicated  m ajor feeding vesse ls (im ages from  C & D  
w ere adap ted  from  [K iessling et al., 2004]).
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2.2.5 Measuring aspects of blood flow and transport
In addition to the architecture o f the microvasculature, other factors are also important 
in determining blood flow and transport in tumours. Parameters such as blood 
velocity/flow rates, blood viscosity, and interstitial fluid pressure all effect the perfusion 
o f nutrients and therapeutic agents.
Blood flow is a dynamic property o f the vascular system and requires measurements to 
be made directly from live or anaesthetised animals within short timescales. Acquiring 
blood flow velocities can be performed using an intravital microscope and video­
capture o f fluorescently tagged red blood cells (RBCs) [Tozer et al., 2001]. Using 
similar techniques to determine local blood velocity, different flow properties in normal 
and tumour vessels was demonstrated by a number o f authors [Leunig et al., 1992] 
[Yuan et al., 1994;Pries et al., 1995b] [Figure 2.5 (A&B)].
Viscosity is an important component o f many o f the theoretical models, affecting 
turbulence in larger vessels and vascular rheology in smaller vessels. Though blood 
viscosity is a very difficult parameter to measure in-vivo, it can be estimated using a 
rheometer or a capillary viscometer [Marinakis et al., 1999].
Once within the tumour vascular system, aspects such as trans-vascular pressure 
gradients now determine how efficiently components being carried in the blood are 
delivered. A key factor affecting the trans-vascular pressure gradient and hence 
transport in tumours is the Interstitial Fluid Pressure (IFP) which is normally high [Jain,
1994]. IFP can be measured using the wick in needle method [Boucher et al., 1990] or 
micropipette and a servo-null system [Boucher et al., 1996;Pries et al., 1997].
The deficiencies in transport o f  oxygen result in zones o f hypoxia and normoxia 
forming throughout solid tumours. These zones in the tumour can readily be studied 
using fluorescently labelled markers such as pimonidazole (hypoxia marker), and 
carbocyanin and Hochest 33341 (perfusion markers), and a standard epifluorescence 
microscope. Quantification o f the fluorescently labelled zones o f tissue can be 
determined as a function o f their distance from the vessel wall using an Imaged  macro 
[Tong et al., 2004]. Local permeability o f the tumour vessels to various macromolecules
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can also be measured using the intravital microscope [Leunig et al., 1992;Yuan et al.,
1995].
Figure 2.5. Correlation between vessel diameter and blood velocity in normal and 
tumour vessels
Arterioles
V nax(m nV s)
Ü  35 
30 
25 
20 
15 
10
Verules
I* •• » A*.
25 0 25
P » a l V e s s e l  D t a i r e l o f  ( t i n )
50
B
0.6
0.5
0.4
0.3
02
0.1
0.0 -4-
I
0 10 20 30 40 50 00 70 0 10 20 30 40 50 60 70 
Turrw Vessel Diameter (jim)
F igure 2.5. (A ) C orre la tion  betw een  vessel d iam eter and  flow  ra tes in no rm al ph ial vessels (A rterio les 
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vessels in (M C alV  m urine m am m ary  carc inom a and hum an g liom a U 87 xenograft) [Y uan et al.. 1994].
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3.1 Introduction
The relationship between structure and function in the vascular system has been the 
source o f much study in the last century, with many complex phenomena being 
observed. Some o f the computational approaches to modelling tumour vascular 
networks [Section 3.2.1-2] and blood flow [Section 3.3.1-4] are reviewed in this 
chapter.
3.2.1 Models of vascular architecture
These models aim to either describe the structure o f a vascular system 
phenomenologically or empirically. Although continuum models are discussed here 
they are not generally used to describe network formation but are included in this 
discussion as they form the basis of some discrete models o f the vessel networks.
3.2.2 Continuum models
These ‘high-level’ models o f angiogenesis represent components o f the system, such as 
endothelial cell density as continuous variables rather than discrete quantities. Although 
this approach is perhaps course grained it can be effective where there are a large 
number o f entities whose collective behaviour can be abstracted.
Blood vessels are built primarily from endothelial cells which under complex 
angiogenic stimulus can organise into vascular systems in-vivo. It was observed during 
in-vitro experiments on matrigel plates that these motile cells retain the ability to ‘self- 
organise’ into ‘vessel-like’ patterns. The self organising behaviour o f  endothelial cells 
in a simplified biological system was studied by Serini et al. using an adhesion-type 
model [Serini et al., 2003]. The adhesion-type model (commonly used in pattern 
formation) was constructed with the assumptions that: i) cell population can be 
described by a continuous distribution o f density n and velocity v depending o f  the 
point X and the presence o f a concentration gradient c o f  the chemoattractant, ii) cell 
population in the early stages o f its development can be described as a fluid o f non-
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directly interacting particles, iii) cells are accelerated by chemoattractant, and iv) 
chemoattractants are released by cells, diffuse and degrade in finite time. With these 
assumptions the following equations are obtained:
— + V.(nv) = 0 [3.1]
dt
— + v.Vv = flVc [3.2]
dt
&  _|= DAc + a n - T  c [3.3] 
dt
where in relation to the chemoattractant, D  is the diffusion coefficient, a rate o f release, 
r rate o f degradation and p  the strength o f cellular response.
Equation [3.1] describes mass balance, [3.2] is a momentum balance with a chemo- 
tactic force term, and [3.3] is a diffusion equation for the chemoattractant produced by 
endothelial cells and degrading in time. The correlation between the biological and 
computational models produces remarkably similar patterns, replicating behaviour such 
as the loss o f network formation below a critical cell density [Figure 3.1 (A&E)] and 
formation o f a ‘swiss-cheese’ structure at high cell densities [Figure 3.1 (D&H)]. The 
importance o f the chemoattractant gradient on the network formation is demonstrated 
by saturating the matrigel with exogenous VEGF-A [Figure 3.1 (l-J)] this is replicated 
in the simulation by removing the chemoattractant term from the equation [3.3] [Figure
3.1 (K&L)]. Similar behaviour has been noted by Gerhart et al. in studies on endothelial 
sprout tip guidance [Gerhardt et al., 2004;Gerhardt et al., 2003]. Although this study did 
not explicitly consider tumour angiogenesis, the development response by the 
endothelial cells to the VEGF saturated gradient has many interesting parallels with the 
hypothesis surrounding abnormal tumour vascular development [Section 2.1].
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Figure 3.1. In-vitro and in-silico models of endothelial cell aggregation
n=50 n = 1 0 0 n=200 n=400
F ig u re  3.1, (A -H ) E ffect o f  increm ental 
endothelial cell num ber per m m ’ (n) on 
aggregation  patterns (A -D ) in-vitro experim ent, 
(E -H ) results from  in-silico s im ulations that 
parallel the in-vivo experim ents using the sam e 
physical values o f  re levant param eters and cell 
num ber. (I-L) E ffec ts o f  sa tu rating  the 
chem oattractan t V E G F -A  on the in-vitro m odel 
(I& J) and (K.&L) the equ ivalen t sim ulation . In the 
absence (I& K ) and  p resence (J& L ) o f  saturated  
chem oattractant. [F or (I-L ) «=125]. A dapted  from  
[Serini et al., 2003].
Endothelial cells in preformed vessels also sprout and form new structures. These 
processes are known to depend on more static extracellular matrix factors such as 
fibronectin and more mobile diffusive chemoattractants generically termed tumour 
angiogenesis factors (TAFs). Most models focus primarily on the impact o f a single 
tumour angiogenesis factor, in reality there are many other factors which influence 
sprout formation and guidance in different ways, some o f which are summarised on 
[Table 2.1].
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Sprout formation is considered by Orme et al [Orme and Chaplain, 1996], using a 
reaction-diffusion model on a one-dimensional domain representative o f the parent 
vessel wall. This model is further expanded by Levine et al. [Levine et al., 2001] where 
the budding site is determined by the interaction o f endothelial cells, TAFs, fibronectin, 
and proteases. Two-dimensional continuum models o f this process were developed 
further by Orme et al. [Orme and Chaplain, 1997] and Anderson et al. [Anderson and 
Chaplain, 1998].
Anderson et al. use this model o f endothelial cell density, chemotaxis and haptotaxis 
[Figure 3.2 (A)], to investigate the effects on cell migration.
Simulations over three dimensionless time points with the haptotactic term equal to 
zero, showed that spatiotemporal evolution o f endothelial cell density exhibited limited 
lateral movement [Figure 3.2 (B)]. In contrast where haptotaxis is included, the ‘sprout 
tips’ are seen to fuse and cell migration towards the tumour (i.e. TAF source) is much 
slower [Figure 3.2 (C)]. The results demonstrate two aspects o f capillary network 
formation. Firstly, a sufficiently strong chemotactic response is necessary for the initial 
outgrowth o f the capillary network. Secondly, the model reveals the importance o f 
interactions between endothelial cells and the extra-cellular matrix in the haptotactic 
response.
A further study considers vessel maturation o f the nascent sprouts [Plank et al., 2004]. 
Here the interaction o f antagonistic angiopoietins (ang-l & ang-2) with the Tie-2 
receptor on initiation and maturation o f the growing stalk are o f great importance. Ang- 
2 leads to the destabilisation o f  the ECs from the matrix and is important to the 
initiation o f  stalk formation, which will only occur in the presence o f VEGF. A ng-l has 
the opposite effect, stabilising the EC interactions. The balance o f these factors is 
important not only in the formation but the also the remodelling o f the vascular 
network.
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Figure 3.2. Endothelial cell migration
Tumour angiogenesis factor 
gradient surface
—  Fibronectin gradient surface
B
4  4 6  o i
F ig u re  3 .2. (A) H aptotaxis fibronectin  concentration grad ien t (red) and chem otax is T A F grad ien t (blue) 
[TA F gradient slopes aw ay from  the tum our source, w hile fibronectin  increases], (B ) tw o d im ensional 
endothelia l cell density  evolu tion  w ithout haptotaxis over an initial plus 3 further tim e po in ts and (C ) tw o 
dim ensional endothelial cell density  evolution w ith hapto tax is over an in itia l p lus 3 further tim e po in ts. In 
both (B ) &  (C) the prim ary vessel is on the left and the tum our on the right. A dapted  from  [A nderson  and 
C haplain , 1998]
3.2.3.1 Discrete models of vascular architecture
Discrete models are required in order to gain a finer resolution o f aspects such as sprout 
branching and anastomosis, and are also required to describe the angioarchitecture from 
the stand point of modelling flow.
Biologically the sprout tip cell with its filopodia [Figure 3.3 (A)] governs the motion of 
the sprout in response to signals in the surrounding media; this forms the basic unit for 
many discrete models. A model o f the sprout tip was considered by Stokes et ah, where
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each sprout tip is characterised by a position and velocity at a given time [Stokes and 
Lauffenburger, 1991] [Figure 3.3(B)]. The evolution o f the tip is governed by a 
stochastic differential equation that comprises a viscous damping term, a white noise 
term to describe the random movement and a chemotactic component for directed 
movement. Branching is accounted for probabilistically and anastomosis occurs when a 
sprout tip is within one cells width o f another sprout tip. The model incorporates a 
branching probability which increases along the TAF gradient as the sprout approaches 
the tumour. However the model fails to adequately account for the formation o f the 
‘brush border’ effect commonly observed in the tumour periphery.
Figure 3.3. Sprout tip structure and migration model 
Endothelial
A  , cell B
Mtotically 
active cell
Dauÿiter
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-05 00  05 W
Figure 3.3. (A) Schem atic o f  an angiogenic sprout. T his idealised abstraction  is used as the basis  o f  
m ost d iscrete m odels, adapted  from  [A nderson and C haplain , 1998]. (B) S tokes and L au ffen b u rg er’s 
discrete m odel ( 1991) the prim ary  vessel is represented  by the horizontal line (units in m m ) [S tokes 
and Lauffenburger, 1991].
The discrete sprout tip model is developed further by Anderson et al. [Anderson and 
Chaplain, 1998]. This model defines its nearest neighbour interactions from a 
discretisation o f the continuum model used to generate the endothelial cell densities in 
[Section 3.2.2]. Discretisation was carried out using Euler finite difference 
approximation (discretisation o f the endothelial equation is available in the appendix o f 
Anderson et al. [Anderson and Chaplain, 1998]). This equation is used to determine the
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EC density in discrete time and space, achieved by averaging the density o f four 
surrounding neighbors at the previous time step. Five coefficients P 0 - P 4 from the 
discrete equation are used to simulate the motion o f an individual endothelial-cell under 
the influence o f chemotactic, haptotactic and random movement (equation [3.4]). These 
coefficients can be considered as being proportional to the probabilities o f the sprout tip 
cell remaining stationary (fg), moving left {Pi), right {Pi), up {Pi) or down {Pi). Each o f 
the coefficients P 1-P 4 consists o f three components given by:
P„ = random movement + biased.chemotactic + biased:haptotactic [3.4]
The phenomenological rules governing branching and anastomosis are defined as 
follows: i) Branching only occurs at sprout tips, ii) there is a time delay between 
branching events determined by a critical endothelial density, iii) the density o f 
endothelial cells required to branch is inversely proportional to the TAF concentration 
so branching is more likely (consequently sprouts will be shorter) as the sprout tip 
approaches the tumour. For anastomosis, as with the Stokes et a i  model, the rules 
simply dictate that it occurs in sprouts o f a certain minimum length, separated by a 
distance o f one cell. Following the joining o f two sprout tips only one goes on to grow, 
the choice o f which is purely random.
The simulation results for A nderson’s model are presented under different conditions 
of: i) TAF source (circular or linear representative o f a large or small tum our 
respectively), ii) the presence or absence o f haptotaxis and iii) presence or absence of 
endothelial cell proliferation [not shown here]. The spatiotemporal evolutions o f 5 
sprout tips are considered over 4 time steps [Figure 3.4 (A-F)]. The first two simulation 
runs are without haptotaxis. In both these runs, the sprouts rapidly proceed towards the 
TAF source. The first case [Figure 3.4 (A)] matches areas o f high endothelial cell 
density described by the continuum model in [Figure 3.2 (B)]. The second case [Figure
3.4 (B)] shows a TAF profile with a different radial geometry, here sprouts converge 
rapidly TAF source again showing little branching. The next two simulations include 
haptotaxis in the model [Figure 3.4 (C)] linear and [Figure 3.4 (D)] radial TAF sources. 
Anastomosis can bee see to occur in both cases at relatively early time points and the 
degree o f branching is dramatically increased, further to this the time taken to migrate is 
significantly increased r = 20 in comparison to the chemotaxis-only case where
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vascularisation has occurred by /=  10. In both these models the formation o f the brush- 
border occurs, again there is agreement with the cell densities o f  continuum model 
[Figure 3.2 (C)] and the branching in [Figure 3.4 (C)].
The results from the discrete model simulations confirm the predictions o f  the 
continuum model that both chemotaxis and haptotaxis are required for the formation o f 
a capillary network at a large scale. These simulation results show the important large- 
scale features o f angiogenesis can be described qualitatively using a continuum model. 
Although the vascular networks generated here are “firmly based on underpinning 
biological processes such as chemokinesis, chemotaxis and haptotaxis” they are by no 
means an accurate description o f the tumour vascular system.
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Figure 3.4. A discrete model o f tumour angiogenesis
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F igure 3.4. N um erical sim ulation  resu lts  from  A nderson  et al. 1998, p aren t vessels at x=0, and tum our 
T A F source at x = l (linear) o r at x=0.5  (radial). E ach sim ula tion  is p resen ted  over 4 tim e points.
(A ) M igration  o f  sprout tips tow ards a linear T A F source w ithou t hap to tax is , show s sim ila r resu lts  to 
the analagous con tinuum  m odel sim u la tion  w hich  show  little lateral m ovem ent. A dd itionally  the 
d iscre te  m odel show s no branch ing  and  consequen tly  little anastom osis. Sprouts connect w ith  the 
tum our by the forth  tim e point.
(B ) U sed the sam e param eter values as sim ula tion  (A ), w ith  a c ircu la r T A F  source in p lace  o f  a linear 
one. T he convergence o f  sprouts in the m iddle  o f  the y -ax is is due to the rad ia l geom etry  o f  the TA F. 
N ote very  little  anastom osis occurs here too.
(C ) M igra tion  o f  the sprout tips tow ards a linear T A F source in the p resen ce  o f  both hap to tax is and 
chem otax is. B oth  extensive sp rou ting  and  anastom osis are  observed  resu ltin g  in the fo rm ation  o f  the 
'b ru sh  b o rd e r’ effect.
(D ) T his includes the sam e param eters as in (B ) w ith  the excep tion  that hap to tax is is included  in this 
m odel. A gain  early  anastom osis is observed  and  som e sprouts are  even  seen  to m igrate  aw ay from  the 
T A F  source. F rom  [A nderson and  C hap la in , 1998].
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3.2.3.2 An empirical approach to modeiling vascuiar architecture
In contrast to the more phenomenological models above, a different approach to 
modelling vascular architecture was proposed by Baish et al. This model used the 
fractal dimension o f vascular networks to select percolation networks statistically 
representative o f tumour and normal tissues [Baish et al., 1996;Baish and Jain, 2000] 
[Figure 3.5 (A)]. The chaotic nature o f tumour vasculature makes a unified numerical 
quantification o f the shape o f these structures very difficult in ordinary Euclidian space 
(although as seen in [Chapter 4] distribution o f a range o f  parameters can be used to 
quantify certain aspects o f the tumour vasculature). In contrast, fractal geometry can be 
used to reveal how the irregularities o f vasculature may be described by the number o f 
similarly shaped vessels at other scales. An estimate o f vessel tortuosity, taken as a 
minimum path dimension, is also measured from the skeletonised images.
Following a study by Gazit et al. on scale-invariant behaviour in vascular network 
formation [Gazit et al., 1995], Baish et al. devised a model representation o f tumour 
vascular networks for use in mathematical modelling o f flow and oxygen distributions. 
The fractal dimension was derived from skeletonised two-dimensional images vessels 
from both tumours and normal tissues [Figure 3.5 (B)] and estimated using the box 
counting method [Bunde and Flavlin, 2004]. A caveat o f this approach is fractal scaling 
only applies over a narrow range o f length scales in the vascular system and it is 
unknown if  the scaling extends to larger vessels. For a truly fractal system scaling 
applies over an infinite series, which is certainly not the case in this instance.
In order to model the complex tumour vascular structure, a particular flavour o f 
percolation theory called ‘invasion percolation’ [W ilkinson and Willemsen, 1983] has 
been found to be particularly useful. The model o f the vascular network starts with a 
square lattice initialised with uniformly distributed random values. Invasion percolation 
is realized by first selecting a start point at the bottom-left com er and invading the 
weakest point on the grid at adjacent to the current position; this growth is iterated until 
the required occupancy is reached. The network is then pruned by removing regions 
with zero flow (dead ends) to provide the ‘backbone’, blood vessels are then assumed to 
connect all adjacent lattice sites on this backbone. Selecting the occupancy enables the 
level o f geometrical heterogeneity to be controlled by the fractal dimension.
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Figure 3.5. Flow in two dimensional percolation networks
A 100% 80%
60% 40%
inlet
outlet
B
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Figure 3.5. (A) Invasion perco lation  netw orks at various levels o f  %  occupancy . G row th  beg ins in the 
bottom  left. T he flow  in each netw ork  is show n w ith the inlet at the bottom -left (green) and  ou tlet at the 
top-right (red). The fractal d im ensions o f  the 100, 80, 60, and  40%  occupancy  netw orks are approxim ately  
2.0, 1.9, 1.8, and 1.6 respectively . (B) Skeletonized vascu lar patterns for (i) norm al subcu taneous arteries 
and veins, (ii) norm al subcutaneous capillaries, and (iii) an adenocarcinom a (L S174T  xenograft tum our) 
[Baish et al., 1996].
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3.3.1 Blood flow modelling
The newly developed vascular network functions to supply the expanding mass of 
tumor cells with nutrients such as glucose and oxygen and, from a therapeutic 
standpoint, intravenously administered drugs. Consequently an important extension of 
the vascular models discussed earlier is to explicitly incorporate ‘blood’ flow through 
the tumor vascular networks in order to explore the behavior in these systems.
Flow through the circulatory system is driven by the hydrostatic pressure created in the 
heart ventricles. Scale and complexity are two key issues for modelling blood flow in 
vascular networks. The largest arteries have diameters o f the order o f 10  ^m and blood 
pressures o f around lOkPa, these exhibit pulsatile flows. At the other extreme, the 
smallest capillaries have diameters o f 10^ m and pressures o f ~ lkPa, demonstrate more 
steady flow. In addition to the range o f flow rates, pressures and vessel size, the 
colloidal properties o f blood also behave differently in these different parts o f the 
vascular system. Given this complex range o f physical properties, each modelling 
endeavour is directed at a particular hierarchy o f the vasculature through some level o f 
abstraction. Consequently each model can only be expected to answer some o f the 
questions posed. At a high level blood is typically treated as an incompressible 
Newtonian fluid with a constant viscosity. In contrast to this, blood at the microscopic 
scale o f the capillary blood should be considered as a compound fluid consisting o f an 
elastic red blood cell (RBC) phase and a non-Newtonian plasma colloid o f platelets and 
proteins fluid phase. Many models in reality assume a simplified fluid model o f blood in 
some respects.
3.3.2 Concepts used in blood flow models
The following section contains a brief discussion o f some important components in 
vascular flow modelling.
Reynolds number
Proposed by Osborne Reynolds [Reynolds, 1883], this dimensionless number is the 
ratio o f inertial forces to viscous forces and is used to determine if  a flow will be
51
laminar or turbulent. Laminar flow occurs at low Reynolds numbers, here viscous 
forces are dominant and flow is characterized by smooth, constant fluid motion. At high 
Reynolds numbers, flow is turbulent, and is dominated by inertial forces, resulting in 
random eddies, vortices and other flow fluctations. Flow in the microvascular vessels 
occurs at low Reynolds numbers and so the assumption o f laminar flow is made for the 
purposes o f  most models.
Re = ^  = —  [3.5]
where, p  is the fluid density, V mean fluid velocity, L characteristic length, p  absolute 
dynamic fluid viscosity, and v kinematic fluid viscosity (where v = // / p).
Hagen-Poiseuille Flow
Laminar flows through channels or tubes are observed to produce a parabolic velocity 
profile as frictional forces are transmitted from the wall regions o f the fluid to the 
central axis (equation [3.9]) [Saltzman, 2001]. In the instance o f a vessel modelled as a 
cylinder [Figure 3.6 (A)] using the equations for conservation o f momentum, the 
following expression (the Navier-Stokes equation for viscous flow) is acquired.
P  ----- — —V P  +  yt/V ' V +  f}g [3.6]
where v is the fluid velocity, p  is the fluid density, p  is the fluid viscosity, p  is the 
hydrostatic pressure and g  is the gravitational force. Flow in a cylinder under normal
circumstances occurs only in the axial direction; v = v ,{ r ) k , where w is a function only
of the radial distance r  from the axis and k  is the unit vector in the z direction. The z- 
component o f the equation expressed in cylindrical coordinates is as follows:
P dt dr r dO —  + Adz
[3.7]
i A
r  dr y
+ 1 cl-v. aA;
-
+
cz'
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This equation can be simplified by making the following key assumptions a) flow is at a 
steady state where = 0 , b )  there is no radial flow i.e. flow is only in the axial
direction v- ,with and c) gravitational forces are insignificant (g% ~ 0). With
these assumptions equation [3.7] can be simplified to:
dp 1 d
dz r dr
r — -  
dr
[3.8]
Equation [3.8] can be solved with the following conditions: p=po at z=  zq\ p =Pl at z = 
L; V- =0 at r=R; and dv /d r  = 0 at r = 0, to give:
giving a parabolic dependence o f velocity on the radial position [Figure 3.6 (B)] 
characteristic o f Hagen-Poiseuille flow. This equation can be integrated over the vessel 
cross-section to obtain the overall rate o f blood flow Q:
Q -  \ \ v . { ^ y d r d 6  — Pl )^^  [3 .10 ]
jV - 8^6
Resistance to flow is a strong function o f radius (R to the minus forth). This effect is 
responsible for the 80% blood pressure drop observed over the arterioles (diameter < 40 
pm) and capillaries.
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Figure 3.6. Poiseuille flow in a cylindrical channel
B
F igure 3.6 . (A ) T ube d im ensions, Po and  Pi are respectively  the p ressu res  at the inlet and  outle t, w ith  
the in let ve locity  F-, L is the length  o f  the elem ent, R is the rad ius and  0 is the  angle  betw een  r and the 
positive  z-axis. (B ) A  cro ss-sec tion  o f  the parabolic  velocity  p ro file  characteristic  o f  Po iseu ille  flow .
D arcy’s Law
Henry Darcy description o f flow through and isotropic porous medium is typically used 
to model flow out o f the vessels and in the interstitium. This law is a simple 
proportional relationship between the discharge per unit area q, fluid viscosity //, 
permeability o f the porous media k  and pressure gradient VP [Saltzman, 2001].
q =  VP [3.11]
P
3.3.3 Single vessel blood flow models
Flow models at the microscopic scale tend to focus on a single capillary or a very 
simple network and are oriented around the haemodynamics o f  the RBCs, plasma, 
endothelial glycocalyx, and extravascular transport.
At the unit level o f the individual capillary element, blood flow exhibits some 
unexpected properties described by the Fahraeus and Fahraeus-Lindqvist effects.
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The flow of a colloidal suspension such as blood in a tube/channel results in the 
suspended elements aggregating along the longitudinal axis o f flow [Figure 3.7 (A)]. 
This clustering behaviour o f red blood cells in small vessels results in a cell free layer 
forming adjacent to the glycocalyx (cell wall) [Pries et al., 2000;Pries et al., 1997]. The 
clustering o f RBCs is linked to the shear forces, which are parabolic across the vessel, 
and lower in the central axis o f the channel than at the edges.
In a similar manner to the shear force, velocity profile is parabolic (though higher 
axially and lower peripherally), this phenomenon has been used to explain the lower 
haematocrit transit time by comparison to the plasma in a vessel segment. This lower 
transit time results in a lower haematocrit in the tube relative to the discharge 
haematocrit and has been termed the ‘Fahraeus effect’ [Goldsmith et al., 1989].
Dynamic model o f RBC clustering have recently been presented by a number o f authors 
using a range o f different mathematical approaches: discrete particle method [Boryczko 
et al., 2003], immersed boundary method [Bagchi, 2007] and multi-component lattice- 
Boltzmann method [Sun and Munn, 2005;Ding and Aidun, 2006;Dupin et al., 
2006;Dupin et al., 2007]. Blood cells in the finest capillaries occupy the whole vessel 
calibre and orient perpendicular to the plane o f flow as shown in [Figure 3.7 (B)]. This 
stacking behaviour is termed the ‘rouleaux’ due to the similarities to a stack o f  coins 
and the velocity profile is blunted, not parabolic. At a simplistic level these rouleaux 
can be treated as a plug-flow, however, the stacking behaviour o f RBCs has also been 
modelled by Boryczko et al. using their discrete particle method [Boryczko et al.,
2003].
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Figure 3.7. Behaviour o f RBCs in vessels
Capillary endothelial cell 
Cell depleted r  ^  layer + glycocalyx
plasma layer z' 1 Fast moving axial channel
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F igure 3 .7 . (A ) A xial c lustering  o f  R B C s in the m icrovascu latu re . H ere R B C  d is tribu tion  co rre la tes  w ith 
the velocity  (o r shear rate) in the vessel [Pries e t al., 1996a] and (B ) in the sm allest cap illa rie s  (6 -10  pm ) 
o f  the m icrovascu la tu re  w here vessel d iam eter is equ ivalen t tha t o f  a R B C , the  cells stack  perpend icu la r 
to the d irec tion  o f  flow  described  as an ax ia l-tra in  or rou leaux , note defo rm ation  o f  the  ce lls  at the central 
constric tion  [B oryczko  et al., 2003].
The Fahraeus-Lindqvist effect on the other hand, relates to the uncoupling o f ‘relative 
apparent viscosity’ and haematocrit, as vessel diameter decreases [Figure 3.8 (A&B)]. 
Both Fahraeus and Fahraeus-Lindqvist effects may be reduced in tumours resulting in 
increased resistance to flow [Sevick and Jain, 1989].
The endothelial surface layer (ESL) or glycocalyx' is implicated in hydrodynamic 
resistance [Pries et al., 1997] and transport [Vink and Duling, 2000]. The influence o f 
the ESL layer is estimated to increase the flow resistance by some 14-21%, equivalent 
to a uniform increase o f 0.5-1 pm in diameter o f  the blood vessel. This effect can be 
seen in [Figure 3.8 (A&B)] where the diameter o f vessel required for the equivalent 
drop in relative apparent viscosity is larger in in-vivo by comparison to in-vitro 
measures in equivalent calibre glass tubes where no ESL is present.
A layer com posed  o f  p ro teog lycans and o ther constituen ts abso rbed  from  the p lasm a.
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Flow heterogeneity may be affeeted at the level o f the individual vessel element. It is 
well documented that tumour blood flow is characterised by both spatial and temporal 
heterogeneity [Yuan et al., 1994;Baish et al., 1997], and this is often attributed to the 
chaotic vessel structures (at the network level). However Mollica et al. have shown that 
a more localised effect can also yield temporally heterogeneous flows at the level o f a 
single capillary element where tumour interstitial pressure induces a modulation o f the 
capillary diameter [Mollica et al., 2003].
While localised effects are important, it is difficult to incorporate them into larger 
systems o f vessels either due to the computational requirements or the increasingly 
complex domain represented by these vessel systems. Models used for flow in networks 
o f blood vessels are discussed in the next section.
Figure 3.8. Vessel diameter and viscosity
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Figure 3.8 . T he F ah raeus-L indqv ist 
effect. D ependence o f  re la tive  apparen t 
v iscosity  on vessel d iam eter fo r 
d ifferen t haem atocrit {Ho) in (A ) in- 
vitro (glass capillary tubes) and  (B ) in- 
vivo (rat mesentefy vessels). N o tice  the 
d ifferen t positions o f  the m in im a (red  
dashed lines). A dap ted  from  [Pries et 
a l„  1996a].
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3.3.4 Vessel network blood flow models
Blood flow in vessel geometries more complex than single vessel elements display 
phenomena that are determined from the properties o f the network. These phenomena 
impact on the pressure, velocity and haematocrit distribution throughout the network.
Similar to the Fahraeus effect described in the previous section, the ‘network Fahraeus 
effect’ [Figure 3.9] concerns the uneven partitioning o f the haematocrit at successive 
arteriolar bifurcations, leading to heterogeneous haematocrit and plasma ratios across 
the network. This, coupled with the tendency o f RBCs to follow the higher flow rate 
pathways, leads to a positive correlation between haematocrit and flow velocity, and a 
-20%  reduction of discharge haematocrit in the capillaries relative to the feeding 
arterioles [Pries et al., 1995b]. In larger vessels the loss o f relatively higher quantities o f 
plasma to the daughter vessels causes a build up o f haematocrit in larger vessels over 
successive bifurcations. This increases the probability o f RBCs travelling through long 
flow pathways and has been termed the ‘pathway effect’. Network geometry largely 
dictates the ‘network Fahraeus effect’ while the network topology is primarily 
responsible for the ‘pathway effect’, pressure distribution and resistance to flow [Pries 
et al., 1996b]. Computationally haematorcrit and vessel radius dependent viscosity have 
been investigated by Alarcon et al. using a bifurcating network model based on the 
principles o f M urray’s Law [Alarcon et al., 2005].
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Figure 3.9. Plasma skimming
F ig u re  3 .9 . The netw ork  F ahraeus effect, ‘p lasm a sk im m ing ’ causes a haem atocrit drop  in p rog ressive ly  
sm alle r vessels. The b lood  cell exc lu s ion  layer is show n by the dashed  line.
Experimental studies of blood flow in-vivo at the network level o f vessels present great 
technical challenges, as it is difficult to resolve the three-dimensional spatio-temporal 
behaviour o f blood, and assay methods can easily affect such a sensitive dynamic 
system. Historically this has limited studies to certain tissues and methods (e.g. rat 
mesentery or window chamber models). To explore concepts where experimental 
studies may be impractical, numerical simulations o f blood flow can provide a means 
investigate the behaviour o f these systems.
A number o f approaches taken to modelling blood flow in the models o f tumour 
vasculature such as those in [Section 3.2.3.1 and 3.2.3.2] are discussed here.
A frequently approach to modelling flow in networks of vessels uses a network flow 
model represented by a system of connected cylindrical pipes o f given length and radius 
[Figure 3.10 (A)]. Structure and topology o f vessel networks are conserved by mapping 
them onto lattices for use in flow models [Figure 3.10 (B)]. A number o f different 
lattice types, for example: two-dimensional square [Baish et al., 1996], two-dimensional 
hexagonal [Alarcon et al., 2004] and three-dimensional cubic [Stephanou et al., 2005]
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lattices, have been used to model tumour vasculature, each differing in the nodal 
connectivity.
With the network structure setup, Poiseuille flow, equation [3.10], is then used to define 
the flow rate through each pipe in the system. By conserving mass (or flow if  an 
incompressible fluid is used) at each node (except sources and sinks), a system o f linear 
equations for nodal pressure is obtained which can be solved numerically. These nodal 
pressures are then used to calculate the flow in each element. With this type o f model, 
simulations can be used to study the effects o f the system topology (nodal connectivity) 
and geometry (vessel length/diameter distributions). A caveat o f these network flow 
models is they approximate blood as a Newtonian fluid so there are limits to which 
interpretations can be taken.
These types o f models may be useful for hypothesis formulation and simulation o f 
clinically important parameters, such as the theoretical effect o f drug action on the 
vascular network (e.g. vascular pruning in anti-angiogenesis/vascular therapies) and 
drug distributions through the network.
Figure 3.10. The network flow model
B
F igure 3 .10. (A ) The schem atic  fo r a sing le  flow  elem ent in a ne tw ork  flow  m odel, Pi and  pj are the 
p ressure at node / and j  respective ly , the elem ent ij has a flow  ra te  o f  Qjj and  a conductance o f  G,f, (B ) a 
netw ork  o f  such elem ents rep resen ting  a particu lar topology. G eom etric  fea tures such as vessel d iam eter 
can  also  be specified  for each elem ent. A dap ted  from  [M cD ougall e t al., 2002].
60
A simplified network model consisting o f a regular grid incorporating extravascular 
flow (Starling’s law) and interstitial flow (D arcy’s law), was used to explore the 
coupling o f interstitial pressure to fluid flow directions with in tumours [Baish et al., 
1997]. This model predicts that fluid flow may be altered in three ways, i) fluid may be 
forced in a more transverse direction, from the centre to the periphery, because o f a loss 
o f fluid at the tumour boundary, ii) improved vascular exchange may lead to fluid 
shortcuts in the interstitium and iii) the vascular flow could be reduced in areas with 
higher interstitial pressure. A key assumption o f a constant haematocrit is made in this 
model, in the instances where fluid loss from the vessels exceeds 10% the haematocrit 
can be expected to increase enough to have an impact on effective blood viscosity.
The invasion percolation models o f tumour vasculature [Figure 3.5 (A)] discussed in 
[Section 3.2.3.2] were also studied with a network flow model [Baish et al., 1996]. The 
influence o f the more convoluted tumour network geometries are compared with those 
o f more regular geometries o f the same occupancy. This model demonstrates that 
regular, space-filling networks produce a fairly uniform distribution o f flow rates in the 
vessels relative to their distance from the main diagonal o f the network". By comparison 
the percolation network simulations yield flow rates that are irregular across the 
network. As the flow divides in regular networks each pathway carries an equivalent 
burden, however, in the percolation networks the distribution o f flow is highly 
asymmetric, and this non-uniformity results in areas in relative high flow and areas o f 
relative stagnant flow. For the same reasons, symmetrical networks also have a far 
higher capacity, maintaining flow across the network even below occupancies o f 10%, 
where the equivalent cutoff point for the percolation networks is 30-50% (after pruning) 
[Figure 3.11].
■ In keep ing  w ith  w hat m igh t be expected  in a healthy  cap illa ry  bed. H ow ever incorpora tion  o f  
haem atocrit term s can resu lt in heterogeneous b lood  flow  even in regu la r lattices [A larcon et al., 2004].
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Figure 3.11. Flow in regular and invasion percolation networks
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F igure 3 .11. Flow  effic iency  th rough  random  and  through space-filling , regu la r ne tw orks w ith  the sam e 
arterio -venous p ressu re  d iffe ren tia l as m easured  b y  the flow  per un it occupancy  (regu la r ne tw orks - so lid  
line and  perco la tion  netw orks - open  circles). A ll flow s are non n a lized  to the flow  th rough  the fu lly  
occupied , regu lar ne tw ork  (32 x 32) [B aish et al., 1996].
The discrete model used to simulate vascular network growth by Anderson et al. was 
used by McDougall et al as the subject o f flow studies o f an injected tracer [McDougall 
et al., 2002;McDougall et al., 2006]. This model employs a two-dimensional network 
flow model similar to that used by Baish et al. The vascular geometries considered 
include networks generated from both linear and circular TAP sources [Figure 3.4 (C & 
D)]. The flow networks for these models were generated by mapping the vessel 
structures to a grid for simulation with each capillary element forming part o f the 
microvasculature assigned a radius drawn from an input probability distribution 
function (type unspecified).
The algorithm used to track concentration profiles o f an injected tracer {drug) is 
computed at each time step: i) the total amount o f drug flowing into each node is 
calculated and ii) new drug concentrations were calculated for all outflow bonds based 
on the computed nodal values. Assumptions made by this model are listed here: i) 
perfect mixing at each node is assumed, ii) the blood is considered to be a Newtonian 
fluid, iii) the blood vessels are modeled as static impermeable cylinders, iv) no reaction
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kinetics were assumed in the uptake o f the drug (later simulations with a flow boundary 
condition, assume removal o f any drug within 40 pm o f the tumour).
Simulations with this model explore the implications o f i) blood vessel radius, ii) fluid 
viscosity and iii) network structure, on fluid flow and drug distribution administered via 
bolus or continuous infusions regimes. The results from these simulations are 
substantial and the discussion o f each is beyond the scope o f this review, however the 
effect o f the two different vessel structures, mean radius and viscosity are considered 
here.
The results of a tracer-drug constitutively infused into the parent vessel show how the 
two vessel geometries (Linear [Figure 3.12 (A)] and radial [Figure 3.12 (B)]) have 
substantially different flow profiles. Firstly branches 1 and 2 supply drug to the tumour, 
however branches 3-5 remove drug from the tumour. The effects o f this tumour ‘drug 
bypass’ is particularly pronounced in the simulation with the circular tumour TAF 
source^ [Figure 3.12 (B)] as the vessels connect up earlier than those in the linear-TAF- 
source model.
Changing the mean radius produced increases in the flow rate and therefore drug 
uptake, however this relationship is non-linear due to the relationship between element 
radius, volume, conductivity and the topology o f the network.
In light o f the well documented poor drug delivery in tumours [Jain, 1994], an 
interesting outcome o f this modeling study is the predicted effect o f viscosities on the 
drug distribution and uptake by the tumour [Figure 3.12 (C&D)]. Reducing blood 
viscosity in the simulation causes the drug to reach the tumour more rapidly as a 
consequence of the inverse relationship between viscosity and nodal flow rates. A 
similar effect to reducing the viscosity is observed by increasing the pressure gradient 
across the parent vessel (unpublished data). This is interesting as it suggests a possible 
therapeutic route which could be used as an adjuvant to conventional drugs. Ideas such 
as this have already been considered by Netti et a i  who have used angiotensin-II to
 ^ S ym bolic  o f  the vessel system s o f  a sm all tum our (radial T A F source) [A nderson  and C haplain , 1998].
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enhance the trans-mural pressure gradient, in this case to improve convection o f 
antibodies to a hypertensive tumour [Netti et ah, 1999].
64
Figure 3.12. Dynamics o f simulated drug distribution 
A B
C
D
F igure 3 .12. B lood flow s in from  the top left through the netw ork  a long  the various netw ork  bond 
e lem ents and out at the top right. Snapshots o f  the tracer concen tra tion  as it flow s from  the parent vessel 
into the vascu lar netw ork derived  from  (A ) a linear T A F source and (B ) a radial T A F source, under 
constitu tive infusion o f  a tracer, coded  (red -  high), (w hite =  in term ediate) and  (b lue = low ). S ubscrip ts 
relate to  the units o f  tim e: (a) t=240s, (b) t=720s, (c) t= 1200s, (d ) t-2 4 0 0 s , (e) t=3600s, (f) t= 7200s, (g) 
t=16 800s, (h) t=36 000s, (i) t=62 400s. P lots o f  the total drug  m ass (y-axis) in the vascu lature  A /  (C), 
and the m ass uptake by the tum our MT* (D ) for three d ifferen t values o f  v iscosity , under continuous 
infusion o f  drug into vascu lature  over tim e (x-axis). V iscosity  (centipoises): 1 ( ‘b lue d iam ond’ upper 
curve), 4 ( ‘p ink square’ m iddle  curve) and 6 ( ‘orange triang le’ low er curve) [M cD ougall et al., 2002].
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Stephanou et al. recently extended the network flow model used by McDougall et a l  to 
three-dimensions [Stephanou et al., 2005]. A comparison o f the flow models with the 
previous two-dimensional models exploring viscosity, network structure and vessel 
diameter show that dimensionality affects results [Figure 3.13 (A&B)]. In both two- 
dimensional and three-dimensional networks, it is evident that at the steady-state, drug 
distribution in the network is not uniformly saturated. In a two-dimensional capillary 
bed the drug only reaches between 65.4% and 80.9% saturation, whilst the three- 
dimensional system only attains 57% to 63.2%. This is due to the numerous “dead-end” 
and re-circulating capillaries within the brush border that contribute little to the flowing 
backbone o f the vasculature, as with McDougall et al. ’s model, the amount o f drug that 
bypasses the tumour due to this is very high (-97  - 99%) This by-passing effect may 
be an artifact o f the single parent vessel model used where the blood returns to the 
parent vessel prior to reaching the tumour. Stephanou et al. raise this issue and plan to 
use more complex models with 3-4 parent vessels [Figure 3.13 (C)].
The model described above was applied by Stephanou et al. to questions such as how 
branching coefficient anastomosis densities affected the network and drug distribution.
Networks with different quantities of anastomosis are considered in relation to the 
branching coefficient, one o f which is shown in [Figure 3.14 (A)]. The branching 
coefficient here relates to the network connectivity z, so for a two-dimensional grid 
node, z can range from 1 to 4. Distributions o f  z are dependant on the type and location 
in the vascular network, an example o f this is shown by the distributions o f  the z values 
in [Figure 3.14 (A)].
The effect o f pruning, (i) random vessels (ii) low flow vessels, and (iii) high flow 
vessels, on drug uptake was also studied, an example is shown in [Figure 3.14 (B)]. 
Findings from this indicate that more efficient drug uptake (up to 130%) may be 
achieved by pruning the network. Up to the marked phase transition at ‘fraction 
removed’ o f 0.06, drug delivery in the network is improved, thereafter it is strongly 
reduced. Targeting the low flow vessels shows remarkably little effect on the actual
 ^ It shou ld  be no ted  that the  value quo ted  here is derived  from  the m odel an d  does no t rep resen t an 
estim ate  o f  an  in-vivo ‘b y -p ass in g ’ effect, bu t ra ther dem onstra te  how  th is behav iou r m igh t m anifest.
66
flow and delivery (analogous to targeting the newly formed vessels), in comparison the 
high flow rate vessels result in rapid shut-down o f the flow to the tumour (analogous to 
targeting mature vessels). Interestingly some o f these concepts are paralleled in a 
similar study made by Tong et al. where VEGF receptor-2 blockade with DC 101 results 
in pruning and normalisation o f the vascular network removing immature vessels and 
fortifying the remaining ones [Tong et al., 2004], the effect o f this was deeper 
penetration o f molecules into the tumors.
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Figure 3.13. A three dimensional model o f network flow 
A _____________________________________ B
c
P a r e n t  v e s s e l s
V a s c u l a r  n e t w o r k s
F ig u re  3 .13 . D rug distribution  in (A ) a tw o-d im ensional vascu lar m odel, and  (B ) a th ree-d im ensional 
vascu lar m odel, in either case a drug  by-passing  is observed  (particu larly  em p h asised  in the three- 
d im ensional m odel), drug d istribu tions are co lour-coded  (red  -  high and b lue  -  low ) concentration . (C) A 
pending  advancem ent on the cu rren t netw ork  flow  m odelling  schem e w here b lood  supp ly  from  m ultip le  
paren t vessels w ill be considered  [S tephanou  et a l., 2005].
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Figure 3.14. Dynamics o f blood flow with simulated vessel pruning
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F igure 3 .14 . (A ) Show s one o f  the th ree vascu lar architectures considered  for investiga ting  the 
con tribu tion  o f  branching coeffic ien t and degree o f  anastom osis (each o f  the three vascu lar arch itectu res 
had a d ifferen t degree o f  anastom osis -  no t show n). T he d istribution  on th e  right show s the d ifferen t 
coeffic ien ts along the axis perpendicu lar to the parent vessel. (B ) S how s th e  effects o f  random  pruning 
vessels (b lack) from  the vascular ne tw ork  until the fraction-rem oved  is - 0 .0 6  up to this po in t there is an 
increase in drug uptake received by  the tum our. A sharp  phase transition  is observed  passed  this value and 
the drug  uptake is m arkedly reduced [S tephanou et al., 2005].
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The final network-oriented vascular model discussed here has attempted to combine 
several aspects o f the tumour in a single model [Figure 3.15 (A-C)]. To this end, 
Alarcon et al. have developed an integrated multi-scale model for vascularised tumour 
growth [Alarcon et al., 2004]. The model takes account o f  both vascular adaptation and 
cell-cycle dynamics to investigate effects such as spatial inhomogeneity generated by 
blood flow through the vessel network. Layered on top o f this vascular network are 
features occurring at the cellular and molecular levels, such as the effects o f oxygen and 
p27 on the cell cycle [Figure 3.15 (B&C)].
In Alarcon et a l ’s model, the vessel elements o f the network flow model are defined on 
a regular two-dimensional hexagonal lattice [Alarcon et al., 2003;Alarcon et al., 2004]. 
Next blood flow, haematocrit and vascular adaptation are incorporated into the model 
[Figure 3.15 (A)]. As a hybrid model vascular adaptation uses a discrete ‘agent based’ 
system, while diffusion o f  chemokines and oxygen is modelled using a continuum 
approach [Figure 3.15 (B)]. The main development o f this hybrid cellular automaton 
model was the coupling o f blood haematocrit (oxygen) and cell growth to produce a 
complex, dynamic micro-environment. For blood flow and vascular adaptation the 
model uses Pries et a i  method [Pries et al., 1995a] [Pries et al., 1998], which describes 
how the lumen o f a vessel adapts to the metabolic demands o f the surrounding tissue 
and the transmural pressure/shear stress balance.
All the computational models reviewed in this chapter, are highly idealised, relying for 
the most part on phenomenological rules to account for the biology. There is currently 
an initiative (Cancer Physiome project), where the goals are to develop very detailed 
models o f a tumour which will take an integrative approach to modelling its various 
components. These models are intended to be more data driven and rigorously 
validated. One o f the tumour types which may serve as focus for the Cancer Physiome 
is colon cancer, due to the large body o f data available on this cancer [Alarcon et al.,
2004]. To this end, the data produced in [Chapters 4 & 5] o f this thesis are o f real value 
to this venture.
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Figure 3.15. An integrated model o f tumour growth
A 600
10 20 30 40 50 6030 40 too
lb ) (Cl
to 20 30 40 ^  fiO 10 20 30 40 M  60
DCÜÛ
1
1CQ0
60 KO
B
( w a ,
C Cdhl-APCCyc-COK
F igure 4 .15 . A n Integrated: m olecular, ce llu lar and vascu la r m odel o f  tum our grow th .
(A ) V ascu larised  tum our m odel (w hite =  tum our cells, v esse ls= hexagonal la ttice), (B ) the s ta tionary  
d is tribu tion  o f  oxygen, and (C ) a  g row th  m odel for cell d iv ision  phases. A dap ted  from  [A larcon  et al., 
2004]
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4.1 Introduction
In light o f studies by Konerding et al. which demonstrated quantifiable differences in 
vessel architecture within regions o f  clinical tumours [Konerding et ah, 2001] and type 
specificity in xenografts lines [Konerding et al., 1999]. It is clear the vascular 
architecture is strongly dependent on the local angiogenic environment. As xenografts 
are separated from their original tissues by a history o f  successive passages^  this raises 
the question of how well, if at all, is the originating clinical vascular architecture 
conserved in a xenograft tumour o f the same cancer type?
The focus o f this chapter is a characterisation o f tumour vascular systems in colonic 
cancers from both clinical and experimental tumours (xenografts). To achieve this, two 
quantitative studies o f the corrosion cast morphology were carried out. The first method 
used a stereoimaging technique described by Konerding et al. ; the second method 
utilises newly available X-ray micro-computed tomography (micro-CT). To our 
knowledge this is the first application o f X-ray micro-computed tomography in the 
study o f corrosion casts o f tumour vasculature. Micro-CT proved to be an excellent 
method for generating microvascular angiographs, enabling new measures such as 
vessel surface area and tortuosity to be determined in three-dimensions.
Clinical colorectal tumours, derived from a number o f locations in the lower bowel, 
have been used to create a numerous experimental xenograft tumours which are 
typically grown subcutaneously in nude mice. Some o f these xenograft lines include: 
HT29(colon), SW1222(colon), LS147T(colon), SW480(colon), SW 620(lymph node 
metastasis), SW48(colon), and SW837(rectum) [Richman and Bodmer, 1988].
For the comparative morphology work carried out in this chapter, two representative 
xenografts were selected for study: (1) LS147T [Figure 4.1 (A)] - a moderate-to-poorly 
differentiated tumour eonsisting of solid chords o f cells with numerous signet ring 
forms, a few glandular acini and large necrotic regions [Figure 4.2 (A)] [Sharma et al.,
2005] [Pedley et al., 2002], and (2) SW1222 [Figure 4.1(B)] - a well differentiated 
xenograft with noticeable structural organisation and morphology. M uch o f this tumour 
is organised into well defined glandular structures [Figure 4.2 (B)], lined with polarised
T he transp lan ta tions o f  tum our tissue in nude m ice  from  one xenograft genera tion  to another.
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columnar-shaped CQ\h and some mucus containing goblet cells. Focal clusters o f signet 
ring cells are also observable in the more solid outer regions o f  SW 1222 xenografts. 
The microvascular systems of these tumours result in a heterogeneous distribution o f 
vessels and both xenografts display hypoxic regions which are particularly emphasized 
in LS147T, an example o f which is shown in [Figure 4.3 (A&B)],
F igure 4.1. Xenograft tumours
F igure 4 .1 . Subcutaneously  g row n  co lorectal xenograft tum ours both  tum ours a lso  show  hem orrhag ic  
regions: (A ) L S I4 7 T  and  (B) S W 1222 (m ouse skin attached behind). F eeding  vesse ls w ere  kep t a ttached  
to the structure .
Figure 4.2. Colon cancer xenograft histology
A b
F igure 4 .2 . H isto logy  sections o f  (A ) L S 147T  and (B ) SW 1222 show ing d iffe ren t g landu lar structures in 
each tissue, g landular acini (arrow s), necro tic  regions (asterisks) and vessel (triang le). T he bar on  each 
im age represen ts 100 pm.
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Figure 4.3. The distribution of vascular and perfused tissue in a xenograft
Figure 4.3. A  com posite im age o f  three fluo rescen t m arkers for; vascu lar endothelia l cells (an ti-Factor- 
V III - red), m ark ing  oxygen perfused  tissue (H oechest 33331- blue) and  hypoxia  m arker (p im onidazole  
- green) in a L S I4 7 T  tum our. (A ) L ow  pow er m agn ifica tion  and  (B) h igh  pow er m agnification . [Pedley  
et al., 2002]
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Earlier in [Chapter 2] it was argued that the vascular system was best studied as a three 
dimensional structure. A number o f different approaches such as 2-photon microscopy, 
physical sectioning and optical coherence tomography, were considered as possible 
methods to elucidate the three-dimensional vascular architecture. Initial studies 
determined that physical sectioning was impractical due to the technical difficulties 
associated with sectioning and image registration. In the case o f two-photon 
microscopy, although a promising technique, this system is constrained to use with 
window chamber xenografts, and additionally was deemed to lack adequate penetration 
o f the sample to make it viable for the intended purposes. No pilot studies were 
attempted with optical coherence tomography as the equipment was not readily 
available.
O f the available methods, corrosion casting best satisfied the goals of capturing three- 
dimensional vascular architecture o f the tumour. Following initial work using 
stereoimaging. X-ray micro-computed tomography was employed for imaging and 
morphometry o f cast architecture. This novel technique enables fully volumetric data to 
be generated, giving new insight into vascular structure, and represents the first use o f 
this technique to study corrosion casts o f tumour vasculature. From this volumetric data 
it is possible to accurately assess microvascular density, vessel cross-sectional area, 
specific vessel surface area and tortuosity o f the microvasculature. It should be noted 
that the references to vessels in the context o f corrosion casts relate to a cast o f  the 
vessel lumen and not the actual vessel (which includes layers o f cells, and proteins 
discussed in [Section 1.3]).
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4.2 Chapter aims
The goals o f this chapter are to determine and quantify the three-dimensional structure 
o f the tumour microvascular system in both clinical and experimental colonic tumours. 
A schematic o f the workflow planned is shown in [Figure 4.4].
I. Corrosion cast architecture: This comprises the first phase o f the project.
Vascular corrosion casts will be produced for use in both stereo-imaging and
microcomputed tomography morphology studies.
II. Stereo-imaging morphometry: The first morphometry study o f cast 
architecture will be carried out to measure vessel branching angle, inter­
branch distance, vessel diameter and inter-vessel distances by means o f 
stereo-imaging.
III. X-ray micro computed tomography: X-ray micro computed tomography will
be used to further explore the structure o f the vascular cast. This will 
complement the stereo-imaging study by generating a volumetric 
representation o f the vascular cast, and will enable previously undetermined 
parameters such as surface area and vessel cross-section area to be evaluated. 
This method will also be assessed as a possible alternative to stereo-image 
analysis.
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Figure 4.4. Workflow schema
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F ig u re  4 .4 . Show s the passage o f  w ork  from  a b io log ica l system  through analysis and  in-silico sim ulation. 
* B lood flow  sim ulations carried  out using the m icrocom puted  tom ography datase ts o f  the tum our vascu lar 
system s are covered  in chap ter 5
4.3.1 Material: clinical tissues
The corrosion casting study included tumour specimens o f clinical cancers excised from 
20 patients (mean age 66 ± 3, 12 male, 8 female) undergoing surgery for primary 
adenocarcinoma, additional precancerous adenomas were found in 6 o f these patients. 
For the adenoma samples: 1-6 samples o f whole adenomas were taken from each o f the 
6 patients. For the adenocarcinoma samples: 3-5 blocks o f adenocarcinomas tssue o f 
0 .8-1cm in diameter were taken from the tumour center, periphery and luminal surface 
in each o f the 20 patients. 2 Control tissue blocks representative o f normal vascular 
architecture were taken from the normal gut mucosal at sites distal to the tumours in 
each of the 20 patients. The sub-division o f adenocarcinoma tissue: tumour periphery.
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luminal tumour surface and core are shown in [Figure 4.5 (A)]. The clinical samples and 
corrosion casting were obtained in collaboration with Professor Moritz Konerding 
[Konerding et al., 2001]. All o f these surgical specimens and tissue samples were 
obtained from the Department o f General and Abdominal Surgery o f the Johannes 
Gutenberg-University Mainz with the written consent o f the patients in accordance with 
the local ethical committee’s approval and legal regulations.
4.3.2 Material: xenograft tissues
The human colorectal cancer cell lines LS147T and SW1222 were grown as 
subcutaneous xenografts in the flanks o f female nude mice (MFI) with average weight ± 
Standard Deviation o f 26.35 ± 1.71g (SW1222 mice) and 30.25 ± 2.41g (LS147T mice). 
Average perfused tumour weight ± Standard Deviation was 0.88 ± 0.27g (SW1222) and 
0.67 ± 0.28g (LS147T). Animals were transported to Germany in accordance with UK 
Home Office regulations.
4.3.3.1 Method: clinical tumour corrosion casting
For the clinical tumours, fresh hemi-colonectomy specimens were excised from patients 
undergoing surgery for colorectal cancer. The main arteries o f the excised tissue were 
cannulated and blood was flushed out with 37 °C heparinated buffered saline prior to 
injection with 80-120mls o f the Mercox CL-2B epoxy polymer. 3-5  tissue samples 
with a diameter o f 0 .8 - 1 .0 cm were excised from the tumour centre, the periphery and 
the invasive edge and/or polyps. After an initial 24 hour in water at 80°C, tissue 
digestion was performed by soaking in NaOH (7%) for 1-2 weeks, changing the 
solution and washing frequently. Following successful removal o f  all tissue, final 
hardening o f the cast was completed by freeze drying overnight. The sample was then 
mounted and prepared for scanning electron microscopy and microcomputed 
tomography.
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4.3.3.2 Method: xenografts corrosion casting
For the colorectal xenografts, 6  tumours o f each xenograft type (SW1222 and LS174T) 
were used for stereo-imaging. Under deep pentobarbital anaesthesia, forearms and hind 
legs o f the mice were pinned to the dissection board and they were then thoracotomized. 
Forceps were pierced through the connective tissue behind the aorta and a suture was 
threaded through. The left ventricle was subsequently pierced with a broken pipette and 
drained o f blood. Through the left ventricle incision the aorta was cannulated and 
secured with the pre-threaded suture. The right atrium was then opened and the vascular 
system flushed through with 15 millilitres o f 37° C heparinated PBS solution (36-38°C, 
0.9% NaCl, pH 7.4).
Prior to perfusion o f the casting polymer, the right forearm was unpinned to relieve 
constriction and allow better perfusion. 7-1 Omis of Mercox CL-2B (Vilene Med. Co., 
Tokyo, Japan) diluted with 20% methylmethacrylate monomers (Merck, Darmstadt, 
Germany) was perfused through the mouse. The aorta was then clamped; the animal 
sacrificed and then soaked in water for 30 minutes to allow the polymer to set.
Post-curing, the tumour was excised for tissue digestion and histology staining, (half o f 
one tumour from each o f the two cell lines was formalin-fixed and processed to paraffin 
for haematoylin-eosin staining to show morphology. After an initial 24 hour in water at 
80°C, tissue digestion was performed by soaking in NaOH (7%) for 1-2 weeks, 
changing the solution and washing frequently. Following successful removal of all 
tissue, final hardening o f the cast was completed by freeze drying overnight. The 
sample was then mounted and prepared for scanning electron microscopy and 
microcomputed tomography.
4.4.1 Method: stereo-imaging morphometry and statistical analysis
Each cast was mounted onto a specimen stub (BAL-TEC AG, Walluf, Germany) with 
conductive silver paste (Plano, Marburg, Germany), stabilized with copper conductive 
bridges and coated with gold in an argon atmosphere to a thickness o f 40-45 nm at an 
amperage o f 30-35 nA (BAL-TEC AG, Walluf, Germany). 10-25 stereo-images o f  each 
cast were collected using a scanning electron microscope (Cambridge Stereoscan 180
80
SEM). Four parameters (inter-vessel distance, inter-branch angle, inter-branch distance 
and branching angle) [Figure 4.5 (B)] were calculated from stereo image pairs 
[Konerding et al., 2001;Konerding et al., 1999;Malkusch et al., 1995]. Image 
digitization, enhancement and 3D-morphometry (stereoptic) were carried out with the 
Kontron® KS 3000 (Kontron, Eching, Germany) image analysis application using 
additional macros developed by Malkusch et al. [Malkusch et al., 1995].
Measurements are calculated as a function o f equivalent pairs o f x-y coordinates on 
each image. The known parallax tilt o f 6  degrees enables linear distances and angles to 
be calculated in three dimensions. Linear distances were measured using two pairs o f 
points, equations [4.1-3], and branching angles with 3 pairs o f points, equations [4.4- 
10]. Computation o f the distances and angles are detailed in [Figure 4.6 (A&B)].
The depth is calculated using parallax angle:
Z|, = (%t, - x ,  J /(2 * s in (6 /2 ) )  [4.1]
Zig = - - \^ ) /(2 * s in (6 /2 ) )  [4.2]
The distance c is given by:
c = ^jdx~ +dy~ +dz~ [4.3]
In a similar to manner to the calculation o f linear distance depth, calculations the depth 
coordinates Z 1.3 is given by:
=(^ir -% ,g )/(2*sin (6 /2 )) [4.4]
=(^2r -%2g)/(2*sm(6/2)) [4.5]
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Z],- = (^ 3,- -  ) /(2 * sin(6 / 2)) [4.6]
The distances a, b and c is given by:
= ( j 2 r - x 3 r ) “ t/x“ = ( x l r - x 3 r ) “ d x ' = { x l r  -  x \rŸ
dy^ = ( y l r  -  y3>rŸ dy^ = (y lr  -  y 3 r)“ dy~ = { y l r  -  ylr)^
dz^ = { z 2 r ~ z 3 r Ÿ  dz~ = ( z l r - z 3 r ) ~  dz~ = {z2r -  z\r)~
b = yjdx^ + dy^ + dz~ c = ^Jdx~ + dy~ + dz^ ^
[4.7] [4.8] [4.9]
The angle 6 between the branching vessel elements is then given by:
0 = arccos((6' +c-a~) l {2bc) ) \ ^QI  k  [4.10]
Graphical display and statistical analysis were performed using MATLAB^
(Mathworks, Natick, Massachusetts, USA). Means o f each parameter class: branching 
angle, inter-branch distance, vessel diameter, and inter-vessel distance for each tissue 
were compared using a pairwise balanced one-way analysis o f variance (ANOVA). This 
test requires an identical sample size across each tissue type, which was created by 
taking N  data points {N being the number o f samples in the smallest group), uniformly 
resampled (matlab randsample) without replacement, from the original data. Logio- 
transformation was required to satisfy the normal distribution requirements o f the 
ANOVA in the case o f inter-branch distance, vessel diameter, and inter-vessel distance 
which were all skewed with a z-score >1.96 [Rorden, 2007]. In all tests the critical 
value was taken at 5%.
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Figure 4.5. Carcinoma sub-regions and vascular architecture parameters
Gut lumen 
▲
Figure 4 .5 . (A ) C ross-section  o f  a tum our/gu t-w all neoplastic tissue (grey). C arc inom a sub reg ions selected  
for study: tum our periphery  (tr), lum inal tum our surface (tz), and tum our core (tt). (G u t lum en [dashed  arrow ], 
invasive front [solid arrow s]). (B) Param eters m easured  by stereo-im age m orphom etry : 1) b ranch ing  angle 
(orange), 2) in ter-branch distance (red), 3) vessel d iam eter (blue) and 4) in ter-vessel d is tance  (green).
Figure 4.6. Distance and angle calculations in stereoimaging
XlgYlg
B
F igure 4.6. (A) For im ages r (red) and g  (green) positions x,y re fer to the coord inate  positions 
on each  im age, z defines a ca lcu lated  depth  value. T he value c is the ca lcu la ted  linear d is tance 
betw een  the tw o three-dim ensional coord inates xir,yir. Zn and X2g,y2g. Z:g.(B) F or im ages r (red) 
and  g  (green) positions x,y re fer to the coord inate  positions on each im age, z defines a 
ca lcu la ted  depth value. T he angle 0 is the calculated angle between a three-dim ensional 
bifurcation.
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4.4.2 Results: qualitative observations of cast architecture
A number o f distinct features are observable in the scanning electron micrographs o f 
each tissue vascular casts.
The normal colonic mucosal capillary plexus layer is arranged in a pseudo-regular 3D 
lattice composed of repeating ‘hexagonal’ and ‘rhomboidal’ units [Figure 4.7 (A)]. This 
plexus is directly supplied by arteries that divide within the submucosa to sub-epithelial 
capillaries, blood is subsequently drained from the mucosal capillaries by venules 
originating immediately under the mucosal surface and leading to the submucosal veins. 
The regular structure observed in the normal mucosa casts was not preserved in either 
clinical samples (adenoma or carcinoma) or xenografts.
An extensively branched tree-like phenotype was observed in the adenoma vascular 
casts. Although branching hierarchy was best preserved in the adenoma [Figure 4.7 
(B&C)], much o f the architectural features commonly associated with tumour 
vasculature (heterogeneity, tortuosity, fenestrations and blind endings) were also present 
in the carcinoma periphery, luminal tumour surface and core [Figure 4.7 (D-F)].
It can clearly be seen that all four clinical tumour vascular architecture are abnormal 
when compared to control mucosa vessels, what was less clear was how they vary with 
respect to each other. While adenoma and carcinoma vessels retain some o f the 
hierarchy observed in the control mucosa [Figure 4.7 (B-F)], xenograft vasculature was 
without comparable organisation [Figure 4.8 (A-F)].
Images o f  casts from LS147T and SW1222 showed clear differences in structure. In 
particular LS147T showed the presence o f large avascular areas, which putatively were 
due to regions o f localised necrosis within the tumour. Although both tumours showed 
an increase in vascularisation at the periphery o f the cast, this was much more 
pronounced in SW1222 casts [Figure 4.8 (C)], in general this tumour was more 
vascularised. Smaller vessels in LS147T casts appeared narrow, poorly organised and 
frequently terminated in blind endings [Figure 4.8 (B)], in contrast to those o f SW1222 
[Figure 4.8 (C)], which were generally larger.
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Some interesting, if  less generalised, observations were made in a number o f casts. In 
[Figure 4.8 (A)] abnormal growth surrounding a large feeding vessel entering a LS147T 
tumour is shown. Here the central vessel can just be made out underneath a dense mat 
o f tortuous sprouts -  this particular form o f vessels was only seen in one cast. In a few 
LS147T and SW1222 casts, flattened nodules o f the casting polymer formed into 
structures which did not resemble vessels [Figure 4.8 (D)]. Leaking polymer is 
indicative o f the vascular tone and porosity as the casting polymer is normally too 
viscous to seep through the pores o f normal vessels. The presence o f abnormal vascular 
wall was a feature o f a number o f tumour casts where large pores and fenestrations are 
highlighted by stubs o f extruded polymer. These extra-vascular extrusions o f polymer 
were highly heterogeneous, ranging from small protrusions on the surface o f the vessel 
to large globular domains (some o f which may also possibly represent regions o f blood 
lakes in the tumour [Konerding, 2005]). These extrusions o f polymer were more 
common in the xenograft casts than the adenoma and carcinoma samples. A good 
example o f aberrant vascular connectivity is shown in [Figure 4.8 (E&F)]. In this 
SW 1222 xenograft there is a direct connection o f an arteriole to a venule with no 
discernable intervening capillaries. Arterial-side vessels are identified by the shape o f 
the oblong endothelial cell nuclei imprints (marked by the black arrow) in the cast 
polymer, whereas the venule endothelial nuclei indentations were more rounded 
(marked by the white arrow). Further anomalies in the local vessel morphology in 
[Figure 4.8 (E)] include the flattened vessels, which is consistent with compressive 
forces exerted by the tum our cells and elevated interstitial pressure.
To some extent a distinct core and periphery were observable in the xenografts, 
although these domains were sometimes not well defined. In some cases, densely 
vascularised regions were observed centrally in the xenograft and conversely avascular 
(and poorly vascularised) regions spread out to the peripheral regions o f both xenograft 
types. This can also be seen in the staining o f normoxic and hypoxic microenvironments 
in LS147T [Figure 4.3 (A)]. There is also some evidence to suggest that the core vessels 
are larger (and often flattened) in both xenografts [Figure 4.8 (E)] (though no time was 
available for quantitative study).
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Figure 4.7. Examples o f normal mucosa and clinical tumour vessels
'ê
$
u
Figure 4.7. Scanning e lec tron  m icrographs o f  the corrosion casts o f  the vessel lum ens from  (A ) contro l 
m ucosa, (B) adenom a low  reso lu tion , (C) adenom a high reso lu tion , (D ) carc inom a periphery (tr), (E) 
carcinom a luminal tumour surface (tz), (F) carcinom a core (tt). [from  K onerd ing  im age Library]
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Figure 4.8. Examples o f LS147T and SW1222 vascular cast architecture
V enous and A rteria l vessels en larged  from  
Panel E
Figure 4.8. (A ) L S147T  abnorm al vessel grow th around  a large supp ly ing  vessel (o range arrow ), (B) 
LS147T poorly  o rgan ised  vessels w ith blind  endings and  shunts w ere com m only  observed  in the 
xenograft casts (green arrow s), (C ) SW 1222 vessels appeared  larger tow ards the core o f  the tum our, 
d irections o f  the tum our core (red arrow s) and periphery  (b lue arrow s); exuding  po lym er (g reen  stars), 
(D ) SW 1222 show ing  large g lobu lar ex travascu lar ex trusions o f  casting po lym er (yellow  arrow s), (E) 
SW 1222 dem onstra tes an  exam ple o f  an arterio -venous shunt; characteristic  indentations o f  arterio le 
(b lack  arrow ) and venule (w hite arrow ) endothelia l cell nuclei can be c lea rly  seen on tw o vessels w hich 
have no ad jo in ing  capillaries and (F) E nlarged sections from  the prev ious panel show ing  characteristic  
endothelial cell indentations on the casting  polym er. Scale bars: 500^m (A,C,E) and200jum(B,D).
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4.4.3 Results: quantitative stereo-image morphometry and statistical 
analysis
Stereo-imaging measurements, as described in [Section 4.4.1], were collected for each 
geometrical parameter (branching angle, inter-branch distance, vessel diameter and 
inter-vessel distance), and the resulting distributions o f these parameters were analysed 
in order to demonstrate statistically significant differences between the cast 
architectures. The number o f samples taken in each instance is listed in [Table 4.1].
Table 4.1. Stereoimaging measurements
Branching
angle
Inter-branch
distance
Vessel
diameter
Inter-vessel
distance
Control 1806 3001 5000 1127
Adenoma 920 1104 3000 1142
Carcinoma* 6284 8889 15250 7200
Periphery -  tr 2306 3517 5250 2627
Luminal 
Tumour 
Surface- tz
2236 3517 5250 2486
Core -  tt 1742 1855 4750 2087
LS147T 860 793 1223 1107
SW1222 827 932 1243 979
T a b le  4 .1 . T he num ber o f  sam pled  data  po in ts fo r each  param eter. T he carcinoma* sam ples rep resen t 
pooled  d a ta  from  periphery (tr), luminal tumour surface(tz) and core(tt). T he  adenomas are not 
separated  into equ ivalen t reg ions for analysis due to the re latively  sm all size  o f  the polyps.
The Control, Adenoma and Carcinoma data were kindly provided by Professor Moritz Konerding, 
University o f  Mainz, Germany. The Xenograft data (LS147T and SW1222) was collected by the Author 
at UCL ’s Clinical Oncology Dept. Royal Free Hospital, London.
The histograms of each o f the geometrical parameters are shown in [Figures 4.9-12], 
ANOVA for each dataset are shown in [Figures 4.13-15].
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Figure 4.9. Distribution of branching angles
Histogram of Control Branding A n^ of Adenoma Branching Angie
0 20 40 60 aO too 120 140 ISO 180
Brandang AntfetDeyeesi
HistoTwn of Cwdnoma Branching A n^ MKtoyam of LS Branching Anj^
Hwoyamof SW B randm gA ^
0 20 40 90 60 too 120 140 180 180
BrandmgAngh, Degrees)
T issue M ean S ta n d a r d S kew
(d eg rees) D ev ia tio n
C ontrol 87.14 29 .10 0.01
A denom a 77.74 34.81 0.26
C arcinom a 73.31 33.57 0.26
L S147T 77.16 29.30 0.286
SW 1222 81.85 27.60 0.166
F ig u re  4.9. H istogram s o f  b ranching  angle  d is tribu tions in: (A ) norm al m ucosa, (B ) adenom a, (C) 
adenocarcinom a, (D) L S147T  and (E ) SW 1222.
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Figure 4.10. Distribution o f inter-branch distances
Histogram of Control Inter-Branch distance
0 too 200 300 400 500 600 7 1 1 0 8 0 0 9 0 0  1000
Inter-Branch distance(Microns)
Histogram of Carcinoma Inter-Branch Distance
0 100 200 300 400 900 600 700 800 900 1000
Inter-Branch Disfance{Microns)
Histogram of SW Inter-Branch Distance
0 100 200 300 400 500 600 700 800 900 1000
Inter-Branch Distance(Microns)
Histogram of Adenoma Inter-Branch Distance
0 100 200 300 400 500 600 700 800 900 1000
Inter-Branch Distance(Microns)
Histogram of LS Inter-Branch Distance
0 100 200 300 400 500 600 700 800 900 1000
Inter-Branch Distance(Microns)
T issu e
C ontrol
M ean  S ta n d a r d  S kew / 
(m ic ro n s )  D ev ia tion  (a f te r  log 
t r a n s fo rm )
28.4951.25
A denom a 54.91
C arcinom a 78.49
L S147T 66.94
SW 1222 104.75
1.61(-0.23) 
31.67 2 .25 (-0 .25 )
70.69 3 .40(0 .30)
50.71 2 .83(0 .18)
70.89 2 .81(-0 .09)
F ig u re  4.10. H istogram s o f  in ter-b ranch  d istance d is tribu tions in: (A ) norm al m ucosa, (B) adenom a, (C) 
adenocarcinom a, (D ) L S I4 7 1  and  (E) SW 1222.
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Figure 4.11. Distribution o f vessel diameters
Histogram of Control Vessel diameter Histogram of Adenoma Vessel Diameter
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Histogram of Carcinoma Vessel Diameter
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Veswl DWMenMlcrani
T issu e M ean S ta n d a r d S k ew /
(m ic ro n s ) D ev ia tio n (a f te r  log 
tr a n s fo r m )
C ontrol 17.72 29.59 5 .66(3 .96)
A denom a 15.97 5.03 0 .80(-0 .14)
C arcinom a 22.66 16.03 3 .12(0 .20)
L S147T 23 .50 22.54 5 .30(0 .37)
SW 1222 38 .96 25.45 2 .15(-0 .18)
F ig u re  4.11. H istogram s o f  vesse l d iam eter d istribu tions in: (A ) no rm al m ucosa, (B) adenom a, (C ) 
adenocarcinom a, (D ) L S147T  and (E ) SW 1222.
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Figure 4.12. Distribution o f inter-vessel distances
Histogram of Control Inter-Vessel distance
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T issu e  M e a n  S ta n d a r d  S kew /
(m ic ro n s ) D ev ia tio n  (a f te r  log 
tr a n s fo rm )
C ontro l 101.53 23 .19  0 .37 (-0 .24 )
A denom a 60.57  37.87  1 .85(0.19)
C arcinom a 1 13.52 115.55 3.30 (0 .33)
L S147T  59.76  55.75 4 .87 (0 .10)
SW 1222 96 .70  64.625 2 .71(-0 .29)
F ig u re  4 .12. H istogram s o f  in ter-vessel d istance d istribu tions in: (A) norm al m ucosa, (B ) adenom a, (C ) 
adenocarcinom a, (D ) L S147T  and  (E) SW 1222.
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Figure 4.13. Boxplot of the branching angle distributions and ANOVA results
Boxplot of Branching Angle DislhbutionsA
160
140
120?
m
tt LS147T SW1222Control Adenoma Carcinoma tr tz
Tissue Type
Branching Angle Multiple Comparison Anova
Adenoma
Carcinomajj
Carcinoma tr
»  Carcinoma tz
Carcionma tt
LSU7T
75 80
Branching Angle (Degrees)
F ig u re  4 .13. (A )B oxplo t o f  the resam pled  data, (B ) the result o f  a pairw ise A N O V A . T he points 
representing  the m ean values for each tissues type. Points w ith  overlapp ing  horizontal w hiskers are not 
significantly  d ifferen t (5%  sign ificance threshold). A lthough  the d istributions o f  this param eter appear 
sim ilar in both  m ean values and  variation, the d istribu tion  o f  vessel branch ing  angle in bo th  adenom as 
and both  xenografts d iffered  sign ifican tly  from  the carc inom a periphery and lum inal tum our surface. * 
Carcinoma_p represen t pooled  data  from  separate  sub-reg ions periphery (tr), luminal tumour siirface(tz) 
and core(tt).
Figure 4.14. Boxplot o f the inter-branch distance distributions and ANOVA results
A Boxplot oflnter-Branch Distance Distributions
2 5
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Control Adenoma Carcinoma tt tt LS147T SW1222tz
Tissue Type
Inter-Branch Distance Multiple Comparison Anova
Control
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16 1.71 1.8 19
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2 2.1
F ig u re  4 .14. (A )B oxplot o f  the resam pled  data  (log,o transform ed), (B) the result o f  a pa irw ise  A N O V A . 
The points represen ting  the m ean values for each tissues type. Points w ith overlapping  horizontal 
w hiskers are no t significantly  d ifferen t (5%  sign ificance  threshold). A general increase in the in ter-branch 
d istance from  periphery  to core  is observed in the carc inom a tissue, a sim ilar increase in this param eter is 
observed betw een  LS147T and SW 122. * Carcinoma_p represen t poo led  data from  separa te  sub-regions 
periphery (tr), luminal tumour surface(tz) and  core(tt).
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Figure 4.15. Boxplot of the vessel diameter distributions and ANOVA results
Boxplot of Vessel Diameter Distributions
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F ig u re  4 .15. (A )B oxplot o f  the resam pled  data (logio transform ed), (B ) the result o f  a pairw ise A N O V A . 
The points represen ting  the m ean  values for each tissues type. Points w ith  overlapp ing  horizontal 
w hiskers are not significan tly  d ifferen t (5%  sign ificance threshold). T he variab ility  is a c learly  featu re  o f  
these d istribu tions o f  this param eter, com pare the relatively narrow  range in the con tro l m ucosa  and  the 
increasing variability  p rogressing  from  carc inom a periphery to core. T he variab ility  o f  the tw o xenografts 
is m ore com parab le  to the variab ility  in the carcinom a core than the adenom a. * Carcinomaj) represent 
pooled  data  from  separate  sub-reg ions periphery (tr), luminal tumour surface(tz) and  core(tt).
Figure 4.16. Boxplot o f the inter-vessel distance distributions and ANOVA results
Boxplot of Inter-Vessel Distance DistributionsA
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F ig u re  4 .16 . (A )B oxplot o f  the resam pled  data (logio transform ed), (B ) the resu lt o f  a pairw ise  A N O V A . 
The points represen ting  the m ean  values for each tissues type. Points w ith  overlapp ing  horizon tal 
w hiskers are  not significantly  d ifferen t (5%  significance threshold). * Carcinoma_p rep resen t poo led  data 
from  separa te  sub-regions periphery (tr), luminal tumour surface(tz) and  core(tt).
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4.4.4 Discussion: stereo-image morphometry and ANOVA results
With exception to the approximately normal distribution seen in the branching angle, 
the other three parameters were broadly consistent with a log-normal distribution^.
Branching angle
As noted in experiments by Gerhardt et al. [Gerhardt et al., 2003;Ruhrberg et al., 2002], 
the nascent vessel sprouts are shown to be misguided by a removal o f proper tumour 
angiogenesis factor patterning and gradient. It was therefore anticipated that aberrant 
sprout guidance would manifest itself by increased heterogeneity in the branching angle. 
Although the tumour tissues evaluated all differed significantly from the control mucosa 
in terms o f their mean value, the different tumour samples and regions had similar mean 
branching angle and did not appear significantly different from each other. The standard 
deviation o f all the distributions also appeared very close, even between control and the 
tumour types; this was surprising as it suggested that the heterogeneity in branching 
angles was more conserved across the different tissues [Figure 4.9].
This normal distribution shape was only observed for branching angle data. This 
symmetry suggests a strong developmental control may be acting to inhibit extremes o f 
branching, which would in turn have adverse effects on flow through the vascular 
network. In the control mucosa we observed a mean branching angle o f 87.14° this 
implied a more predominantly square or rhomboidal configuration o f the mucosal 
vascular lattice, and less so than the hexagonal arrangement as previously reported in 
[Konerding et al., 2001;Fait et al., 1998].
The ANOVA results [Figure 4.13 (B)] showed that the mean branching angle value of 
SW1222 was indeed different from the carcinoma tissue (p<0.05). Branching angle for 
adenoma, carcinoma (core) and LS147T tissues are not significantly different from each 
other. Mean values o f branching angle in both peripheral and luminal tumour surface 
samples o f carcinoma tissue are both narrower than in the core (although narrowly 
outside o f the significance boundary). This may be a consequence o f the greater
 ^ P robab ility  M odel-B ased  A nalysis o f  T um or V ascu lature  D ata, it w as a rg u ed  here  that the branching  
angle m ay be better represen ted  by  a be ta-d istribu tion , because the range  o f  th is d is tribu tion  effectively  
has an  upper and  low er lim it [O gunnaike et al., 2005].
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branching density in these regions, as indicated by the smaller inter-branch and inter­
vessel distances in these regions [Figure 4.14 (B)].
In relation to which xenograft provided the best approximation o f clinical carcinoma 
architecture, mean branching angles are: LS147T (mean 77.16°), SW1222 (mean 
81.85°) and carcinoma (mean 73.31°). Despite being slightly larger in the SW1222, the 
ANOVA results do not show significant differences between the xenograft [Figure 4.13 
(B)].
Inter-branch distance
Insight into the vessel density and branching rate in each tissue sample was provided by 
distributions of inter-branch distance [Figure 4.10]. In carcinoma samples, the most 
angiogenic regions bordered the normal and tumour tissue (i.e. the carcinoma periphery 
samples), the greater sprouting frequency results manifests through the reduced mean 
inter-branch distance measures [Figure 4.14 (A)]. Due to their relatively small size, 
xenografts and adenomas were not analysed by region, however a visual inspection o f 
the casts scanning electron micrographs suggest smaller inter-branch distances are also 
present in the peripheral regions o f both LS147T and SW1222 [Figure 4.8 (C)].
Pavlopoulos et ai. report that “branching counts are significantly higher” in carcinoma 
than adenoma [Pavlopoulos et al., 1998], in their study bifurcation density was 
determined by the number o f ramifications per 100 sections. The stereoimaging analysis 
here shows that this may only the case in the carcinoma periphery. This can be seen in 
[Figure 4.14 (B)] which clearly shows inter-branch distance in the pooled carcinoma 
data, carcinoma luminal tumour surface and core are all significantly higher than in the 
adenoma, consequently these tissues have a lower branching frequency. Flowever as no 
delineation was made between the different carcinoma regions in the study by 
Pavlopulos et al. it was not possible to establish whether this conclusion is due to the 
regions o f carcinoma tissue selected or the limitations o f the two-dimensional method 
used to evaluate branching.
Mean inter-branch distances in clinical control, adenoma and carcinoma periphery are 
not significantly different from each other. Mean inter-branch distances for the 
carcinoma regions show a significant increase from both luminal tumour surface and
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periphery to the carcinoma core. In the case o f the tum our core, this region is outside the 
highly angiogenic edge o f the tumour, and has reduced sprout formation, consequently 
longer regions between branches. The reason for the differences in branching distance 
in the luminal tumour surface and periphery were not clear as both these regions lie on 
the periphery o f  the tumour.
In relation to which xenograft provided the best approximation o f clinical carcinoma 
architecture, mean inter-branch distances are: LS147T (mean 66.94pm), SW1222 (mean 
104.75pm) and carcinoma (mean 78.49pm). ANOVA results suggested there was no 
significant difference between the means o f the LSI47T and the pooled carcinoma, 
which was not the case for SW1222. Therefore with respect to inter-branch distance, a 
better match was made by the LS147T to the carcinoma vascular architecture Figure 
4.14(B )].
Vessel diameter
One noticeable difference in the vessel diameter distributions was the range o f 
variability in this parameter [Figure 4.11 (A)]. This can be seen to increase from the 
carcinoma margins (both tr and tz) through to the core where the spread o f diameter was 
largest [Figure 4.15 (A)]. The incremental trend in increasing vessel diameter from 
control mucosa > adenoma > carcinoma has been correlated with tumour progression 
from benign to malignant states. These results concur with findings o f Pavlopulos et al. 
where several vessel size-defining parameters where measured in both adenoma and 
adenocarcinoma tissues (from two-dimensional sections). All parameters relating to 
vessel calibre (perimeter, major and minor axes, and area) were found to be 
significantly larger in the adenocarcinoma by comparison to the benign adenomas 
[Pavlopoulos et al., 1998].
In relation to which xenograft provided the best approximation o f clinical carcinoma 
architecture, the mean values o f vessel diameter are: LS147T (mean 23.5pm) and 
SW1222 (mean 38.96pm) and carcinoma (mean 22.66pm). The ANOVA results 
showed that the mean vessel diameter o f LS147T was not significantly different from 
the pooled carcinoma data and therefore provided a closer match to the carcinoma tissue 
than SW1222 which was significantly larger [Figure 4.15 (B)].
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Inter-vessel distance
Although the inter-vessel distance does not directly contribute to the haemodynamical 
properties o f the tumour vascular system, it is nevertheless an important attribute in 
determining the hypoxia in the tissue and it is also an indicator o f local metabolic 
burden o f the tumour tissue [Hlatky et ah, 2002]. Increased variability in this parameter 
was observed in the tum our tissues relative to the normal mucosa samples which have a 
very narrow range for this parameter, again confirming the loss o f vessel density from 
the peripheral regions. Increased angiogenic activity and consequently vascular density 
in the periphery carcinoma samples results in a transition from a wider mean inter­
vessel distance in the normal mucosa to a shorter distance in the tumour periphery 
which increases again in the luminal tumour surface and tumour core as vascular 
density drops Figure 4.16 (A)].
In relation to which xenograft provided the best approximation o f clinical carcinoma 
architecture, mean inter-vessel distances are: LS147T (mean 59.76pm), SW1222 (mean 
96.7pm) and pooled-carcinoma (mean 113.52pm). ANOVA results suggested that with 
respect to inter-vessel distance, a better match is made in this case by the SW 1222 to the 
carcinoma vascular architecture Figure 4.16 (B)] %
4.5.1 Method: X-ray micro-computed tomography
Micro computed tomography or ‘micro-CT’ is an X-ray imaging technique similar in 
principle to the ‘computed (aided) tomography’ (CT or CAT) systems used in hospitals 
though as the name implies, micro-CT scanning resolution is greatly increased by 
several orders o f magnitude. With the most recently available micro-CT machines such 
as the SkyScan 2011 x-ray nanotomograph, very fine scales o f internal structure can be 
determined at resolutions o f up to 150 nm^. The scanning resolutions o f these machines 
are more than sufficient to capture the finest microvascular vessel elements, as the 
scanning resolution is several orders o f magnitude lower than the smallest vessels 
observed in-vivo.
’ Som e doubt is cast over the  re liab ility  o f  stereo im age in ter-vessel d is tance  m etric and  its use as an 
estim ate o f  m icrovascu lar density , as the results from  m icro -tom ography  m easures [Sections 4 .5 .2 -3 ], 
w hich provide a m ore d irec t m easu re  o f  m icrovascu lar density , show ed that SW 1222 have h ig h e r vessel 
densities than L S147T.
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Micro-computed tomography works by collecting several hundred o f x-ray projections 
(shadowgram) o f a sample object from different angular views, as it rotates on a high- 
precision stage illuminated by a micro-focused x-ray source [Figure 4.17 (A)]. From 
this series o f shadowgram projections (an X-ray attenuation image), a computer cluster 
is used to reconstruct cross-section images o f the object using a modified Feldkamp 
cone-beam algorithm [Figure 4.17 (B)]. These reconstructed images represent the 
internal microstructure and density o f the sample. The series o f cross-sections (z-stack) 
through the sample object can be scrolled through to: inspect internal structure, select 
particular volumes o f interest, perform 3D morphometry, and generate virtual-models of 
the object for visual inspection using volume or surface rendering algorithms. Three 
dimensional representations o f the tomography z-stacks were produced by ray-tracing 
volume rendering using Volsuite [Bryan, 2005].
Micro-CT provides the advantage o f visualising corrosion casts as a truly three- 
dimensional object. This technique enables very accurate measures o f vessel density and 
cross-sectional area, which were previously crudely estimated by inter-vessel distance 
and vessel diameter in the prior stereo-imaging system. Microvascular specific vessel 
surface area was also measured using a count o f the edge-lining voxels.
Corrosion cast samples for high resolution scans were frozen in water and cut to 
appropriate sizes, then thawed in a freeze-drier. This step was necessary to prevent 
damage to the delicate casts. Prior to scanning, whole or cropped samples o f the 
corrosion casts were fixed to an acrylic sample podium with epoxy adhesive (Araldite, 
Huntsman Advanced Materials). The casts were scanned in a micro-CT scanner 
(Skyscan 1172, Kartuizersweg, Belgium) at voxel resolutions o f between 1-3 pm^, with 
an angular rotation interval o f  0.25°. Scanning time was approximately 8-10 hours. 
Reconstruction o f the scanned sample was carried out on a 3-node computer cluster 
(using Nrecon/NreconServer application), taking approximately 8-16 hours.
Once scanned and reconstructed the tomography data is then assembled into a RAW 
file; due to memory constraints this process required a reduction in resolution by 33- 
50% depending on the size o f the initial sample and scan settings. Thresholding o f the 
grey-scale images was performed with Imaged [Rasband, 2006] to a yield a binary 8-bit
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image o f segmented vessel and void space. Generation o f  the binary image however 
resulted in a number o f ‘holes’ [Figure 4.18 (A)] due to lower polymer density in the 
axial regions o f the cast vessels (and hence a lower grey-scale value) and small localised 
inhomogeneities in the polymer. These holes were digitally ‘filled’ using an ImageJ  
hole-filling algorithm. Another technical problem identified related to a characteristic 
distortion around a portion o f the smaller vessels in a small number o f samples. The 
result was a ‘star’ shaped artefact in the reconstructed tomography image [Figure 4.18 
(B)]. Possible causes include ‘beam hardening’ where lower energy X-rays are absorbed 
as the polychromatic beam passes thought the specimen. The effects o f beam hardening 
are known to produce pronounced edges and streak artefacts, however these effects 
were relatively unaffected by beam hardening correction filters. This effect was always 
seen in the smaller vessels, particularly those with greater spatial degrees o f freedom. 
One possibility is resonance in the sample, due to minute vibrations made by the x-ray 
tomography machine’s ventilation fan [Myllys, 2006]; however the capture time at each 
angular increment is in the order o f minutes and is perhaps too long to justify this as a 
possible cause. One further contributing factor might be the crystallisation o f the 
MERCOX polymer. It is noted that MERCOX sets at higher density on the surface 
[Figure 4.18 (A)], as the smaller vessels are thinner, it is likely that their overall density 
is higher and might be contributing to the observed distortion.
Three-dimensional morphometry included measures for microvascular density, specific 
vessel surface area and vessel cross-sectional area; all measurements were carried out 
on the segmented 8-bit datasets. Microvascular density is expressed simply as a ratio o f 
voxels determined to be inside the vessel divided by the total number o f voxels in the 
cuboid domain. An estimation o f  specific vessel surface area was established by 
counting the number o f voxels adjacent to void voxels, divided by the total number o f 
voxels in the cuboid domain. It should be noted that this metric is resolution dependant 
and can only be used to assess the surface area o f high resolution samples. Although not 
studied here, a less resolution dependant estimate o f surface area might be performed 
fitting a triangular/polygonal isosurface mesh to the vascular surface using for example 
some variant o f the marching cubes algorithm. The mean vessel cross-sectional area 
(Vessel Calibre) [Figure 4.19 (A)] was determined by initially producing a skeleton 
(medial axis transform) o f the 3D vessel geometry and then fitting a spline to the central 
axis o f the skeleton (skeletonisation software was provided by Tuomas Turpinen
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[Hyvaluoma et al., 2007]). A surface perpendicular to each point along the spline is then 
calculated as delimited by the vessel/void voxel boundary.
The micro-computed tomography datasets also presented the possibility o f measuring 
tortuosity o f the tumour microvasculature in three-dimensions. Although this property 
o f tumour vessels is frequently observed in the literature [Gerhardt et al., 
2003;Konerding et al., 2001;Konerding et al., 1999;Konerding, 2006], with the 
exception of a study by Tozer et a l [Tozer et al., 2005], this aspect remains largely 
unquantified. The lack o f  tortuosity quantification in previous studies is largely due to 
the absence o f an accurate method for determining tortuosity due to the three- 
dimensional nature o f this parameter in the micro vasculature.
Tozer et a l  only used a single distance-metric to define tortuosity; however tortuosity is 
only partly defined by this metric. A more holistic approach to quantifying tortuosity 
was employed by Bullitt et a l  using a semi-automated method [Bullitt et ah,
2003;Bullitt et ah, 2004]. Three metrics which characterise different aspects o f vessel 
tortuosity were calculated from the segmented vascular structures: (1) Distance Metric 
(DM) -  a ratio between the actual curved path o f the segmented vessel and the linear 
distance between its endpoints, (2) Inflection Count Metric (ICM) -  a sum of the 
minima o f total curvature (inflection points) made by the vessel between its endpoints, 
and (3) Sum O f Angles Metric (SOAM) -  the sum o f total curvature between endpoints 
normalised by the path distance.
Bullitt et a l  originally developed this method to study vessel tortuosity from Magnetic 
Resonance Angiography (MRA). This method has been adapted by simply substituting 
the MRA datasets with binarized micro-computed tomography datasets. Although the 
resolution of the data was much higher in micro-computed tomography, the principles 
remained the same. The process for this analysis involved two steps: (1) semi­
automated segmentation o f  the micro-computed tomography datasets, which was carried 
out using VTreeSD [Figure 4.19 (B)], and (2) the tortuosity measurements on these 
segmented vessels using AnalyseVess3 [Figure 4.19 (C)].
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Figure 4.17. Schematic o f the X-ray micro computed tomography device
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F ig u re  4.17. (A ) Schem atic o f  the X -ray  tom ography m achine. A ttenuation  o f  the X -ray  th ro u g h  a 
corrosion  cast is used to p roduce a set o f  shadow gram  im ages o f  the cast at 0.25° increm en ts th rough  
180°. (B) R econstruction  o f  the co llection  o f  x-ray attenuation  im ages on a para lle l co m p u te r y ie lds a z- 
stack  o f  im ages (o rthogonal to the shadow -gram  im ages). T he voxel greyscale  in tensity  is p ropo rtiona l to 
density  on the reconstructed  im ages. A  ray-traced vo lum e rendering  can be used to v isua lise  the 3D  
structure o f  the z-stack.
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Figure 4.18. Pre-processing of tomography data
*
m
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F ig u re  4.18. Each case the processing  is done on a greyscale  im age (left), b inarised  (m iddle) and  filtered  
(right): (A ) hole filling  algorithm  and  (B) m edian filtering
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Figure 4.19. Determination o f vessel cross-sectional area and vessel tortuosity
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F ig u re  4 .19. (A ) T he process th rough  w hich  the cross-sec tional surface perpend icu lar to the v esse l axis 
w as com puted . T he b inary  im age (left) is used  to generate a th in  skeleton  (m iddle), w hich is used  to  fit a 
sp line to the axis. T he cross-sec tional surface delim ited  by the vesse l-vo id  boundary  is de term ined  
perpendicu lar to the central sp line, (B) V TreeSD  segm entation  in terface; b inarized  tom ography  d a tase t 
(w hite), sem i-au tom ated  segm en ted  vessels (overlay  in red), (C ) 3D  v iew  o f  segm ented  vessels u sed  for 
the to rtuosity  calcu lations (carc inom a dataset).
104
4.5.2 Results: 3D microvascular architecture as revealed by 
tomography
Both stereoimaging and tomography (3D volume reconstructions) show that the vessel 
hierarchy was better preserved in the control, adenoma and carcinoma vasculature in 
contrast to the vessels o f  the two xenografts [Figure 4.20 (A-L)]. The capacity to 
‘virtual section’ the rendered structure was particularly useful for inspecting the 
structure beneath the immediate line o f sight, using this facility it is possible to better 
appreciate how vessels are connected together [Figure 4.20 B,D,F,H&J].
Rendered images o f clinical samples: control mucosa [Figure 4.20 (A&B)], Adenoma 
[Figure 4.20 (C&D)] and carcinoma [Figure 4.20 (E&F)], all showed greater 
consistency in branching hierarchy and organisation, with larger vessels feeding a well 
organised bed o f capillaries. The characteristic branching patterns seen in the control 
mucosa stereoimaging could not be shown here as these delicate structures were 
damaged during cast transport between Germany and Finland.
Low resolution scans o f  SW 1222 and LS147T reveal a substantially different vascular 
morphology was present in these two xenografts. Both xenografts were grown in 
identical conditions which suggest that the cellular environments in these two tumours 
are substantially different. Large vessels in LS147T can clearly be seen to be flattened 
in concentric layers, indicating that there was a compressive force being exerted on the 
vessels o f the tumour [Figure 4.20 (G&H)].
A virtual section showing the core region o f LS147T [Figure 4.20 (G&H)] this tumour 
harbours substantial avascular regions which are more abundant throughout the 
structure than in the SW1222 tumour [Figure 4.20 (I&J)]. One common feature of the 
SW1222 casts was the appearance o f hyper-vascularised islands o f tissue, which 
although observed throughout the tissue were particularly concentrated around the edges 
[Figure 4.20 (K&L)].
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Figure 4.20. 3D renderings o f micro-computed tomography data
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F ig u re  4.20. 3D  rendering  o f  corrosion  cast m icrocom pu ted  tom ography  A ) norm al m ucosa, B) norm al 
m ucosa cu t-aw ay  , C ) A denom a, D) A denom a cu t-aw ay, E) A denocarcinom a, F) A denocarc inom a cu t­
aw ay, G ) L S 147T  xenograft w hole d ig itised  cast vo lum e rendering , H) L S 147T  xenog raft cut-aw ay 
show ing  large avascu lar regions. I) SW 1222 w hole d ig itised  cast volum e rendering , J) SW 1222 xenograft 
cut-aw ay genera ted  by v irtual section ing , (K ) high reso lu tion  SW 1222 and (L) a cropped  volum e o f  the 
high reso lu tion  SW 1222 vo lum e from  the edge o f  the xenograft, this reg ion  is a lm ost com pletely  
com posed  o f  vascu lar tissue. (G /H ) and (I/J) are low  reso lu tion  renderings o f  w hole xenografts  
dem onstrate  the pow er o f  X -ray  m icro-com puted  tom ography to determ ine vascu lar system s in w hole 
tum ours. T hese datasets how ever w ere not used in the m orphom etry  study  w hich w as restric ted  to the use 
o f  h igh reso lu tion  scans.
108
4.5.3 Results: quantitative morphometry of cast micro-computed 
tomography
Analysis o f the cast tomography data was carried out on 3-6 samples cuboid volumes of 
between 2-12mm^ for each tissue type. Using the computed medial axis, several 
thousand cross-sectional measurements were made perpendicular to the vessel axis 
throughout the whole vessel network. MVD and SSA were also determined for each 
sample volume. The spread o f measured characteristics from samples across each tissue 
type is shown in [Figure 4.21 (A-G)].
The vessel calibre o f clinical tissue samples: control, adenoma, and LS147T are spread 
over a similar range and their mean values are also similar (the carcinoma values were 
lower). In contrast SW1222 tumours demonstrate a larger mean vessel calibre (mean 
-6x10^ pm^) [Figure 4.21 (A)]. The results here parallel stereo-image measures o f 
vessel diameter. An exact comparison is not possible since the stereo-imaging technique 
does not take into account the variation in vessel shape. It is also noted that the 
variability in vessel calibre appears consistent across the samples for all tissues except 
those o f SW 1222 where there is a greater spread [Figure 4.21 (B)].
Results for the microvascular density study [Figure 4.21 (C)] show this characteristic is 
elevated in SW1222 tumours (mean 0.25) by comparison to the other tissues: control 
mucosa (mean 0.13), adenoma (mean 0.049) and carcinoma (mean 0.051) tissue), 
LS147T(mean 0.08).
Measurements made on the specific vessel surface area [Figure 4.21 (D)] were similar 
in control mucosa, adenoma and carcinoma but were particularly variable in the 
LS147T and SW1222 tissues. For SW1222 the surface area is generally higher due to 
the combination o f greater MVD and larger calibre vessels.
The three measures used to describe vessel tortuosity displayed quite different results, 
owing to particular aspects o f each tortuosity definition. DM and SOAM in particular 
did not exhibit any clearly interpretable results [Figure 4.21 (E&G)]. The ICM does 
however consistently measure higher in SW1222 samples [Figure 4.21 (F)], which on 
visual inspection could be qualitatively deemed the more tortuous.
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Figure 4.21. Micro-computed tomography morphometry
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4.5.4 Discussion: X-ray micro-computed tomography results
Both stereo-imaging and micro-computed tomography studies of the vasculature in the 
colorectal tumours have been used to elucidate numerical data describing the local 
structure and properties o f a selection o f  tumour vascular systems. These measures 
provided insight into how the xenografts differed from each other and the tissues they 
deemed to represent. Here the application o f micro-computed tomography has to proven 
to be an excellent new method for determining the three-dimensional structure and 
properties of corrosion casts.
Vessel diameter and cross-sectional metrics were both used to determine vessel size. In 
this respect, vessels cannot be assumed cylindrical (especially in the xenograft tumours) 
so the linear definition o f the vessel calibre as measured by stereo-imaging is therefore 
less reliable than measuring vessel calibre using a surface perpendicular to the axis o f 
the vessel. Both measures however indicate that SW1222 tumours displayed much 
wider vessels than LS147T tumours. In this study as no measurements such as oncotic 
pressure or vessel maturation were made, it is therefore difficult to give precise reasons 
why the vessels in SW1222 are larger. What was known prior to the analysis was 
SW1222 tumours are better differentiated than that of LS147T line. This could offer up 
a possible explanation for the differences observed in the two xenograft lines as the 
vasculature in each case will be affected by the local organisation o f the tissues.
Microvascular density (MVD) and inter-vessel distance (IVD) were both used to 
estimate the local quantity o f vascular tissue. MVD is an important characteristic 
property o f the tumour which affects nutrient and drug delivery to the tumour. The IVD 
provides some estimation o f this parameter however the technique is not wholly 
satisfactory. IVD is problematic; firstly, it is based on point-to-point measures o f linear 
distance between vessels, giving rise to some degree o f operator bias due to point 
selection. Secondly, the scanning electron micrographs restrict measurement to the line- 
of-sight, so vessels in the background remain immeasurable. By contrast the 
tomography technique for measuring this parameter is greatly improved by using a 
volumetric measure o f density and the automation o f the measurement. MVD was 
highest in SW1222 tumours with all but the one sample registering above the maximum 
value found for the clinical and control tissues.
I l l
The greater MVD in the SW1222 tissues could explain the improved response to 
therapy in this tumour line [Sharma et al., 2005], and a similar dependence o f tumour 
growth on vessel density is shown at least phenomenologically by Alarcon et al. 
[Alarcon et a l ,  2004]. MVD has also been cited as a prognostic value [Janot et a l ,  
1996]. Although MVD was found to demonstrate some difference between carcinoma 
and adenoma, additional study would be required to determine the value o f micro­
computed tomography for use as a prognostic tool. Further to this, the knowledge o f 
avascular spaces shape, size and distribution is important to the hypoxic properties o f 
tumours and so is o f value to the fields o f radiobiology, and the development o f 
radiosensitizer and bioreductive drugs.
A further advance o f micro-computed tomography is the capacity to measure new 
parameters relating to the vessel architecture. The specific vessel surface area (SSA) of 
the vasculature cannot be estimated from the stereo-image data. This provides some 
insight into the underlying architecture in the vascular network, as it is dictated by both 
the vessel shape and volume. SSA represents a better measure than MVD for defining 
the transport capacity o f  the vascular tissue as it is directly dependent o f the calibre o f 
vessel in the volume, whereas a the MVD is ambiguous in this respect. Consistent 
values o f MVD were found in the tissues studied, and the specific vessel surface area 
mapped fairly closely to the MVD in most cases. The exception here was the LS147T 
tumours where the specific vessel surface area is relatively larger, which was due to a 
greater abundance o f smaller vessels in some o f the LS147T samples.
The possibility o f analysing vessel tortuosity at the microvascular level will be of 
particular interest to the field o f anti-angiogenesis/vascular therapy, as a number o f 
studies such as those by Jain et al. show these treatments were followed by a reduction 
in vessel tortuosity [Jain, 2001b], this process termed ‘vascular renormalisation’ is 
evident in the use o f anti-angiogenesis antibodies, such as DC 101 [Tong et a l ,  2004]. 
Much o f the prior works on vessel tortuosity are focused on specific tissues such as 
mesentery and retina which are convenient since these vessels grow as a planar two- 
dimensional layer. Outside this limited context, only the use o f  two-photon microscopy 
on window chambers has enabled the calculation o f tortuosity metrics in three 
dimensions in microvascular [Tozer et a l ,  2005]. The use o f  micro-computed
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tomography datasets in this study here shows that tortuosity values can be determined in 
three-dimensions from any tissue where a vascular cast can be generated (this is 
important as 2-photon microscopy is restricted to use with window chambers, where the 
tumours are somewhat squashed by comparison to their normal growth).
Tortuosity measures for the control and clinical tissues were generally similar in 
magnitude. ICM is elevated in all samples o f SW1222, as shown in the cast stereo- 
images and volume renderings. These tumour vessels form highly dense networks with 
a tightly packed structure that necessitates higher frequency curves. The SOAM data 
was less clear to interpret than the ICM results. One carcinoma sample did show a much 
higher SOAM value; on inspection this sample showed the presence o f a large number 
o f coiled surface capillaries, which was interesting because the ICM is less sensitive to 
these types o f structures -  demonstrating the value o f multiple tortuosity metrics.
The results o f this study suggest both ICM and SOAM are better metrics for vascular 
tortuosity than DM. Tozer et al. also found that DM is an ineffective discriminator o f 
vessel tortuosity for differentiating between the vasculature o f two tumour types. The 
problem with DM as a measure o f tortuosity is, that it is purely the ratio between 
effective and linear distances. It is for example, unable to differentiate between, a highly 
sinusoidal vessel and one with a gentler but larger curvature, where both vessels have 
equivalent length and displacement.
4.6 Chapter conclusions
The decision to use the corrosion casts rather than an injected radiopaque contrast agent 
was primarily due to the consultation with Sky scan [Corps and Folarin, 2006] which 
suggested greater image quality and segmentation would be achieved by scanning the 
naked casts. With hindsight there are some reasons why scanning the un-corroded cast 
may prove advantageous. Adding contrast agents such as lead, osmium or iodine to the 
casting polymer would enable the scanning to be done without removal o f the tissue 
[Bentley et al., 2002], so that identifying feeding vessels from the whole tumour would 
be greatly facilitated. It was observed that scanning distortion [Figure 4.18 (B)] was 
reduced where the vasculature was densely connected, so the problem with vibration in
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the smaller vessels may also be resolved as the surrounding tissue would support and 
restrict their movement. Implementing this system is not straightforward, as other 
problems may arise from using an injected contrast agent as the basis o f the angiograph. 
These include how to scan the sample without it drying up, as scanning times can 
exceed 10 hours, this would necessitate housing the sample in a water tight seal to 
prevent drying and contraction o f the tissue and subsequent distortion o f the 
tomographic data.
The corrosion casts o f the tumour vascular system provide good insight into the three 
dimensional structure o f the vasculature. Using micro-computed tomography, the 
analysis o f the vessel structure and architecture can be automated and provides many 
advantages over conventional stereo-imaging techniques. The stereo-imaging and 
micro-computed tomography techniques used in this chapter complement o f each other. 
The resolution o f scanning electron microscopy currently exceeds that o f m icro­
tomography imaging systems, so it is good for studying the more qualitative aspects o f 
the cast (particularly the surface detail). While the use o f micro-computed tomography 
data opens up many more possibilities for quantitative morphometry o f the vascular 
network.
The stereo-imaging and micro-computed tomography results suggest that although both 
xenografts studied here differ from the architecture o f the clinical tumours the 
architecture o f the LS147T tumour is a better match o f the clinical carcinomas presented 
in the current study.
Micro-computed tomography results here demonstrate that the vascular network can be 
accurately resolved for a whole xenograft tumour. The technique has significant 
advantages over other tomographical method such as serial sectioning employed by 
Brey et al. [Brey et al., 2002] [Braumann et al., 2005] or the 2-photon microscope 
system used by Barber et al. [Barber et al., 2003b]. Further to its use as a morphological 
tool for studying the structure o f the tumour vascular system, the tomography data is 
also used to define three-dimensional vascular network geometries for use in blood flow 
simulations in the next chapter.
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5.1 Introduction
Modelling the behaviour o f the tumour vascular system is o f great therapeutic interest as 
it is central to the pathology o f all solid tumours, determining aspects such as; hypoxia, 
drug/nutrient delivery, tumour growth and métastasés [Chapters 1-4]. Several studies 
have highlighted the importance o f tumour vascular architecture and structure as the 
primary factor o f aberrant haemodynamics and transvascular flow [Jain, 1988]
[Fujimori et al., 1999;Huxley and Rumbaut, 2000;Munn, 2003;Konerding, 2006].
Attempts to address flow phenomena in tumours using a range o f computational models 
have tended to focus on network flow models, see [Chapter 3] [Baish et al., 
1996;Chaplain and Anderson, 2004;Chaplain, 1995], Stephanou [Stephanou et al., 
2004;Alarcon et al., 2004;Alarcon et al., 2005]. One factor common to each o f these 
model systems is the use o f a highly abstracted or simplified vascular architecture which 
cannot adequately describe the functional properties o f the microcirculatory system. 
Since vascular architecture is so strongly coupled to the haemodynamic function, this 
lack o f fidelity remains a major shortcoming in these models and greatly limits their 
application and validity [Pries et al., 1995b]. To address this gap, a novel computational 
method for modelling blood flow in a morphologically correct three-dimensional 
vascular system is presented here.
Through studies o f corrosion cast architecture in [Chapter 4], it was shown that vessels 
in clinical and experimental colorectal tumours exhibit substantial differences in 
architecture and structure. These differences not only encompass the distinction 
between normal and tumours vessels, but also define characteristics associated with 
each tumour type. In this chapter an investigation is carried into whether the 
hydrodynamic contribution o f different vascular morphologies can be determined 
through simulation. X-ray micro-computed tomography datasets of corrosion casts 
determined in [Chapter 4] were used to define virtual vascular networks for a Iattice- 
Boltzmann fluid flow simulation.
It is acknowledged here that the fluid-model o f blood referred to in this chapter is highly 
idealised as the single phase fluid does not take into consideration the known non-
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Newtonian properties o f blood^ discussed in [Section 3.3.1]. Although a visco-elastic, 
multiphase colloidal model o f blood is theoretically possible using the lattice Boltzmann 
method, these models are still in development. Additionally the use o f a non- 
Newtonian/single-phase simplification was necessary to meet the computational 
demands o f simulations with the available resources.
5.2 Chapter aims
Objectives for this chapter include:
I. Adapt the Iattice-Boltzmann method (LBM) and appropriate flow boundary 
conditions to use with X-ray microcomputed tomography images o f vascular 
corrosion casts.
II. Test the LBM model in a simple symmetric bifurcation, to determine if there 
is a hydrodynamic justification for the highly conserved distributions of 
tumour branching angles.
III. Using the LBM model, evaluate blood flow in portions o f vascular networks 
from control and tumour datasets. Determine how characteristic changes in 
the network affect blood flow through the system.
IV. Demonstrate the viability o f blood flow simulations using the LBM model in 
the vascular system of a whole xenograft tumour.
 ^ The non-N ew tonian  p ropertie s  o f  co llo idal suspensions such  as b lood are  active area o f  research  in the 
fie ld  o f  Ia ttice-B oltzm ann m ethods. T he application  o f  m ore com plex rep resen ta tions o f  b lood  is 
d iscussed  in [C hapter 6] as a poss ib le  ex tension to this m odel.
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5.1. Workflow schema
Sim ple (tube & 
bifurcation) geom etries  
Sections 5.4 & 5.5
Flow benchm arks: 
Sections 5.4 & 5.5
K.
Sm all vessel networks study: 
Sections 5.6 Flow Studies: 
Sections 5.6 & 5.7
W hole  tum our vascular 
geom etry: Sections 5.7
F ig u re  5.1 S how s the passage  o f  w ork  from  sim ple  tube  flow s w here the sim ulations w ere benchm arked  
through p rog ressive ly  com plex  vessel g eom etries derived  from  m icrocom puted  tom ography  datasets (from  
C hap ter 4).
5.3.1 Background: mesoscopic fluid models
The balancing act between domain size, resolution and computation power bear very 
strongly on most non-trivial computational fluid dynamics problems. The choice o f 
fluid model was therefore important to the problem o f simulating blood flow in the 
complex vascular space o f a tumour.
Continuum methods like the Navier-Stokes equation have significant limitations in 
handling geometrically complex boundaries, such as those encountered in tumour 
vascular systems. At the other extreme are techniques such as molecular dynamics 
where the time evolution o f a molecular system is (usually) governed by Newtonian 
mechanics and for computational purposes, the analytical equations describing the
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motion o f individual molecules are discretised. However due to the scale o f the tumour 
vascular system, using molecular dynamics for modelling blood flow problems is 
clearly not possible. In contrast to continuum and molecular dynamics methods, a newer 
approach termed the Iattice-Boltzmann method has been used here. This method uses a 
discrete counterpart o f the Boltzmann equation that sufficiently encapsulates the 
essential micro/mesoscopic physics required to describe macroscopic averaged 
properties so they satisfy the known equations for quantities such as pressure and fluid 
velocity.
5.3.2 The lattice gas method (LGM)
The Iattice-Boltzmann method was derived initially from the lattice gas method prior to 
the realisation that it constituted a discrete form o f the Boltzmann equation. In both 
these methods the use o f discrete velocities enables great computational efficiency, and 
as the interactions are purely local, parallélisation is simple.
The computational limitations o f molecular dynamics methods in the mid-1980s 
resulted in a new approach based purely on conservation laws (particle number, 
momentum, energy). This method, called the ‘lattice gas cellular autom ata’, considers a 
system o f lattice bound ‘fictitious particles’ that represent underlying groups o f smaller 
molecular components o f the fluid [Frisch et al., 1986]. These particles, although larger 
than the underlying molecules in the fluid are much smaller than the smallest length 
scale. This is acceptable as the macroscopic attributes do not directly depend on 
microscopic behaviour o f the fluid, as can be seen from low-Mach flow simulations in 
air and water at equivalent Reynolds numbers, the results remain the same despite the 
clear difference microscopic behaviour in a gas and fluid. Using a limited number o f 
particles which are restricted to a small number o f  velocities forms the central basis for 
LGM. These spatial discretisations, coupled with discrete time and simple momentum 
conserving Boolean collision rules, allow large scale simulations to be run at 
comparatively low computational cost. There were however problems associated with 
lattice gas methods, for example equations o f motion may depend on
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inertial/translational frames, a contradiction o f Galilean invariance^, and there is a 
tendency for the results to harbour a large amount o f noise, requiring substantial 
averaging to generate meaningful results [Succi, 2001]. These problems are addressed 
by the Iattice-Boltzmann model.
5.3.3 The Iattice-Boltzmann method (LBM)
The LBM was developed to solve the problems associated with LGMs and further 
develops the concept o f fluid discretisation. The two most important differences in 
LBM lie in the treatment o f the fluid particles and their collision. Firstly in LBM the 
individual fluid particles from the LGM are no longer the fundamental unit o f the fluid 
discretisation. In their place floating point numbers are used to represent the ensemble 
average o f the fictitious particle density and velocity distributions. So in effect, LBM 
represents pre-averaged version o f the LGM.
The field o f LBM as a fluid dynamics method is comparatively new, and has seen 
strong development over the last two decades. LBM is considered an alternative to other 
finite-element and finite difference Navier-Stokes solvers due to its relatively simple 
implementation, parallélisation, handling complex geometrical boundaries and multi- 
component flows.
The initial appeal o f LBM s for use in modelling flow in tumours was their successfully 
application to micro-scale flow simulations in other porous media such as rock 
[Manwart et al., 2002] and paper [Rasi et al., 1999]. In these media, the pore length- 
scale are similar (~10-10^ pm) to that o f the finest vessels (capillaries) in the tumour 
micro vasculature. Furthermore the complexity o f the boundry surfaces o f these porous 
media is similar to that o f the microvasculature. As noted by Buick et a i,  LBM fluid 
models could also be applied to the full range o f vascular flow regimes, ranging from 
large-scale flows, such as those observed in the aorta, down to micro-vascular blood 
flow in the smaller vessel systems [Buick.J.M. et al., 2003]. The relative simplicity and
G alilean  invariance; a p rin c ip le  o f  rela tiv ity  sta ting  that physica l law s rem ain  constan t fo r all in itial 
fram es.
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success o f LBM at treating complex boundaries was a key attribute o f the method, 
especially in light o f the tomography results in [Chapter 4].
The LBM as noted previously can actually be derived by discretising the Boltzmann 
equation [Chen and Doolen, 1998]. For a particle density distribution entering site r  at 
time t denoted f-  (r, t) , the direction o f the velocity o f this particle distribution is given
by Ci, i being the index o f the lattice directional vectors. For a given lattice with a time 
step r] and lattice spacing X the particle velocities v/ are thus:
v . = c - — [5.1]
7
The evolution o f the distribution is given by a convective streaming step and the 
collision from the prior distribution state:
+ + = + [5.2] ,
where Q ..{rj)  is the collision operator. The effect o f the collision term produces either
an increase or decrease in particles o f type i. The collision operator used in this case is 
the Lattice-BGK (Lattice Bhatnagar-Gross-Krook) [Bhatnagar et al., 1954]. The major 
simplification is achieved by replacing the function associated with relaxation to 
equilibrium by a single relaxation time parameter Ç.
[5.3],
where is the local equilibrium distribution equation [5.5]. For a three dimensional
19-velocity lattice such as D3Q19, the available velocities are 0 for the rest ‘particle’, 6 
velocities to the nearest neighbour (face-centred), and 12 velocities to the next-nearest- 
neighbour (edge-centred) [Figure 5.2 A]. T h e f o r  the D3Q19 model is given by:
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f   ^ 1 1 A
-{eq) 1 + — (c,. •«) + —^ (c ,  »)"
V c, 2c, 2c, y
[5.5] ,
where the lattice speed o f sound is:
c ,= l /V 3  [5.6],
the weight factor coj is 1/3 for rest particles, I / I 8  for particles moving nearest- 
neighbours and 1/36 for particles moving to next-nearest neighbours.
Macroscopic properties o f the fluid such as density p, velocity u and momentum tensor 
77 are recovered by summing suitable moments o f the distribution functions:
= [5.7]
/=[
p{r j )u{ r , t )  = 5 ^ v ./ . ( r ,0  [5.8]
/=!
= [5.9]
! = l
/  is the number o f lattice directions given by c, and a and [3 are spatial components o f 
the velocity vectors.
Interaction between the fluid domain and the vessel wall on the lattice are specified by 
the boundary conditions imposed at the solid nodes neighbouring fluid nodes [Figure
5.2 (B)].
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Figure 5.2. Schematic o f the Iattice-Boltzmann model
B
fluid nodes { o
mirror nodes {
A
W
wall
Inlet face  
outlet face
0
o'
100
150
150
Figure 5.2. Features o f  the Iattice-B oltzm ann m odel boundary  conditions. (A ) Show s the velocities o f  the 
th ree-d im ensional face-cen tred-hypercubic (D 3Q 19) lattice. The vertices are on  the in tersec tion  o f  3 
orthogonal p lanes i.e. 6 face cen tred  (red) and  12 edge-cen tred  (b lue) (B ) a tw o d im ensional schem atic  o f  
the d ig itised  vessel, show ing  the in teraction  o f  flu id  nodes (w hite) w ith the d ig itised  vessel ‘w a ll’ w hich 
lies h a lf  w ay betw een the so lid /flu id  nodes, the void  space is show n w ith  the (b lack ) nodes, and  the 
resulting  velocity  (b lack arrow s) [note in 3D  the num ber o f  outgoing velocities is ac tua lly  5 no t 3]. (C)
A n exam ple o f  a sm all vessel geom etry  (velocity  field), show ing the inlet and ou tle t faces o f  the flow  
sim ulation  dom ain.
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5.3.4 Simplifications
Blood is a complex fluid whose properties are influenced by the local vascular system 
as discussed in [Chapter 3]. LBM ’s have recently been used for simulating particle 
suspension flows [Ladd, 1994a;Ladd, 1994b;Ding and Aidun, 2006], but modelling the 
colloidal aspects o f blood within the complex boundaries o f the tumour vasculature are 
outside the scope of this thesis. With this caveat in mind, flow properties o f the 
simulated blood are greatly simplified by considering it as a homogeneous single-phase, 
incompressible fluid. Since the primary goal o f these simulations is to explore the 
possibility o f using corrosion cast tomography datasets as a viable geometry for the 
LBM, these conditions are relaxed.
The model also makes the assumption o f inelastic static vessels; again this was done in 
order to keep the implementation o f the boundary condition simple.
5.3.5.1 Boundary conditions
Three boundary conditions were required for the Iattice-Boltzmann model [Figure 5.2 
(B&C)]; 1) inlet(s), 2) outlet(s) and 3) fluid-vessel boundary surface. Each condition 
requires that some information be provided to the fluid at the limits o f the simulated 
domain; this information is then transmitted to the bulk fluid through the particle 
distribution streaming step. The necessary heuristic and extrapolations that were 
required to close the system are discussed in the following sections.
5.3 5.2 Fluid-vessel Interface no-slip boundary condition
The vessel lumen-fluid interface was implemented using the no-slip boundary condition 
described by Succi [Succi, 2001]. This boundary condition was considered physically 
appropriate as the vessel wall glycocalyx (endothelial surface layer) strongly attenuates 
net fluid motion at the wall [Pries et al., 2000;Pries et al., 1997;Secomb et al., 1998].
The no-slip boundary condition makes the assumption that the fluid adjacent to the solid 
interface has a zero velocity relative to the vessel wall in this instance. This approach is
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realised by implementing the half-way bounce-back rule where the discretised ‘fluid 
particle’ momentum is reversed half-way between the adjacent fluid and solid nodes. 
The half-way bounce-back scheme was also attractive for practical reasons as it is both 
simple and computationally efficient. The half-way bounce back boundary condition 
can give second-order accuracy in simple geometrical applications; however for our 
complex vascular system it is first-order accurate [He et al., 1997] [Chen and Doolen, 
1998;Ziegler, 1993] provided minimum o f -1 0  o f lattice nodes spanning the average 
vessel [Buick.J.M., 2005]. More sophisticated fluid-solid boundary conditions have 
been suggested and are second-order [Filippova and Hanel, 1998], but these are largely 
restricted to regular geometrical domains or require neighbouring nodes for 
interpolation where many schemes have non-trivial mass conservation problems.
5.3.5.3 Inlet(s) boundary condition
One obstacle was how to define a driving force for the flow study, as commonly used 
solutions such as pressure gradient and body force could not be applied to the problem. 
In the case o f the pressure gradient boundary condition, the pressure gradient across the 
multiple inlets and outlets was not known a posteriori, whereas a bodyforce term could 
not be used due to the multiple directions o f flow [Figure 5.2 (C)]. However the inlet 
velocity could be defined as estimates for arteriolar blood flow are known [Table 5.1]. 
The difficulty with this approach was that the vessel inlet shapes tended to be irregular, 
as they were determined by the cross-section o f the tomography image at the inlet face. 
This meant defining a parabolic velocity profile [Zou and He, 1997] was not possible. 
Instead ‘Ladd’s moving w all’, effectively a constant uniform velocity distribution, was 
implemented for the inlet(s) [Ladd, 1994b]. This inlet condition was applied to one face 
o f the domain [Figure 5.2 (C)].
A problem encountered in the LBM simulations was the presence o f oscillations in the 
velocity field; these were transmitted from the inlet to the rest o f the fluid domain. A 
method for handling this problem was found by averaging the distribution functions o f 
the incoming inlet-links. At each time-step the five inbound links (D3Q19) are 
calculated as defined by Ladd’s velocity boundary condition. In the following time step.
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an average value for each inbound link is calculated over the present and preceding time 
steps.
5.3.5.4 Outlet(s) boundary condition
Simple periodic boundary conditions have been used with the lattice-Boltzmann method 
for the study o f fluid flows in complex porous materials such as rock and paper 
[Manwart et al., 2002]. In these materials the boundary surface is defined by the 
connectivity o f thousands o f independent pores. The ‘porous’ structure o f 
microvasculature, although complex, is quite different to that of paper and rock. This 
means the direction o f flow is strongly dependent on the sample, which is not 
guaranteed to be unidirectional. In the vascular geometries derived from micro­
computed tomography datasets, each o f the vessel geometries used evolved from inlet 
vessel(s) into a network that eventually exited the limits o f the domain through multiple 
outlet faces. The remaining 5 faces where the vessels exited the simulated domain were 
dedicated as outlet-faces [Figure 5.2 (C)].
The outlets o f the domain also required special attention. In this situation, off-lattice in­
coming links from the ‘open’ outlets must be handled in such a way that the velocity o f 
the bulk fluid remains unchanged or minimised. This represents a particular application 
o f the ‘missing-data’ (incoming links) problem described by Chikatamarla et al. where a 
practical solution is to approximate the missing information using Grad’s Distribution 
[Chikatamarla et al., 2006].
5.3.5.5 LBM simulator applications and input parameters
Two simulator codes developed in collaboration with Keijo Mattila (University of 
Jyvaskyla, Finland) were used in the following studies [Mattila and Hyvaloma, 2006]. 
The first was used for testing boundary conditions, benchmarking behaviour and 
accuracy o f the fluid dynamics model in the case o f simple channel flows. The second 
program was developed for simulating flows using micro-computed tomography 
datasets.
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The ultimate goal was simulation o f flows in whole xenograft scans, so substantial 
computing facilities would be required. To meet these requirements simulations were 
carried out on an Altix 3700 (Silicon Graphics Incorporated, Mountain View, 
California), with 112GB shared memory, 56 processors (Itanium2 1.3 Ghz/3 MB cache 
processors) and an operational speed o f up to 135GFlops.
Geometry data for flow simulations in the tumour vascular networks was supplied in a 
binary format generated by the Sampler program [Mattila and Hyvaloma, 2006], whose 
input was a stardust file derived from an 8-bit X-ray micro-computed tomography z- 
stack (RAW format). Files file relating to the geometry constitution are listed in 
(Appendix A 1.2-4). A parameters/z/e (*.in) (Appendix A T I) detailing the various 
simulation parameters (such as lattice decomposition and velocity) was used for 
configuring the simulator application. Output from the simulation takes the form o f 
three files: an output summary file  (*.dat), an evolution record file  (*.evol), and a binary 
velocity/density fie lds f i le  (*.fields) (formats are listed in Appendix A2.1-3).
The flow regime for the simulation is matched through the dimensionless Reynolds 
number determined from published values o f kinematic viscosity and velocity as related 
through equations [5.10 and 5.11]. The velocity at the inlet tumour vessel(s) was taken 
to be equivalent to that o f normal vessels; this was considered a reasonable estimation 
as noted by Jain et a l,  where micro vascular pressures in the arterial side o f the tumour 
are nearly equal in tum our and normal vessels [Jain, 1988].
Re = —  [5.10]
V
The Reynolds number [Section 3.3.2] was calculated using published values for 
kinematic viscosity (v) 5.48x10^ m^.sec ’ [Kobayashi et al., 2002] and velocity (F) 
1x10’^  m.sec ’ [Bloor, 1968] over a similar size range o f microvascular blood vessels. 
The characteristic length scale L was taken as the diameter o f  the tumour vessels as 
determined in the previous chapter (7x10'^ m to 4x10^ m). Together this situates the 
dimensionless Reynolds number for this flow regime between (3.7x10'^to 7.3x10'^), 
which is firmly in the laminar range. In order to match this to the simulation, the lattice
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kinematic viscosity, as specified by He et al. [He et al., 1997], is given as a function of 
the relaxation time
V =
2 ^ - 1 [5.11]
Using a single relaxation time =7) equation [5.11] gives a viscosity o f 1/6. By taking 
a characteristic distance o f 10 lattice units so suitable hydrodynamic behaviour is 
recovered and the above Reynolds number range, the appropriate velocity for the 
simulation is given by equations [5.10] as (2.2x10'^ to 1.2x10 lattice units per time 
step.
Table 5.1. Relevant physiological parameters
Parameter Value Reference
Reynolds
Number
0.51, 1,2 t[Kobayashi et al., 2002]
3 x 1 0 ^ * [Popel and Johnson, 
2005]
1 [Bloor, 1968]
Microvascular 
Flow Velocity
1 xlO^ pm/sec $[Bloor, 1968]
2 ,5 , 10x10^ pm/sec t[Kobayashi et al., 2002]
Kinematic
Viscosity
5.48x10'^ m"/sec t[Kobayashi et al., 2002]
1.2x10^ m^/sec (for blood plasma) [Lee et al., 2004]
Mean Vessel 
Diameter range
20-40 pm Chapter 4 [Section 4.4.3]
Minimum Vessel 
Diameter
7-40 pm Chapter 4 [Section 4.4.3]
T a b le  5.1. N ote: t  param eters in [K obayash i et al., 2002] relate to arterio lar d iam eter 110 pm  and |  
[B loor, 1968] refers to a sm aller rep resen ta tive  vessel d iam eter o f  10 pm  in hum an. * In [P opel and 
Johnson, 2005] refer to cat sarto rius m uscle.
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5.4.1.1 Method: error analysis in straight channels and tubes
The lattice-Boltzmann simulations using the boundary conditions described in [Section 
5.3.5.1-5] were investigated numerically to determine the behaviour o f flow at the inlet 
and outlet o f the domain. Although these simple geometries do not imply the same 
behaviour in the complex system o f vessels, they provide an important benchmark for 
the behaviour in a system with a known analytical solution.
Benchmark studies were carried to estimate the Error Ev o f the lattice-Boltzmann 
simulation using the velocity inlet/open-flow outlet boundary conditions defined in 
[Section 5.3.5.1-3] within channel and tube flows.
The global error in the velocity o f the z component (in this case) Ey is given by equation 
[5.12]. The flow is taken in the direction o f the z axis.
E. =
\u. - u .
E M
[5.12]
where i f  is the analytical and M the simulated LBM velocity in the z direction o f the 
channel.
The analytical solution for the velocity in a channel formed between two walls 
separated by a distance // ,  where h is the distance from the centre o f the channel is most 
conveniently expressed in terms o f  the maximum velocity [White, 2006a]:
1 -
h 
{ H
V )
[5.13]
where, umax 2
Similarly the analytical solution for velocity in a tube with a radius R, where r  is the 
distance from the centre o f the tube [White, 2006b] is expressed as:
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«;'('•)=w„»x ' “ u
[5.14]
where, u„„ =
In both equations [5.13] and [5.14] u^ax is the velocity at the centre o f the channel and 
Have is the injection velocity at the inlet.
5.4.1.2 Method: flow in cylindrical tubes
The shape o f the velocity profile o f the inlet and outlet was studied using a cylindrical 
tube geometry. This shape represents the best approximation o f a micro-tomography 
dataset vessel for analytical purposes. The analytical velocity field in these regions was 
compared with the solutions derived using the lattice-Boltzmann method with particular 
attention to the inlet and outlet boundary conditions.
Each simulation was carried out using a straight tube geometry with the dimensions; 23 
by 23 by 101 lattice units. The inlet velocity was set to +2.6x 10 "^ lattice units/time-step 
and the simulation was run till a steady state was achieved. Inlet-link averaging over 2 
time-steps was used on the incoming links at the inlet.
5.4.1.3 Method: a study of error behaviour
Two specific anomalies were observed in the velocity profile o f  the tube simulations, 
the first being a distortion at the inlet and outlet and the second a small, but definite 
oscillation o f the velocity field through the channel. These two sources o f error could 
pose problems for simulations in more complex geometries, so their behaviour was 
studied further to determine how they could either be eliminated or managed.
The inlet and outlet both distorted the velocity profile o f a number o f adjacent nodes 
extending into the tube. The distance this distortion extended into the channel was 
investigated further by considering the effect o f inlet velocity [Figure 5.4 (A)] and
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channel height [Figure 5.4 (B)] on the anomaly. The error Ey is given as a function o f 
distance from the inlet or outlet in each case. The simulations were carried out in a 
channel geometry: lOx by lOOy by z* lattice units (periodic boundaries in the x-axis 
limits of the domain and flow in they  direction). For the ‘inlet velocity’ experiments: 
inlet velocity range was 1x10'^- 1x10'^ lattice units/time-step and a constant channel 
height (z-axis=10*). For the ‘channel height’ experiments: channel height z-axis range 
used was 5 -  90* lattice units with a constant inlet velocity o f +2.6x10'"^ lattice 
units/time-step.
The transient oscillations in the velocity profile with and without inlet-link averaging 
[Figure 5.4 (C)] were investigated to determine how these could be removed. The 
simulations were carried out in a channel with the dimensions: 10 by 100 by 10 lattice 
units (periodic boundaries in the x-axis limits o f the domain and flow along the y-axis). 
The inlet velocity was set to +2.6x10"^ lattice-units/time-step.
All simulations were run till a steady state was achieved.
5.4.2.1 Results: error analysis In straight channels and tubes
The following sections ([Sections 5.4.2.2-4]) present observations o f error analysis as 
demonstrated in channel and tube flows.
S.4.2.2 Results: flow in cylindrical tubes
The velocity profile surface for the analytical solution equation [5.14] [Figure 5.3 (A)] 
shows the symmetrical velocity profile which runs along the tube. The recovered 
velocity profile from the lattice-Boltzmann model shows a marked distortion at the inlet 
and outlets [Figure 5.3 (B)]. A superimposition o f the two surfaces is shown in [Figure
5.3 (C)], and shows there is very little difference between the two solutions in the 
central region o f the tube.
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The error surface plot [Figure 5.3 (D)] shows clearly where the analytical and 
numerically determined fields are different, giving a clear impression o f the effects o f 
the shapes o f the distortions in the field at the inlet and outlet o f the channel.
The shape o f the inlet [Figure 5.3 (E)] and outlet [Figure 5.3 (F)] distortions, as revealed 
by their transverse views, are similar though not identical. This is shown more clearly 
by the peaks o f an error surface plot [Figure 5.3 (D)], where the inlet has 4 fairly 
equally sized error peaks while the outlet region has 6 o f differing size.
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Figure 5.3. Properties o f the inlet and outlet boundaries
Analytical Velocity Field: Tube Flow B LBM Velocity Field; Tube Flow
Ai^alytical And LBM Velocity Fields Tube Row D Error In The Velocity Field
I I Analytical
outlet
LBM Velocity Field: Tube Flow LBM Velocity Field: Tube Flow
outlet
F ig u re  5.3. F low  behav iou r at the in let (z= 0) and  ou tle t (z=100) faces fo r flow  in a cy lindrica l tube. (A ) 
A naly tical parabolic  velocity  su rface, (B ) L B M  veloc ity  surface, (C ) superim position  o f  the velocity  
profile  in the LBM  (so lid -red) and  analy tic  so lu tion  (clear-grid ) fo r tube flow  -  the analy tica l p ro file  is 
a lm ost com plete ly  recovered  ~ 10  nodes, (D ) m ean  e rro r in the velocity  fie ld , (E ) in let ve locity  p rofile  
v iew ed a long  the z-axis, and  (F) ou tle t ve locity  p ro file  v iew ed along  the z-ax is. In each  case flow  is in 
the z-ax is, velocity  (2 .6x10'^ L U /t).
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5.4.2.3 Results: a study of error behaviour
The error contributed by the inlet and outlet regions appear to resolve after 8-10 lattice 
units into the channel (see dashed line on [Figure 5.4 (A)]) and does not depend 
strongly on the inlet velocity.
The dependence of inlet/outlet error regions was also assessed as a function o f channel 
height with a constant length [Figure 5.4 (B)]. Each experiment increases the aspect 
ratio so it was expected that some increment in the error would be observed, but this 
would be in the range o f the increased aspect ratio. The error could be considered local 
with respect to channel height (see inset where the aspect ratio is constant [Figure 5.4 
(B) inset]).
Initial implementations o f the inlet/outlet velocity boundary conditions yielded an 
oscillating velocity profile which extended through out the channel [Figure 5.4 (C)j. It 
was found that this could be minimised by averaging the density o f the incoming links 
over 2 time-steps (incrementing the number o f time-steps over which the incoming 
density was averaged >2 did not have any additional effect).
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Figure 5.4. Inlet/outlet and artefact propagation
In let/O utlet E rror P ro p a g a tio n  In C h an n e l Flow. V e lo c ity  S tu d y
10“
outlet
inlet-210
,-4
10 '
10 '
10' inlet veK ) .001
ID
10'
1210'
D is ta n c e  F ro m  In le t/O u tle t (LU)
X ig"® Inlet/O utlet P ro p a g a tio n  In C h an n e l Flow: C h an n el H eightB
outlet 
->*■ inlet
2 .5
ieig h t= 2 5lu”
h e ig h t= 5
0 .5
D is ta n c e  F rom  In let/O utlet (LU)
F ig u re  5.4. E rror in troduced by the 
boundary  conditions. (A ) P enetration  
o f  the inlet(blue)/oLitlet(red) error as 
a function  o f  d istance from  each 
boundary  and inlet velocity , (B) 
penetration  o f  the 
in let(b lue)/ou tle t(red) error as a 
function  o f  d istance from  each 
boundary  and  channel height 
(equ ivalen t expansion  at a constan t 
channel aspect ration: inset) and (C) 
cum ulative error perpend icu lar to 
flow  show s the oscilla tions in the 
velocity  profile using the in le t/ou tle t 
boundary  conditions w ithout 
averag ing  (b lue), these oscilla tion  are 
a lm ost to tally  rem oved by averag ing  
the velocity  at the incom ing links o f  
the inlet (red), averag ing  w as over 2 
tim e steps. F low  is in the y-axis, 
velocity  (2 .6x10  " LU /t).
X 1 0 '^  O sc illa tio n  O f V e lo c ity  W ith  A n d  W ith o u t Inlet A ireraging
2.666
2 .6 6 4
S  2 .6 6 2
2 6 6
2 6 5 6  W ith o u t Inlet A veraging
 W ith  Inlet A veraging
2 .6 5 4
100
y
135
5.4.3 Discussion
The presence o f multiple outlets where the pressure gradient was unknown a posteriori 
proved to be a particularly difficult problem, and a complete agreement with the 
analytical solutions could not be found. First attempts at a solution employed a 
predefined (density) to yield a pressure gradient over the system and open boundary 
conditions at the outlets [not shown]. This initial attempt system suffered from 
problematic oscillations in the velocity, which propagated through the channel and 
could only be eliminated in the case o f a linear channel perpendicular to the inlet plane. 
In the case o f tilted tubes, transient oscillations caused large error to accrue. Under these 
circumstances the adoption o f Ladd’s velocity inlet in conjunction with multiple open 
outlet boundary conditions, was a practical if  imperfect approach which at least allowed 
the elimination o f these transients oscillations in all simple geometries studied.
For the boundary conditions finally used, the main deviation from the analytical 
solution lay in the regions immediately following the inlet and preceding the outlet. 
These error regions manifested as a partial inversion o f the parabolic velocity profile in 
the centre o f the channel. This behaviour is caused by the uniform and Grad distribution 
used to approximate the incoming links at both inlet and outlet, after 10 nodes normal 
Poiseuille velocity profile is restored with the correct shape and amplitude. Localisation 
of the inlet/outlet error regions was investigated to determine if the inlet velocity and 
channel height affected how far into the channel the distortion extended. The inlet 
velocity did not appear to affect the size o f  the artefact region, as normal Poiseuille flow 
was recovered accurately within -1 0  lattice units into the channel. The height o f  the 
channel does cause some expansion o f this error region (however if  the aspect ratio o f 
the tube or channel is restored, the normal flow is restored within -1 0  lattice units 
distance into the channel). Given the results o f these tests in simple geometries, a 
practical solution managing these inlet and outlet artefact would be to contract the 
domain o f analysis by 10 lattice units at each side o f the micro-tomography vessel 
systems.
The transient oscillations observed without inlet incoming link averaging, seemed to 
arise from the use o f  the velocity inlet boundary condition (Ladd’s moving wall) in
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conjunction with the open-outlet boundary conditions. These transients could be almost 
completely eliminated by including an inlet-averaging step over two time steps.
In conclusion, the boundary condition requirements for simulating flows in complex 
vessel systems were substantially more complicated than initially anticipated. Solutions 
to these problems necessitated new ideas and combinations o f boundary conditions. 
Here significant progress was made on the problem o f simulating fluid injection at an 
inlet in conjunction with multiple outlet regions o f undefined size, direction and shape.
5.5.1 Method: simple bifurcating channels
The next series o f  experiments extended the simple tube and channel flow by simulating 
flow in more complex bifurcating tube geometries. Here the parent vessel element was 
used as the inlet and the termini o f each daughter vessel the outlet. This geometry also 
allowed the multiple outlet faces o f the simulation domain to be tested.
Despite the variability o f other parameters such as inter-branch distance and vessel 
diameter, the branching angle distribution from each tumour type was remarkably 
consistent with respect to the tissues studied. In [Section 4.4.3] it was shown that mean 
branching angle o f the control mucosa was 87.14°, while that o f the tumour types was 
adenoma=77.74°, carcinoma=73.31°, LS147T=77.16° and SW 1222=81.85°. Konerding 
et al. have suggested that this may “indicate a common basic architectural principle 
which cannot be transgressed, and which is retained across different types o f normal 
tissues and tumours” [Konerding et al., 1999]. The simple bifurcating vessel geometry 
forms the fundamental repeating unit o f most vascular systems and provides an 
opportunity to observe how flow behaviour is affected by branching angle.
Simulations were carried out on this basic symmetrical bifurcation [Figure 5.5 (A)] 
geometry for branching angles in the observed range o f -15-180° and rarely observed 
branching angles with (>180°). For each simulation a symmetrical bifurcating channel 
with daughter branches at a specified angle 6 was used. A z-stack 8-bit image o f the 
bifurcating vessel was constructed with the ImageJ  application and compressed into a 
RAW file then subsequently converted into a geometry dataset for the simulation.
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Bifurcating vessels were constructed with branching angles ranging from 30-240°, the 
channels were 30 lattice units high and between 80 and 140 lattice units long, and the 
inlet on the right was set to a velocity o f 2.67x 10'"^  lattice units per time step.
An estimate o f shear stress above the no slip boundary was given by evaluating the 
relative rate o f parallel flow in the simulated velocity field, post simulation. This is 
given by, equation [5.15], where shear stress r  is expressed by: /y the dynamic viscosity, 
gradient o f the u the velocity perpendicular to y.
v = [5.15]
dy
The simple bifurcating structure was additionally used to test the boundary conditions 
o f the outlet domain which were perpendicular to the inlet.
5.5.2 Result: simple bifurcating channels
The velocity, pressure and shear fields are shown in the panels o f [Figure 5.5]. A 
constant channel width was used to factor out the effect o f the calibre o f the parent and 
daughter vessels so the effective channel size doubles between the parent and daughter 
elements. Consequently both pressure and velocity drop after the bifurcation point. The 
boundary conditions appear to perform well with the inlet and outlet error regions 
localised and normal Poiseuille flow recovered in the main channel regions.
Plotting global maximum velocity as a function o f branching angle shows the velocity is 
fairly consistent until 120° after which it drops sharply to a low o f 180° [Figure 5.6]. It 
is interesting to note this coincides with the bulk o f bifurcation angles measured for 
tumours and control tissue.
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Figure 5.5. Flow properties at the vessel bifurcation
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F igure 5.5. (A ) A sym m etric b ifu rca ting  channel. 
L is the length  o f  each  vessel e lem en ts , P is the 
paren t e lem ent and inlet, D 1&2 are the daugh ter 
elem ents and ou tle ts . The d iam eter o f  both 
daugh ter elem ents is equal to that o f  the paren t, 0 is 
the branch ing  angle. E lem ent w id th -2 4 , he igh t= 29 , 
length=60 lattice units. (B -J) B ifu rca ting  angles; 
30°, 40°, 60°, 80°, 90°, 120°, 180°, 200° and  240°. 
H eatm aps show ing: (1) velocity  fie ld , (2)
‘p ressu re’ density  fields and (3) shear stress.
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Figure 5.6. Branching angle flow effects
Bifurcation A ngle  vs M ax VelocityX 10
5.55
5.54
5.53
I  5.52 
t  5.51
I  5.5
5.49
5.48
Angle (Degrees)
F igure 5.6. S im ulation  o f  flow  a single sym m etrica l b ifu rca ting  channel show ing  the g lobal m axim um  
velocity .
5.5.3 Discussion
Stereoimaging measurements suggested that branching angle distributions in tumour 
vessels were consistent with the distribution shape observed for normal vessels. The 
similarity in distribution shape raised the possibility that branching outside optimal 
range may incur a hydrodynamic cost in a similar way to the vessel calibre branching 
optimality determined by M urray’s laws [Gafiychuk and Lubashevsky, 2001;Alarcon et 
al., 2005].
The hypothesis that branching in tumour vessels is restricted to the more acute range of 
angles stands to reason, as beyond angles o f 120° the pressure reflecting o ff the far wall 
o f the daughter vessels becomes greater as the wall straightens out. This is also seen in 
the shear stress, with high shear values on the apex o f the bifurcation. These studies, 
although currently quite simplified, are an example o f how simulations can be applied 
to biological questions.
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5.6.1 Method: comparison of flow simulations in small vascular 
networks for all 5 tissues
Building on progressively more complex geometries, the next group o f experiments 
attempted to replicate a well defined behaviour o f in-vivo blood flow in tumours. The 
behaviour in question was an observation by Leunig and Yuan et a i ,  that correlation 
between vessel diameter and the corresponding local velocity was high in regular 
networks, but low in more chaotic networks o f tumour vessels [Leunig et al., 1992] 
[Yuan et al., 1994], (see [Chapter 2] [Figure 2.5 (A&B)]). In the study by Leunig et a l,  
measurements were made on the vessels o f the LS147T tumour and compared to 
striated muscle vessels in mice, whereas the study by Yuan et a l  used glioma tumour 
xenografts and the control was phial vessels in rat.
To assess characteristics o f flow in the vasculature o f 4 tumours and 1 control tissue 
from the tomography datasets discussed in the previous chapter, vessel networks where 
suitable inlets could be identified were cropped from the main volume. These sub­
volumes were used to define simulation geometries for each tissue.
3 control mucosa (K l-3), 4 adenoma (A 1-4), 6 carcinoma (C l-6), 3 LS147T (L I-3) and 
6 SW1222 (S I-6) volumes were used for this study. The uneven numbers o f datasets 
was the results o f limited supply o f scanned datasets, and some scans were not of 
suitable quality to use for flow simulations. Each data set had previously been processed 
into a binary image as detailed in the previous chapter [Section 4.5.1]. Inlet velocity was 
set at 2.67x 10'^ lattice-units per time step. Simulations were run until the average 
momentum between time iterations changed by less than 1 x 10'^. For convenience, 
velocity was maintained as lattice units per time step (LU/t), this can be converted to 
mm per Sec, velocity (mm/sec) = simulation velocity x [effective resolution] x 1000).
As described in [Section 4.5.1], the vessel cross-sectional area was determined 
perpendicular to the local axis o f flow. An average velocity magnitude was determined 
from the equivalent cross-sectional surface in the velocity field and was used to 
represent the local velocity. The correlation between these two values was examined 
graphically as a scatter plot and numerically by a Pearson correlation coefficient.
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5.6.2 Result: comparison of flow simulations in small vascular 
networks for all 5 tissues
An example o f the velocity field from a simulation is shown in [Figure 5.7], where it is 
possible to see how the velocity profile changes depending on the local geometry and 
topology o f the vasculature.
The mean and standard deviation o f the velocity magnitude for each simulation are 
given in [Figure 5.8]. From this figure the inter-sample variation appears quite large, 
particularly amongst both adenoma and carcinoma. In both xenografts the velocity is 
substantially lower.
Flow simulations carried out on different tissues [Table 5.2] are presented in [Figures 
5.9-13]. Flere correlation between local flow velocity and vessel calibre was most 
consistently positive in control mucosa, adenoma and carcinoma (control=0.32±0.1, 
adenoma=0.36±0.13, carcinoma=0.36±0.33) compared to xenografts 
(LS147T=0.15±0.23, SW1222=0.15±0.18). The degree o f correlation between vessel 
calibre and velocity was particularly variable in the carcinoma simulations [Figure 5.11] 
with C l-3 showing a high much higher positive correlation [mean 0.65±0.09] between 
vessel size and velocity, than C4-6 [mean 0.06±0.05].
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Figure 5.7. An example o f  a velocity magnitude field from a LBM flow simulation in a 
micro-CT vessel geometry
180
180
140
120
100
140
160
180
Figure 5.7. A n exam ple o f  a 3D  velocity  m agnitude fie ld  (red^h igh , b lue= low ) o f  a sm all vessel 
netw ork  from  a hum an carc inom a, rendered  w ith a linear alpha m ap for voxel tran sparency  in o rd e r to 
show  internal areas o f  h igh  an d  low  velocities w ith in  the vessels, (side v iew , upper pane l; top  v iew , low er 
panel), all axes are in la ttice  un its (here lL U = 3 .3pm ).
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Figure 5.8. Mean and standard deviation o f simulated velocity in tomography samples
Simulation Global Mean And Standard Deviation Of Velocity
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F ig u re  5.8. T he m ean  and  standard  dev iation  o f  the fluid velocity  from  each o f  the sim ulations in each 
tissue sam ples. M ean velocity  is g iven in m m  per sec, as scaled  according to the tissue sam ple scan 
resolution. X -axis labels re late  to the relevan t da tasets sum m arised  in [T able 5.2].
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Table 5.2. Physical characteristics o f the samples
Tissue
Type
Sample Microvascular 
Density 
(vessel fraction 
of total volume)
Average 
Cross- 
Sectional 
Area (pm^)
Sample
Resolution
(pm^)
Vessel
Calibre-
Velocity
Pearson’s
Correlation
Coefficient
Control K1 0.16 1.24E+03 330 0.33
K2 0.13 8.26E+02 330 0.22
K3 0.11 7.46E+02 2.40 0.41
Adenoma A l 0.05 7.99E+02 3.96 0.35
A2 0.06 9.16E+02 3.96 0.29
A3 0.05 7.37E+02 3.96 0.25
A4 0.04 6.32E+02 3.96 0.54
Carcinoma Cl 0.03 2.99E+02 330 0.59
C2 0.03 3.13E+02 4 3 9 0.61
C3 0.03 3.83E+02 4 3 9 0.75
C4 0.07 8.89E+02 3.63 0.06
C5 0.09 9.29E+02 3.63 0.11
C6 0.06 6.08E+02 3.63 0.02
LS147T LI &08 1.27E+03 4 3 0 0.01
L2 0.05 8.75E+02 4 3 0 0.02
L3 0.13 5.20E+02 4 3 0 0.41
SW1222 SI 0.10 2.13E+03 3.96 0.07
S2 0.11 1.55E+03 3.96 0.01
S3 0.37 1.31E+03 333 0.15
S4 0 3 9 1.03E+03 333 0.16
S5 0 3 7 1.97E+03 333 0.02
S6 0.12 2.16E+03 333 0.49
T able 5.2. Physical characteristics relating  to tom ography dataset o f  the contro l m ucosa and 4 tum ours
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Figure 5.9. Scatter-plot o f  vessel calibre vs. simulated velocities in control mucosa
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Figure 5.9. Correlations between cross-sectional surface area (LU^) x-axis and velocity (LU/t) y-axis.
Pcor is the Pearson correlation coefficient. Control mucosa datasets Kl-3.
149
Figure 5.10. Scatter-plot o f  vessel calibre vs. simulated velocities in adenoma
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F ig u re  5 .10 . C o rre la tions b e tw een  c ro ss-sec tio n a l su rface  a rea  (L U ") x -a x is  and  v e loc ity  (L U /t) y -ax is . 
Pcor  is the P earson  co rre la tio n  co e ff ic ien t. A d en o m a d a ta se ts  A 1-4.
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Figure 5.11. Scatter-plot o f  vessel calibre vs. simulated velocities in carcinoma
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Figure 5.11. Correlations between cross-sectional surface area (LU^) x-axis and velocity (LU/t) y-axis.
Pcor is the Pearson correlation coefficient. Carcinoma datasets C l-6.
151
Figure 5.12. Scatter-plot o f  vessel calibre vs. simulated velocities in LS147T
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Figure 5.12. Correlations between cross-sectional surface area (LU") x-axis and velocity (LU/t) y-axis.
Pcor is the Pearson correlation coefficient. LS147T datasets L I-3.
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Figure 5.13. Scatter-plot o f  vessel calibre vs. simulated velocities in SW1222
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Figure 5.13. Correlations between cross-sectional surface area (LU^) x-axis and velocity (LU/t) y-axis.
Pcor is the Pearson correlation coefficient. SW1222 datasets S I-6.
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5.6.3 Discussion
Global mean and standard deviation o f the velocity in each simulated fluid domain are 
given in [Figure 5.8]. These values proved to be highly variable across the samples, 
with some samples, particularly o f xenograft tissue, exhibiting a much greater resistance 
to flow than the vasculature o f other tissues.
The lower values for global mean velocity seen in the flow simulations for control 
mucosa may be the result o f a greater quantity o f smaller vessels in this tissue 
(consequently the low vessel calibre/diameters measured in [Chapter 4]), and the same 
is true for LS147T. The greatest surprise was the flow simulations for SW1222 tissue 
which, like LS147T, yielded very low global mean flow velocity. SW1222 vessels 
being larger than those o f the other tissues studied were expected to have higher flow 
velocities, but SW1222 vessels were also more tortuous (see [Chapter 4]), which goes 
some way to explaining this apparent contradiction.
Pearson’s correlation across simulations for each tissue type suggested that the better 
organised tissues o f the control, adenoma and carcinoma conduct flow more freely (thus 
at higher velocities) than the more chaotic vessels o f the xenograft tissues. In the 
control, adenoma and carcinoma where the global velocity is high for a particular 
sample, the correlation between vessel calibre and velocity magnitude is generally also 
high for that tissue type. There were exceptions, most notably in the two xenograft 
tissues, where, simulations L3 and S6 have surprisingly high correlation values but have 
a relatively low global mean velocity; it was not clear why this resulted. This study 
attempted to replicate an observation that correlation between vessel diameter and local 
blood velocity was high in normal tissues but much lower in tumours. Through studies 
o f vascular architectures in [Chapter 4] it was clear that organisation was greater in all 
clinical tissues (control, adenoma and carcinoma) than in the xenografts - with SW1222 
being particularly different to the other tissues studied. This said it would be prudent to 
conduct more detailed studies using a greater number of larger samples in order to 
discount for the local variability in the corrosion casts.
This study represents the first attempt to simulate flows in geometrically accurate 
microvasculature with the view to determining how the local architecture affects the
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flow behaviour. Although many aspects have been simplified for the purpose o f creating 
a viable simulation, this method provides a genuinely new paradigm for study o f 
microvascular flow in a biological context. Building on this, it should be possible to use 
this system to explore clinically important questions, such as the observation by 
Fujimori et al. ([Fujimori et al., 1999]) that blood velocity is higher in adenomas than in 
carcinomas -  such behaviour may well be influenced by the different vascular 
architectures in these tumours.
5.7.1 Method: whole tumour simulations
The final study was carried out to demonstrate how corrosion cast X-ray-tomography in 
conjunction with an LBM model could be used to simulate flow for whole three- 
dimensional tumour vascular systems. This demonstration is an important stepping 
stone in the development o f a platform for investigating drug delivery in a realistic 
vascular model in-silico. For this purpose a xenograft tumour cast (LS147T type) was 
scanned and processed in the same manner as detailed in [Section 4.5.1]. The use of 
xenograft tumour rather than clinical tumour was purely a matter o f convenience as 
these tumours could easily be grown up to specified size for the X-ray tomography 
machine (which as previously indicated has certain size/resolution constraints). The 
roughly spheroid tumour was also delineated from the host tissue by a fibrous capsule, 
and the host vascular system which defined major inlet/outlets to the system could be 
easily identified.
The sample size largely determines the upper limit o f the tomography scan resolution, 
and thus the computational domain o f the simulation. These constraints dictated that the 
whole sample could not exceed ~lcm^. The scan resolution o f  the whole LS147T cast 
was made at 2.4 pm^; due to computational requirements the simulation domain used a 
resolution o f 15.84 pm^, and therefore only accounted for the larger vessels in the 
domain. This restriction was necessary in order that the simulation o f such a large 
volume could be achieved on the UCL Altix within the 48hr time limit (research student 
quota).
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5.7.2 Result: whole tumour vessel simulations
The tumour vessel geometry used in the simulation is shown in [Figure 5.14 (A)]. A 
three-dimensional scatter-plot o f the lower, inter-quartile and upper quartile ranges o f 
velocity are shown in three separate panels [Figure 5.14 (B-D)], and demonstrate the 
spatial distribution o f flow velocities o f different magnitudes. The lower velocity 
regions (first quartile) [mean=0.0213 mm.sec '] are predominantly discontinuous and 
are distributed towards the periphery o f the tumour. This was in keeping with the higher 
hydrostatic resistance o f smaller peripheral vessels in the highly angiogenic edge o f the 
tumour. Regions o f intermediate [mean=0.4 mm.sec '] and high [mean=2.4 mm.sec '] 
velocity on the other hand are restricted to a smaller group o f larger vessels [Figure 5.14 
(D)].
T able 5.3. Mean flow velocity and vessel calibre associated with Figure 5.14
Flow velocity percentile 
ranges
Mean velocity Mean vessel cross-sectional area
0-25 4.74C-6 LU/t 
(0.02 mm.sec ')
41.47 LU^ 
(656.88 mm")
50-75 8.95C-5 LU/t 
(0.4029 mm.sec ')
100.60 LU^ 
(1593.5 mm^)
75-100 5.42e-4 LU/t 
(2.44 mm.sec ’)
165.85 LU" 
(2627.91 mm")
T ab le  5.3. T hree flow  regim es iden tified  in the tum our sim u la tion  [F igure 5.14] w hich corresponds to 
d iffe ren t flow  velocities and vesse l sizes in the tum our.
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Figure 5.14. Whole xenograft blood flow simulation
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F ig u re  5 .14. P ro jec tions o f  a w h o le  L S 147T  flow  sim ulation . (A ) R endering  o f  the vesse l geom etry  
derived  from  the tom ography  da ta se t, (B -D ) show  the m edial axis o f  the v esse ls  w ith  d iffe ren t local m ean  
velocity : (B ) 25 th  percen tile  ran g e  *m m /sec (C ) 50-75percen tile  range (D ) 75-lO O percentile range. 
(S am ple  Res. 15.84pm ^). A xes a re  the th ree spatia l d im ensions.
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5.7.3 Discussion
The vascular periphery o f a xenograft is highly angiogenic and dominated by small 
vessels. In the simulation the distribution o f the first quartile o f velocities (mean 0.02 
mm.sec ') was clearly located in these smaller (mean cross-section 656.88 pm^), 
peripheral vessels [Figure 5.14 (B)]. These low velocity regions are also very 
fragmented as a result of frequent constrictions in the vasculature, which increased the 
local hydrostatic resistance.
The vessel sizes increase as the vascular density declines from the tumour periphery to 
the tumour centre (though not quantitatively studied in the xenografts here, it is evident 
from observations o f  the casts). In these areas with reduced vascular density, numerous 
vessel compressions and elongated vessel segments are observed. The presence o f large 
vessels (mean 2627.91 pm^) which penetrate into the interior o f the tumour register as a 
number o f high velocity (mean 2.44 mm.sec ') conduits o f flow [Figure 5.14 (D)].
The whole tumour vascular model presented here is aimed at demonstrating simulation 
o f flow in a realistic tumour vascular system and this method has substantial advantages 
over all the network flow models discussed in [Chapter 3]. The network flow model 
approach, as a gross simplification o f a vascular network, will not be able to replicate 
the subtle behaviour o f tumour blood flow and hence, tumour growth, drug 
delivery/action or other such physiology function where the vascular system is 
important.
A caveat o f  the simulations used here was in order to simulate the system o f vessels in a 
whole tumour with the available computing resources, it was necessary to lower the 
resolution o f the vessel system and thereby discount the capillary scale vessels. In a 
normal vascular system this omission would present a greater problem as the capillary 
system connects both arterial and venous vessels. Flowever due to the aberrant 
connectivity o f  higher order vessels in the tumour, flow simulations are possible 
through this network. Furthermore, there is little reason why the original data provided 
here should not be used for future higher resolution simulations as the micro-computed 
tomography data included the capillary scale elements o f the xenograft.
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Finally in relation to the further application o f these types o f models, a similar view was 
held by Kohandel et al. in their recent publication on the action o f anti- 
angiogenic/cytotoxic drugs on tumour growth [Kohandel et al., 2007] “a better starting 
point might be to use high-resolution anatomic images o f the vasculature derived either 
from non-invasive imaging or histopathologic examination o f tumor specimens”. With 
this in mind micro-CT/LBM  models may provide an excellent starting point.
5.8 Chapter conclusions
In this chapter a new method for in-silico simulation o f blood flow within a tumour 
microvascular system is demonstrated. The method advances previous vascular models 
by using a morphologically correct three-dimensional vascular architecture in 
conjunction with a lattice-Boltzmann fluid model, in order to compute flow in the 
vascular tissues in tumours and normal vessels. The use o f microcomputed 
tomography/LBM  flow to yield 3D flows in tumour vascular systems is a first, and 
represents a significant advancement on prior systems discussed in [Sections:].2.1 & 
3.2.2] which have typically tried to generate a highly abstracted system o f vessels either 
from ab-initio angiogenesis models [Kohandel et al., 2007;Anderson and Chaplain, 
1998;Chaplain and Anderson, 2004;Stephanou et al., 2004;Alarcon et al., 2004;Alarcon 
et al., 2005] or from simplified two-dimensional image data [Baish and Jain, 1998;Baish 
and Jain, 2000;Baish et al., 1996].
Development of the Lattice Boltzmann simulation
The multiple-outlet boundary problem was solved by using velocity boundary 
conditions at the inlet and open boundary conditions at the outlets o f the vasculature 
near the border o f the domain. To our knowledge this is the first time this has been 
applied. These inlet/outlet conditions used are associated with a mild distortion o f the 
flow field around the inlet and outlet regions. However tests in channel, tube and simple 
bifurcation geometries suggest that the impact o f this distortion was minimal and does 
not distort the bulk o f the flow field; these regions were therefore handled post­
simulation.
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Flow in a symmetric bifurcation
Simulation o f flow in a simple symmetric bifurcation provided a more complex 
geom etry to test the LBM model and boundary conditions. Observation o f the velocity 
and pressure fields suggest that the system behaves as expected.
The symmetric bifurcation also represents the fundamental unit o f most vascular 
systems; using this we were able to show that the preferred branching angles for all 
tissues in the stereo-imaging study occurred over the range which is minimally resistant 
to flow.
Flow in small vessel networks
In order to provide an assessment o f the impact o f flow in each o f the tumour types, a 
comparison o f the velocity field in small sub-volumes o f cast tomography derived from 
the 5 tissues (control, adenoma, carcinoma, LS147T and SW1222) was made. It was 
shown in certain cases that the vascular tissues which demonstrated better hierarchy in 
the organisation o f the vessel elements also showed better correlation between vessel 
calibre (as given by the cross-sectional surface) and the mean velocity at that surface. 
These results suggest some parallel with in-situ observations by other authors. One goal 
o f this study was to identify which xenograft type (LS147T or SW1222) better 
reproduced the simulated flow profiles o f carcinomas. However, the observed level 
variability and the limited number o f tomography datasets that could be acquired in the 
available time have hampered the conclusions in this case.
Flow in a whole tumour
The final simulation successfully demonstrated the application o f  the LBM model to the 
vascular system o f a whole xenograft tumour. The objective here was to demonstrate the 
viability o f such an approach to model flow, where the contribution o f local geometry, 
and topology to flow was derived directly from the information in the original scanned 
vasculature.
The methods described for the derivation o f vascular networks o f whole tumours is 
highly effective, and the data adaptable. It is conceivable that these types o f data could 
be used by other vascular model flow models where more complex schemes are being 
proposed. This could include blood-bom e tracer representative o f  therapeutic agents.
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whose transport was conducted by the lattice-Boltzmann fluid. The quantitative 
differences between the transport properties in normal and tumour tissues could then be 
assessed.
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6.1 Future work
This thesis has prompted many ideas which for reasons o f limited time and resources 
could not be accommodated within the scope o f  the project. It is nevertheless fitting to 
discuss them briefly in this chapter.
6.2.1 Future corrosion casting and tomography work
A key outcome o f the work carried out in this thesis was the generation o f  a detailed 
method for producing tomographic images from corrosion casts o f tumour vessels. As 
demonstrated by the results obtained, the new method is very successful and to our 
knowledge exceeds the highest resolution rendering o f tumour vascular architecture 
reported in the literature. This has opened up many possibilities and interesting 
applications. Over the course o f the project, these images have generated great interest 
from other scientists in the field.
All the corrosion casting work was performed in Germany due to a restriction in our 
site-licence for carrying out this type o f  work. A new licence has since been secured for 
the Department, which will greatly facilitate future casting work and enable more robust 
studies to be carried out using the techniques outlined in [Chapters 4&5].
This study included two colorectal xenografts which represented either end o f the 
pathophysiological spectrum, one being a well differentiated and one a poorly 
differentiated tumour. While interesting similarities and differences between these 
tumours and clinical samples were found, it is now important to extend this study to 
include an extended range o f colorectal models. This will allow us to determine their 
wider importance as pre-clinical models, and their potential use for predicting response 
in clinical trials.
Clinical tumours are also o f  real interest as they represent the ideal basis for any 
vascular model. Although the X-ray micro-computed tomography machines limits the 
size o f whole tumours that can be scanned, patients commonly have smaller polyps in
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the size range o f -1cm . 3D information these smaller clinical tumours would be o f great
value to us and collaborators'®.
6.2.2 A 2-polymer casting strategy to differentially mark venous and 
arterial vessels in tumour corrosion casts
The current method employed for generating this data could be improved further for the 
purposes o f assisting the identification o f inlets and outlets o f the vascular system. Clear 
identification o f veins and arteries was more difficult for the casts as the endothelial 
markings were not always present on the tumour vessels. To assist this in the future, a 
novel method for casting the tumour vascular system with two differentiable polymers 
is proposed here. The system utilises two casting agents, the first is the same M ERCOX 
polymer used previously, and the second is a mixture o f MERCOX and a size- 
controlled microsphere suspension which can easily be identified in the tomography 
data. The first polymer would be perfused systemically (e.g. from aorta to right- 
ventricle for mouse tumours) to identify the venous vessel system. Before this is set, the 
second casting agent is applied to mark the arterial vessels [Figure 6.1], as the 
microspheres are too large to pass through the capillary system.
Size-controlled embolising agents should be formed from a suitable material that is 
differentially radiopaque to the MERCOX polymer, with a minimum size larger than 
the capillary elements (e.g >5-20microns in diameter). Readily available polystyerene 
based microspheres manufactured by Polysciences [Polysciences, 2007], could be used 
for such a purpose.
P ro fesso r M oritz  K o nerd ing , P ro fe sso r E lizabeth  B ullitt in re la tion  to to rtuosity  stud ies in 
m icrovascu la r da tasets [B u llitt e t al., 1999;B ullitt et al., 2003] and D r A llo n s  H oekstra , in re la tion  to 
vascu larised  tum our sim u la tio n s [H oekstra , 2006].
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F igu re  6.1. A method for differentially labelled arterial and venous vascular corrosion 
casts
p2 p1 Aorta Arterioles
Mouse
Capillaries 
10p m
Venules Veins P1
F ig u re  6 .1 . D iffe ren tia lly  labe lled  artery  and  vein  casting  schem e. T he  prim ary  casting  p o lym er P 1 is 
no rm al M E R C O X  and  P2 is a secondary  casting  po lym er con ta in in g  a su spension  o f  m icro spheres (15 - 
20 p m  in  d iam eter) w h ich  can n o t pass th rough  the cap illa ries and so P2 m arks the arteries. T he  p resence  o f  
m ic ro sp h eres  can  easily  be d e tec ted  in the tom ography  data.
6.2.3 Validation of micro-CT segmentation and flow analysis
More sophisticated benchmarks could be made between the cast vessels using stereo- 
imaging and micro-CT to improve confidence in the results. These could include a 
standard test for segmentation accuracy performed using pre-measured samples o f 
MERCOX, under a range o f  imaging settings, mercox densities and sample shapes. 
Calibrations such as this would help further standardise o f the segmentation process.
Flow analysis could be validated in conjunction with new developments in micro-MRl 
machines, which will allow the validation of 3D blood flow models in-situ by analysing 
the flow o f tracer agents through the system over time.
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6.3.1 Computation power
The localised interactions used in the lattice-Boltzmann method means it is readily 
scalable and further development o f this model system for practical application o f whole 
tum our blood flow simulation requires higher resolution grids and high-performance 
computing solutions. W ith the decreasing cost o f  compute-power and improving 
imaging resources, multi-scale in-silico tumour simulations can be realised.
The limitation on com puter time determined the size and resolution o f the simulations 
which could be performed on the UCL Altix parallel computer. Owing to this 
restriction, only lower resolution simulations were possible for the whole tumour. 
Consequently these simulations lacked the finest vessels (capillary scale). The original 
micro-tomography data does however include these finer scale capillary systems, and 
future plans are to use this higher resolution data for flow simulations on a larger 
parallel computing infrastructure, such the grid-scale simulations described by 
Venturoli et a i  [Venturoli et al., 2005].
6.3.2 Extensions of the blood flow model
The main challenge facing any vertical integration project, such as modelling tumour 
blood flow, lies in how the different strata o f the system are incorporated in the global 
model and what is required o f the model. From an experimental perspective, measures 
and studies o f  velocity, pressure, wall shear stress, viscosity and cellular aggregation 
will also be o f importance to the development and validation o f  these models. Currently 
much o f this difficult experimental work and the infrastructure for its dissemination is 
underway in the M icrocirculation Physiome project [Popel et al., 1999;Popel et al., 
1998].
The ultimate goal o f incorporating elements such as blood cells and drug molecules into 
the model is one example o f  how such systems can rapidly grow in complexity. Here 
again lattice-Boltzmann models are attractive. In this area authors such as Ladd [Ladd, 
1994b;Ladd, 1994a] lead the way with work on lattice-Boltzmann colloidal suspensions 
and flows, and many groups are working on how to adapt methods to the application of 
cellular suspensions in blood flow. Typically, larger suspended particle are modelled 
off-grid. Here a particle m ight have a radius encompassing many grid points, and is 
assigned initial translational and rotational components o f velocity. The boundary
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conditions o f  the fluid are then updated at each time-step in accordance with the particle 
velocity, and the change in momentum o f the fluid distribution functions at the 
particle’s surface. It is abundantly clear that this is a hugely challenging problem but 
significant progress has being made on lattice-Boltzmann models which are inclusive o f 
visco-elastic [Lallemand et al., 2003] and colloidal [Ding and Aidun, 2006;Chatter]i and 
Horbach, 2005] [Cates et al., 2004;Hyvaluoma et al., 2005;Dupin et al., 2006;Dupin et 
al., 2007] properties.
Once a suitable method o f modelling the haematocrit is established, it will be possible 
to develop an accurate formulation for the temporal and spatial distribution o f oxygen 
and model its effects in the extravascular environment, particularly in relation to the 
metabolism o f  cellular components, cytotoxic drugs and radio-therapies. Preliminary 
work o f this type was conducted on two-dimensional distributions o f vessels, but many 
aspects o f this are strongly dependent on a reliable three-dimensional model [Dasu et 
al., 2003;Kohandel et al., 2007]. With the availability o f a detailed three-dimensional 
model o f the vascular and avascular spaces, provided by the micro-tomography 
techniques developed in this thesis, progress can now be made in this area.
A further area o f  interest lies in the elucidation o f wall shear-stress in the tumour. This 
has been o f  keen interest in regard to the action o f  anti-vascular drugs, where the action 
o f shear on ‘rounded up ’ endothelial cells may be important to the mechanism o f these 
agents [McDougall et al., 2006]. Shear stress was not discussed in this thesis, but it can 
readily be determined from the velocity field data [Artoli, 2007] generated in our 
studies. The influence o f the vascular architecture on local wall shear stress would be a 
very interesting extension to the current work.
These developments will provide a greater depth o f understanding o f microcirculation 
physiology in both normal and disease states such as tumours, and will assist not only 
with optimising the design o f  therapeutic agents and drug delivery vehicles, but also 
may also offer a way o f  predicting response to treatment for clinical trials.
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Appendix
Appendix 1 
A1.1 - Parameter input file (*.in)
# Input geometry (0=sample,l=surface triangles)
0
# Geometry file
channel_25x25xl01_fIuid_23x23xl01.smp
# Resolution (x y z)
1 1 1
# D e c o m p o s i t i o n  (x y z or file name)
1 1 1
# Maximum number of iterations 
1 0 0 0 0 0
#Relative error for convergence study 
l e - 4
# Flow direction (x=0,y=l,z=2) (must be z for velocity inlet)
2
# Body force # or inlet v e l o c i t y
0 . 0 0 0 2 6 6 6
# Fluid l a y e r s  (or clone layers in positive z face for velocity inlet; 
0
# Domain bound.cond. (0=slip,l=no-slip,2=periodic,
# 3=velocity inlet and free flow outlet)
3
# Fluid-solid bound.cond. (0=SBB,1=L1BB,2=Q1BB,3=MR)
0
# Momentum averaging (O=off,l=on)
0
# Relaxation mode (lin.BGK = 0, BGK = 1 ,
# MMM -  2 ,  MRT = 3)
1
# Relaxation parameters (
# tau for lin.BGK and BGK;
# shear and bulk tau for MMM;
# si,s2,s4,s9,slO,sl6,we,wej, wxx,
# a n d  mean density for MRT)
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# MRT-BGK
# 0 . 2 5  0 . 2 5  0 . 2 5  0 . 2 5  0 . 2 5  0 . 2 5  3 . 0  - 5 . 5  - 0 . 5  1 . 0
# "optimal" MRT
# 1 . 1 9  1 . 4  1 . 2  0 . 4  1 . 4  1 . 9 8  0 . 0  - 7 . 5 4  0 . 0  1 . 0
# MRT-MMM with bgk parameters
# 1 . 0  1 . 0  1 . 0  1 . 0  1 . 0  1 . 0  3 . 0  - 5 . 5  - 0 . 5  1 . 0  
# 1 . 0  1 . 0
1 . 0
# Initial velocity (x y z)
0 . 0  0 . 0  0 . 0
# Initial density of the fluid
1. 0
# Time interval for statistical output 
100
# Time span for permeability averaging
# (or number of time steps for velocity inlet
# averaging, 1 equals to no averaging)
2
# Time step to start IMR 
100
# Time interval for IMR 
50
# Time span for IMR momentum averaging
4
# Characteristic diameter of the system 
2 0 . 0
# Number of velocity outputs after simulation
5
# Time interval for velocity outputs after simulation 
10
# Offset for velocity o u t p u t  domain 
0 0 0
# Domain size for velocity output 
89  89  89
# base file name for output files 
channel_2 5x2 5x101_fluid_2 3x2 3x101
# execution info
Simulation of fluid flow in a channel for the purpose of benchmark 
studies on the Ladds velocity inlet, and Grads Open outlet boundary 
conditions. This tube is a 25x25x101 lattice unit domain, with the
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fluid domain in a square cross section 23x23x101, leaving a single 
node bounding wall around the fluid d o m a i n .
A1.2 - Micro-computed-tomography (*.raw)
Binary RAW file. Voxels are encoded as a sequence of:
(O=void voxel) and (255=fluid voxel)
The void voxels are analogous to the solid phase in the stardust file
A1.3 - Stardust file (*.st)
A simple text encoding of the RAW file as a sequence of:
(l=solid node), (0=fluid node).
A1.4 - Sample file (*.smp)
# Dimensions of the sample (x,y,z)
2 5  25  10 1
# Order of the sample data (lead, median, rear)
# When sample data is traversed, index for the lead
# coordinate grows fastest and index for the rear
# coordinate grows slowest 
0 1 2
# Number of phases or if there are only two phases,
# phase number for the first phase segment 
1
regoaaf@chemd2 01:~ / Simulâtor/NewSIMULATION_FILES/tube> cat 
channel_25x25xl01_fIuid_23x23xl01.smp | more
# Dimensions of the s a m p l e  (x,y,z)
25  25  101
# Order of the sample data (lead, median, rear)
# When sample data is traversed, index for the lead coordinate grows 
#fastest and index for the rear coordinate grows slowest
0 1 2
# Number of phases or if there are only two phases,
# phase number for the first phase segment 
1
# Phase segments and if there are more than two
# phases, index of the phase for each segment
26  
23  
2
23 (...etc)
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Appendix 2 
A2.1 - Simulation results summary file (*.dat)
#Porous 3D simulation parameters
#Input geometry format 
sample
#Geometry file
channel_2 5x2 5xl01_fIuid_2 3x2 3xl01.smp 
#Resolution (x y z)
1 1 1
#Divisions (x y z)
1 1 1
#Decomposition file
#Maximum number of iterations 
1 0 0 0 0 0
#Relative error for convergence study 
0 . 0 0 0 1
#Flow d i r e c t i o n
2
#Body force 
0 . 0 0 0 2 6 6 6
#Fluid layer 
0
#Domain boundary condition 
3
#Fluid-solid boundary condition 
0
^Momentum averaging 
o f f
fRelaxation mode 
1
#Relaxation parameters 
1
#Kinetic viscosity 
0 . 1 6  6 6 67
tinitial velocities (x y z)
0 0 0
#Initial velocity file
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#Initial density of the fluid 
1
#Time interval for statistical output 
100
#Time span for permeability averaging 
2
#Time step to start IMR 
100
#Time interval for IMR 
50
#Time span for IMR momentum averaging 
4
#Characteristic diameter of the s y s t e m  
20
#Base name for output files 
channel_2 5x2 5xl01_fIuid_2 3x2 3xl01 
#Execution info
Simulation of fluid flow in a channel for the p u r p o s e  of benchmark 
studies on the Ladds velocity inlet, and Grads Open outlet boundary 
conditions. This tube is a 25x25x101 lattice unit domain, with the 
fluid domain in a square cross section 23x23x101, leaving a single 
node bounding wall around the fluid d o m a i n .
#Porous 3D sample information
#Fluid nodes in the sample 
5 3 4 2 9
# S a m p l e  p o r o s i t y  
0 . 8 4 6 4
#Specific surface area of the sample 
0 . 1 4 7 2
#Permeability
0
#Tortuosity
0
#Pressure loss coefficient k_0 
0
#Total moment um (including fluid layers)(x y z)
3 . 9 1 8 1 5 e - 1 2  3 . 1 7 7 6 7 e - 1 2  - 1 4 . 2 6 3 6  
tSample moment um (x y z)
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3 . 9 1 8 1 5 e - 1 2  3 . 1 7 7 6 7 e - 1 2  - 1 4 . 2 6 3 6
#Average velocity in the sample (x y z) 
7 . 3 2 7 0 7 e - 1 7  5 . 9 4 2 2 e - 1 7  - 0 . 0 0 0 2 6 6 6 4 2  
#Total mass (including fluid layers)
5 3 4 9 3 . 4  
#Sample mass
5 3 4 9 3 . 4
#Porous 3D simulation information
#Simulation dimensions 
25  25  101  
#Time iterations 
2 9 0 0
#Time spent in the computational kernel (s) 
2 2 4 . 0 0 5
#Simulation date and time 
Sat Sep 1 13:07:37 2007 
#Number of processors involved 
1
#Porous 3D workload information (process 0)
#Number of l a t t i c e  nodes (including ghost layers) 
27 27  1 0 3
#Number of fluid nodes (i n c l u d i n g  g h o s t  layers) 
6 5 3 9 1
A2.2 - Simulation evolution results file (*.evol)
# columns: 1. time step, 2. t o t a l  mass, 3. t o t a l  mom. x-dir, 4. total 
mom. y - d i r , 5. total mom. z-dir, 6. sample mass, 7. sample mom. x - d i r ,  
8. sample mom. y - d i r ,  9. sample mom. z-dir
1 0 0  5 3 4 4 3 . 1  - 5 . 3 0 8 7 4 e - 1 3  7 . 6 1 5 9 6 e - 1 3  - 6 . 0 7 2 3 6  5 3 4 4 3 . 1  - 5 . 3 0 8 7 4 e - 1 3  
7 . 6 1 5 9 6 e - 1 3  - 6 . 0 7 2 3 6
2 0 0  5 3 4 5 6 . 6  - 4 . 2 8 9 8 e - 1 3  1 . 6 4 8 0 6 e - 1 3  - 1 0 . 0 7 1 6  5 3 4 5 6 . 6  - 4 . 2 8 9 8 e - 1 3  
1 . 6 4 8 0 6 e - 1 3  - 1 0 . 0 7 1 6
3 0 0  5 3 4 6 5 . 1  - 2 . 4 3 0 7 6 e - 1 3  - 9 . 7 7 9 6 8 e - 1 4  - 1 0 . 5 8 6 8  5 3 4 6 5 . 1  - 2 . 4 3 0 7 6 e - 1 3  -  
9 . 7 7 9 6 8 e - 1 4  - 1 0 . 5 8 6 8
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4 0 0  5 3 4 7 1 . 5  1 . 1 6 0 6 e - 1 3  3 . 7 8 6 5 5 e - 1 4  - 1 1 . 0 0 6 4  5 3 4 7 1 . 5  1 . 1 6 0 6 e - 1 3  
3 . 7 8 6 5 5 e - 1 4  - 1 1 . 0 0 6 4
5 0 0  5 3 4 7 6 . 5  1 . 2 2 1 3 8 e - 1 3  2 . 8 7 8 7 4 e - 1 3  - 1 1 . 8 4 3 3  5 3 4 7 6 . 5  1 . 2 2 1 3 8 e - 1 3  
2 . 8 7 8 7 4 e - 1 3  - 1 1 . 8 4 3 3
60 0  5 3 4 8 0 . 6  3 . 2 8 2 2 e - 1 3  2 . 6 8 3 5 1 e - 1 3  - 1 2 . 5 0 9 2  5 3 4 8 0 . 6  3 . 2 8 2 2 e - 1 3  
2 . 6 8 3 5 1 e - 1 3  - 1 2 . 5 0 9 2
7 0 0  5 3 4 8 3 . 6  5 . 0 4 6 9 7 e - 1 3  3 . 4 8 2 3 5 e - 1 3  - 1 2 . 9 0 5  5 3 4 8 3 . 6  5 . 0 4 6 9 7 e - 1 3  
3 . 4 8 2 3 5 e - 1 3  - 1 2 . 9 0 5
8 0 0  5 3 4 8 5 . 8  5 . 6 9 8 8 4 e - 1 3  4 . 9 5 1 9 8 e - 1 3  - 1 3 . 2 0 1 7  5 3 4 8 5 . 8  5 . 6 9 8 8 4 e - 1 3  
4 . 9 5 1 9 8 e - 1 3  - 1 3 . 2 0 1 7
90 0  5 3 4 8 7 . 6  6 . 6 7 5 0 4 e - 1 3  7 . 1 5 3 4 1 e - 1 3  - 1 3 . 4 5 3 2  5 3 4 8 7 . 6  6 . 6 7 5 0 4 e - 1 3  
7 . 1 5 3 4 1 e - 1 3  - 1 3 . 4 5 3 2
1 0 0 0  5 3 4 8 9  9 . 3 7 7 9 8 e - 1 3  8 . 7 4 1 4 5 e - 1 3  - 1 3 . 6 4 8 2  5 3 4 8 9  9 . 3 7 7 9 8 e - 1 3  
8 . 7 4 1 4 5 e - 1 3  - 1 3 . 6 4 8 2
1 1 0 0  5 3 4 9 0  9 . 4 4 3 5 2 e - 1 3  1 . 0 3 4 6 6 e - 1 2  - 1 3 . 7 9 2 4  5 3 4 9 0  9 . 4 4 3 5 2 e - 1 3  
1 . 0 3 4 6 6 e - 1 2  - 1 3 . 7 9 2 4
1 2 0 0  5 3 4 9 0 . 8  1 . 3 9 5 6 5 e - 1 2  1 . 4 7 6 1 2 e - 1 2  - 1 3 . 9 0 2 3  5 3 4 9 0 . 8  1 . 3 9 5 6 5 e - 1 2  
1 . 4 7 6 1 2 e - 1 2  - 1 3 . 9 0 2 3
1 3 0 0  5 3 4 9 1 . 4  1 . 7 3 0 2 8 e - 1 2  1 . 4 8 8 4 6 e - 1 2  - 1 3 . 9 8 7 7  5 3 4 9 1 . 4  1 . 7 3 0 2 8 e - 1 2  
1 . 4 8 8 4 6 e - 1 2  - 1 3 . 9 8 7 7
1 4 0 0  5 3 4 9 1 . 9  1 . 8 0 0 3 6 e - 1 2  1 . 5 4 1 1 9 e - 1 2  - 1 4 . 0 5 3 3  5 3 4 9 1 . 9  1 . 8 0 0 3 6 e - 1 2  
1 . 5 4 1 1 9 e - 1 2  - 1 4 . 0 5 3 3
1 5 0 0  5 3 4 9 2 . 2  1 . 9 7 9 0 1 e - 1 2  1 . 5 7 9 2 e - 1 2  - 1 4 . 1 0 3 3  5 3 4 9 2 . 2  1 . 9 7 9 0 1 e - 1 2  
1 . 5 7 9 2 e - 1 2  - 1 4 . 1 0 3 3
1 6 0 0  5 3 4 9 2 . 5  2 . 0 0 4 5 6 e - 1 2  1 . 7 5 1 0 9 e - 1 2  - 1 4 . 1 4 1 6  5 3 4 9 2 . 5  2 . 0 0 4 5 6 e - 1 2  
1 . 7 5 1 0 9 e - 1 2  - 1 4 . 1 4 1 6
1 7 0 0  5 3 4 9 2 . 7  2 . 1 3 5 3 9 e - 1 2  2 . 0 7 5 1 5 e - 1 2  - 1 4 . 1 7 1  5 3 4 9 2 . 7  2 . 1 3 5 3 9 e - 1 2  
2 . 0 7 5 1 5 e - 1 2  - 1 4 . 1 7 1
1 8 0 0  5 3 4 9 2 . 9  2 . 3 4 7 0 2 e - 1 2  1 . 9 9 3 8 6 e - 1 2  - 1 4 . 1 9 3 6  5 3 4 9 2 . 9  2 . 3 4 7 0 2 e - 1 2  
1 . 9 9 3 8 6 e - 1 2  - 1 4 . 1 9 3 6
1 9 0 0  5 3 4 9 3  2 . 3 0 6 8 8 e - 1 2  2 . 1 7 6 3 8 e - 1 2  - 1 4 . 2 1 0 9  5 3 4 9 3  2 . 3 0 6 8 8 e - 1 2  
2 . 1 7 6 3 8 e - 1 2  - 1 4 . 2 1 0 9
2 0 0 0  5 3 4 9 3 . 1  2 . 4 3 8 7 e - 1 2  2 . 1 6 5 4 4 e - 1 2  - 1 4 . 2 2 4 1  5 3 4 9 3 . 1  2 . 4 3 8 7 e - 1 2  
2 . 1 6 5 4 4 e - 1 2  - 1 4 . 2 2 4 1
2 1 0 0  5 3 4 9 3 . 2  2 . 5 5 1 8 4 e - 1 2  2 . 3 4 9 6 8 e - 1 2  - 1 4 . 2 3 4 2  5 3 4 9 3 . 2  2 . 5 5 1 8 4 e - 1 2  
2 . 3 4 9 6 8 e - 1 2  - 1 4 . 2 3 4 2
2 2 0 0  5 3 4 9 3 . 2  2 . 6 1 9 4 6 e - 1 2  2 . 5 7 1 9 9 e - 1 2  - 1 4 . 2 4 2  5 3 4 9 3 . 2  2 . 6 1 9 4 6 e - 1 2  
2 . 5 7 1 9 9 e - 1 2  - 1 4 . 2 4 2
2 3 0 0  5 3 4 9 3 . 3  2 . 8 8 2 6 9 e - 1 2  2 . 8 6 5 5 7 e - 1 2  - 1 4 . 2 4 8  5 3 4 9 3 . 3  2 . 8 8 2 6 9 e - 1 2  
2 . 8 6 5 5 7 e - 1 2  - 1 4 . 2 4 8
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2 4 0 0  5 3 4 9 3 . 3  3 . 1 2 8 0 8 e - 1 2  2 . 9 0 4 5 2 e - 1 2  - 1 4 . 2 5 2 6  5 3 4 9 3 . 3  3 . 1 2 8 0 8 e - 1 2  
2 . 9 0 4 5 2 e - 1 2  - 1 4 . 2 5 2 6
2 5 0 0  5 3 4 9 3 . 3  3 . 2 4 7 4 9 e - 1 2  2 . 9 4 0 7 2 e - 1 2  - 1 4 . 2 5 6 1  5 3 4 9 3 . 3  3 . 2 4 7 4 9 e - 1 2  
2 . 9 4 0 7 2 e - 1 2  - 1 4 . 2 5 6 1
2 6 0 0  5 3 4 9 3 . 3  3 . 4 3 2 0 2 e - 1 2  3 . 0 5 5 2 3 e - 1 2  - 1 4 . 2 5 8 7  5 3 4 9 3 . 3  3 . 4 3 2 0 2 e - 1 2  
3 . 0 5 5 2 3 e - 1 2  - 1 4 . 2 5 8 7
2 7 0 0  5 3 4 9 3 . 3  3 . 6 6 8 0 2 e - 1 2  3 . 1 4 5 5 e - 1 2  - 1 4 . 2 6 0 8  5 3 4 9 3 . 3  3 . 6 6 8 0 2 e - 1 2  
3 . 1 4 5 5 e - 1 2  - 1 4 . 2 6 0 8
2 8 0 0  5 3 4 9 3 . 4  3 . 6 4 0 1 7 e - 1 2  3 . 0 0 0 7 e - 1 2  - 1 4 . 2 6 2 4  5 3 4 9 3 . 4  3 . 6 4 0 1 7 e - 1 2  
3 . 0 0 0 7 e - 1 2  - 1 4 . 2 6 2 4
2 9 0 0  5 3 4 9 3 . 4  3 . 9 1 8 1 5 e - 1 2  3 . 1 7 7 6 7 e - 1 2  - 1 4 . 2 6 3 6  5 3 4 9 3 . 4  3 . 9 1 8 1 5 e - 1 2  
3 . 1 7 7 6 7 e - 1 2  - 1 4 . 2 6 3 6
A2.3 - Simulation fields file (density rand velocity u) (*.fields)
The file is layed out in this format.
positions: [x] [y] [z]) [density] (velocity components: [xv][yv][zv]
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Appendix 3
List of Publications
•  Three-dimensional Analysis o f tumour vascular corrosion casts using Stereo- 
imaging and M icro-computed Tomography. AA Folarin, MA Konerding, J 
Timonen, B, Pedley, S Nagl. American Journal o f Physiology (pending 
publication).
•  Simulation o f  microvascular hydrodynamics using Lattice Boltzmann Method with 
X-ray micro-computed tomography o f tumour vascular corrosion casts, AA Folarin, 
J Timonen, MA Konerding, S Nagl (pending publication).
•  A boundary condition for arbitrary shaped inlets in Lattice-Boltzmann simulations. 
K. Mattila, J. Hyv' aluoma, A. Folarin, T. Rossi. International Journal For 
Numerical Methods In Fluids (Submitted for publication 2008).
• Predicting Response to Radioimmunotherapy from the Tumor M icroenvironment o f 
Colorectal Carcinomas. R. Barbara Pedley, Ethaar El Emir, Uzma Qureshi, Jason
L. J. Dearling, Geoffrey M. Boxer, Innes Clatworthy, Amos A. Folarin, Mathew P. 
Robson, Moritz A. Konerding, Sylvia Nagl, and Richard H. J. Begent. Accepted for 
publication 2007. Cancer Res. 2007 Dec 15;67(24); 11896-905.
•  Conference Publication
o Probability M odel-Based Analysis o f Tumor Vasculature Data Babatunde 
A. O gunnaike', Claudio A. Gelm i', Amos Folarin^, Sylvia Nagl“, and 
Moritz A. Konerding^, The 2005 Annual Meeting (Cincinnati, OH) 
Cincinnati, OH
177
Appendix 4
Glossary of acronyms
A
ADEPT -  Antibody Directed Enzyme Pro-drug Threrapy.
ANOVA -  Analysis o f Variance. A statistical test for comparing the mean values o f 
multiple populations.
B
BC -  Boundary Condition.
BSA -  Bovine Serum Albumin.
c
CCD -  Charged Coupled Device, the light sensitive array used various forms o f digital 
image capture.
D
D3Q19 -  A lattice o f three dimensions associated with 18 velocities and 1 rest velocity. 
This lattice system is one o f a number that satisfies the symmetry requirements o f the 
Lattice Boltzmann Method.
DM -  Distance Metric. A tortuosity metric determined by the ratio o f tortuous distance 
to linear distance made by a path in space.
DNA -  Deoxyribonucleic Acid.
E
EC -  Endothelial Cell.
ECM -  Extracellular Matrix, a collection o f proteins and proteoglycans that occupy the 
space between cells.
ESL -  Endothelial Surface Layer. A layer o f hydrated glycoproteins that lubricate the 
internal surface o f the blood vessel.
F
FPC -  Familial Polyposis Coli, a hereditary condition associated with the formation o f 
multiple colo-rectal polyps.
FGF-2 -  Fibroblast Growth Factor 2.
H
HÏF -  Hypoxia Inducible Factor, the transcription factor associated with regulating 
gene expression at HRE sites.
HRE -  Hypoxia Response Element, a promoter associated with mediating response to 
oxygen deprivation.
178
I
ICIVl -  Inflection Count Metric. A measure o f tortuosity based on the number o f full 
inflections made by a line in space. 
iFP -  Interstitial Fluid Pressure.
L
LBM -  Lattice Boltzmann Method.
LGM -  Lattice Gas Method.
LS147T -  a moderate-to-poorly differentiated xenograft tumour consisting o f solid 
chords o f cells with numerous signet ring forms, a few glandular acini and large 
necrotic regions.
LU -  Lattice Units.
M
MERCOX, Mercox-CL2B -  a epoxy resin with a low viscosity when unset, commonly 
used as a filling agent for casting biological specimens.
MRM -  Magnetic Resonance Microscopy, a high resolution magnetic resolution 
imaging system.
MVD -  M icrovascular Density. A measure relating to the fraction o f space occupied by 
vascular tissue in a whole tissue sample.
R
RBC -  Red Blood Cell.
SEM -  Scanning Electron Microscope.
SOAM -  Sum O f Angles Metric. The integral o f angles made by a tortuous path in 
space relative to the linear distance between start and end points.
SSA -  Specific Surface Area. A measure o f surface area relative to volume.
SW1222 -  a well differentiated xenograft, with extensive vascularisation and noticeable 
structural organisation and morphology.
I
TAF -  Tumour Angiogenesis Factor, a generic reference to agents involved in the 
vascularisation process.
TNM -  tumour, node, metastasis classification system for colorectal cancers. This 
scheme qualifies a tumours progression depending on the extent o f the presence and 
absence o f these traits.
u
ÜCL -  University College London.
VEGF -  A range o f diffusible cytokines associated with promoting vessel growth. 
VCT -  Volume Computed Tomography.
X
X-ray Micro-CT, Micro-CT, (pCT) -  Micro Computed Tomography.
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